The gastric H,K-ATPase: investigations of its structure and function by Uem, T.J.F. van
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/114080
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
The gastric НДС-ATPase: Investigations of its 
structure and function 
Tom J.F. van Uem 

The gastric НДС-ATPase: Investigations of its 
structure and function 
Tom J.F. van Uem 

The gastric НДС-ATPase: Investigations of its 
structure and function 
een wetenschappelijke proeve op het gebied van de 
Natuurwetenschappen 
in het bijzonder de biochemie 
Proefschrift 
ter verkrijging van de graad van doctor 
aan de Katholieke Universiteit Nijmegen, 
volgens het besluit van het College van Decanen 
in het openbaar te verdedigen op 
maandag 27 april 1992 
des namiddags te 1.30 uur precies 
door 
Thomas Johannes Frandscus van Uem 
geboren op 9 april 1962 te Nijmegen 
Promotor: Prof. Dr. JJ.H.H.M. De Pont 
The investigations described in this thesis were carried out at the Department of 
Biochemistry, University of Nijmegen, the Netherlands, under the direction of Prof. 
Dr. JJ.H.H.M. De Pont. Financial support was obtained from the university research 
pool (UOP). 
Financial support for the printing of this thesis was obtained from Astra Phannaceu-
tkaBV. 
Voor Tina, Tim en Jan 
Voor jullie eindeloze liefde, 
geduld en begrip 
DANKWOORD 
Graag wil ik iedereen bedanken, die middels medewerking, adviezen, stimule-
ring en morele steun heeft bijgedragen tot de totstandkoming van dit proefschrift. 
In de eerste plaats gaat mijn dank uit naar de medewerkers van de vakgroep 
Biochemie en van de groep Celfysiologie, met wie ik in de afgelopen jaren op prettige 
wijze heb mogen samenwerken. In het bijzonder betreft dit Herman Swarts, die 
gedurende het laatste anderhalf jaar een groot gedeelte van het experimentele werk 
op vakkundige wijze heeft uitgevoerd en Lieveke de Caluwé, die mij op mijn eerste 
schreden in de wereld van de moleculaire biologie heeft begeleid. 
Mijn erkentelijkheid gaat eveneens uit naar de stagiaires en doctoraalstudenten 
Gerrit van Hall, Patrick van Breugel, Jos Moorman, Alexandra van Vliet en Mariëlle 
de Moei, die met grote inzet hun bijdrage aan dit onderzoek hebben geleverd. 
Ook bedank ik Wilbert Peters en de overige medewerkers van de vakgroep 
Gastroenterologie voor hun hulp bij het aanleren van de techniek voor de produktie 
van monoclonale antilichamen. 
Verder wil ik mijn ouders, familieleden, vrienden en vriendinnen bedanken 
voor de grote belangstelling voor mijn promotieonderzoek. 
Tenslotte wil ik Tina bedanken voor haar geduld en haar nimmer aflatende 
interesse. 
CONTENTS 
Chapter 1: Structure and function of gastnc H,K-ATPase. 
Chapter 2: A monoclonal antibody against pig gastric Η,Κ-ATPase, 
which binds to the cytosolic E, · K* form. 25 
Chapter 3: Determination of the epitope for the inhibitory monoclonal 
antibody 5-B6 on the catalytic subunit of gastric 
Mg2+-dependent H'-transporting and K*-stimulated ATPase. 33 
Chapter 4: Immunochemical studies of gastric Η,Κ-ATPase using 
monoclonal and polyclonal antibodies. 41 
Chapter 5: Effect of free fatty acids and detergents on Η,Κ-ATPase. 
The steady-state ATP phosphorylation level and the 
orientation of the enzyme in membrane preparations. 59 
Chapter 6: Expression of the catalytic subunit of gastric Η,Κ-ATPase 
in insect cells using a baculovirus expression vector. 
A preliminary study. 71 
Chapter 7: General discussion and summary. 81 
Samenvatting 87 
Curriculum vitae 91 

CHAPTER 1 
Structure and function of gastric H,K-ATPase. 
Tom J.F. Van Uem and Jan Joep H.H.M. De Pont 
Department of Biochemistry, University of Nijmegen, 
P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. 
slightly modified from: 
Van Uem, T.J.F. and De Pont, JJ.H.H.M. (1992) Structure and function of gastric H,K-
ATPase. In: Molecular aspects of transport proteins (De Pont, JJ.H.H.M., ed.) Elsevier 
Biomedical Press, Amsterdam, in press. 
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INTRODUCTION 
The secretion of gastric acid by the parietal 
cell in the gastric mucosa is a complex process 
that is regulated by a variety of stimuli, such as 
histamine, gastrin and acetylcholine [1-3]. The 
final link in this process is formed by the gas­
tric, Mg2+-dependent, HMransporting, and K*-
stimulated adenosinetriphosphatase (E.C 
3.6.1.36) (Η,Κ-ATPase), which delivers H + to 
the lumen in exchange for K* by an ATP-
driven catalytic cycle, thereby generating a pH 
gradient of more then 6 units across the secre­
tory membrane [4-6]. Stimulation of the 
parietal cell leads to large morphological 
changes and results both in a translocation of 
Η,Κ-ATPase from the intracellular tubulovesi-
cular membrane system to the apical secretory 
membrane, and in the activation or insertion, 
of K+ and СГ pathways in the secretory mem­
brane of the cell [7-9]. The ATP-driven H+/K+ 
exchange, together with the K* and CI' flux 
from cell to lumen, then results in a net 
hydrochloric acid secretion. 
Gastric Η,Κ-ATPase belongs to the class of 
phosphoen^me-forming ATPases or P-type 
ATPases, which includes the more generally 
distributed Ca-ATPase and Na.K-ATPase 
[10,11]. These ATPases are also called 
E^-type ATPases, since these pumps exist in 
two major conformational states, E, and Ej, 
with different affinities and orientation of 
cation-binding sites. Characteristic for the 
P-type ATPases is a catalytic a-subunit with an 
apparent molecular mass of 100 kDa that is 
phosphoiylated at an aspartyl residue during 
ATP hydrolysis, and the inhibition by micro-
molar concentrations of vanadate. Until re­
cently Na,K-ATPase was the only enzyme of 
this class that was also reported to contain a 
glycosylated ß-subunit. Recently however, it has 
become clear that gastric Η,Κ-ATPase contains 
also, in addition to the catalytic a-subunit, а 
glycosylated ß-subunit [12]. This makes gastric 
Η,Κ-ATPase structurally more closely related 
to Na,K-ATPase than to Ca-ATPase. 
A number of reviews dealing with the phy­
siologic role of Η,Κ-ATPase in acid secretion 
[13,14], the catalytic cycle of Η,Κ-ATPase 
[14,15], the structure of Η,Κ-ATPase [15], 
functional domains of Η,Κ-ATPase [16], the 
preparation of gastric Η,Κ-ATPase [17], the 
ion transport properties of Η,Κ-ATPase prepa­
rations of stimulated and non-stimulated 
parietal cells [7] and Η,Κ-ATPase as a pharma­
cological target [18] have been appeared. 
In this chapter we will review the recent 
investigations of the structure of both a- and 
ß-subunit, and the function of gastric 
Η,Κ-ATPase. We will proceed from a brief 
overview of the tissue distribution to succes­
sively structure, kinetics, transport properties, 
lipid dependency, solubilization and reconstitu­
tion, and inhibitors of Η,Κ-ATPase that may 
label functionally important domains of the 
enzyme. 
TISSUE AND CELL DISTRIBUTION 
Gastric Η,Κ-ATPase has been purified 
from several species, including frog [4], dog [5], 
hog [19], rabbit [20], rat [21] and human [22]. 
The enzyme is unique for the parietal cell in 
the gastric mucosa as has been demonstrated 
by immunocytochemical studies with polyclonal 
and monoclonal antibodies directed against the 
catalytic a-subunit and the recently identified 
ß-subunit of the enzyme [23-25]. A K*-depen-
dent ATP-driven proton pump however, similar 
to gastric Η,Κ-ATPase, appears also to be 
located in the rabbit distal colon [26,27] and 
the rabbit outer medullary collecting duct 
[28-30]. The enzyme and transport activities 
that have been purified and studied in these 
studies were all ouabain-insensitive. In rat and 
guinea pig distal colon an ouabain-sensitive 
ATP-driven H'TK* exchange mechanism has 
also been demonstrated that is not identical 
with either Na,K-ATPase or gastric 
Η,Κ-ATPase [3132]. The fact that these 
colonic and kidney Η,Κ-ATPases are just simi­
lar and not identical with gastric Η,Κ-ATPase 
has been confirmed recently by Northern blot 
analysis of mRNA from a number of rat tissues 
with specific a- and ß-subunit probes, demon-
strating that both subunits are only expressed 
in the stomach [12Д5]. 
STRUCTURE OF ЩС-ATPASE 
The catalytic a-subunit 
In case of Η,Κ-ATPase it appears that the 
catalytic a-subunit is a single protein with an 
apparent molecular mass of around 95 kDa on 
reducing aciylamide gels. The homogeneity of 
the 95 kDa peptide however is a subject of 
dispute. Partial resistance of the 95 kDa 
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peptide against tryptic digestion [33] and the 
generation of three groups of peptides upon 
isoelectric focussing of the 95 kDa peptide [24] 
favored heterogeneity of this subuniL Contrary 
to the results of Saccomani et al. [33], 
Helmich-De Jong et al. [34] found a nearly 
complete trypsin sensitivity of the catalytic 
subunit and therefore suggested homogeneity 
of iL Sedimentation studies, N-terminal amino 
acid analysis and alkylation with citraconic 
anhydride [35] did neither reveal heterogeneity 
of the catalytic subuniL Recently the existence 
of multiple forms of the catalytic subunit was 
also suggested by immunoblotting of pig gastric 
microsomes, yielding signals at M
r
=88 kDa and 
M
r
=94 kDa [36], and by cell free translation of 
rabbit gastric mucosal messenger RNA, resul­
ting In immunoprecipitable polypeptides with 
apparent molecular masses between 88 kDa 
and 94 kDa [37]. In the latter study it was con­
cluded that co- or posttranslational modifica­
tions and proteolytic activity could not be the 
cause for the observed heterogeneity. Contrary 
to NaJC-ATPase however, which has three 
isoforms of the catalytic a-subunit [38,39], so 
far only a single a-subunit of НДС-ATPase has 
been identified by molecular cloning [40-42]. 
The catalytic subunlt of rat, pig, and 
human H.K-ATPase has a molecular mass of 
114 kDa in each case and comprises 1034 or 
1035 amino acid residues [40-42]. The predic­
ted porcine amino acid sequence corresponds 
to the N-terminal 17 amino acid sequence 
identified by Lane et al. [43]. The interspecies 
homology is 98%, whereas the overall amino 
acid homology with the sheep kidney 
NaJC-ATPase catalytic subunit is 62% [44]. 
Moreover, the Η,Κ-ATPase gene also shows a 
great similarity to the NaJC-ATPase gene in 
exon/intron organization [42,45], indicating that 
these two ATPases derived from a common 
ancestral ATPase. The regions of greatest 
homology between the Η,Κ-ATPase and 
Na,K-ATPase catalytic subunit appear around 
the phosphorylation site at Asp586 (numbering 
refers to the porcine sequence) [46], the puta­
tive ATP-binding region that includes the 
pyridoxal phosphate reactive site Lys*" [47,48] 
and the fluorescein-5-ísothiocyanate (FITC) 
reactive site Lys518 [49,50], as well as a region 
between residue 157 and 300, which has been 
proposed as part of a energy transduction 
region [40,44]. 
Information about the putative folding of 
the Η,Κ-ATPase catalytic subunit through the 
membrane has been obtained by the combined 
use of hydropathy analysis according to the 
criteria of Kyte and Doolittle [51], identifica­
tion of sites sensitive to chemical modification 
[46,48,50,52-55], and localization of epitopes of 
monoclonal antibodies [56]. The model of the 
НДС-ATPase catalytic subunit (Fig. 1) that has 
emerged from these studies shows ten trans­
membrane segments and contains cytosolic N-
and C-termini [53]. This secondaiy structure of 
the catalytic subunit is probably a common 
feature of the catalytic subunits of P-type 
ATPases, since evidence supporting a 10 
α-helical model with cytosolic N- and C-termini 
has also been published recently for both 
Ca-ATPase of the sarcoplasmic reticulum and 
Na^ C-ATPase [57-59]. 
Hydropathy analysis predicted that there 
are four major transmembrane domains 
(M1-M4) prior to the phosphorylation site at 
Asp1". The existence of these four transmem­
brane segments in the N-terminal half of the 
catalytic subunit is generally accepted for all 
P-type ATPases. The four transmembrane 
sequences are followed by a large cytosolic 
loop that contains the phosphorylation site 
Asp3", the pyridoxal phosphate site Lys'"7 and 
the FITC site Lys5". These residues are sug­
gested to be located at or near the catalytic 
ATP-binding site. Besides the latter two sites 
the predicted cytosolic loop contains also Cys*75 
and Lys™, which corresponding amino add 
residues in NaJC-ATPase can be modified by 
the ATP-site directed probe fluorosulfonyl-
benzoyl adenosine (FSBA) [60]. Although it в 
generally presumed that this loop has a cyto­
solic disposition, the possibility that part of the 
cytosolic loop between M4 and M5 is mem­
brane inserted has been proposed recently after 
demonstrating that one of three potential 
N-linked glycosylation sites at residues 225, 493 
and 730, namely Asn"3, contains N-linked car­
bohydrate [61,62]. Electron microscopy of 
inside-out-oriented gastric vesicles indicated 
that the majority of this oligosaccharide moiety 
is at the extracellular side [62]. Two extra 
membrane-spanning segments between M4 and 
M5 however, leading to an extracellular loca­
tion of the oligosaccharide moiety at Asn*0, do 
not fit with the observed solubility of proteo­
lytic fragments of Η,Κ-ATPase that contain the 
phosphorylation site, the FTTC-binding site, 
and the carbohydrate moiety at Asn4* [61,63]. 
Hall et aL [62] attempted to explain the 
luminal disposition of Asnm by interaction of 
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Fig. 1. Model for the possible bansnicmbranous organization of the poiane НД-ATPase oB-protomer, 
based on sequence information [40,41] 
The a-subunit is modeled with 10 transmembrane segments (Ml-MIO) and shows the following 
identified amino acid residues (bold): D386, the phosphorylation site [46]; KS18, the FTTC-reactive site 
[50]; K497, the pyridoxal phosphate reactive site [48]; C823 and C893, the omeprazole reactive sites 
[52]; Q105 to K172, the mDAZIP-labelled (an analog of SCH 28080) fragment [55]; N493, the carbo­
hydrate containing residue [62]. Potential N-glycosylation sites at N225 and N730 [41], potential sites 
of phosphorylation by cAMP-dependent protein kinase at S363 and S953 [41], and the amino acid 
residues C673 and K736, corresponding to FSBA-reactive residues in Na,K-ATPase [60], are also 
shown. The ß-subunit shows 6 potential N-glycosylation sites and 6 conserved cysteine residues that 
form the three disulfide bonds of the Na.K-ATPase ß-subunit [83,84]. 
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part of the cytosolic domain between M4 and 
M5 with the hydrophobic membrane-spanning 
peptides. This hypothesis however, does not fit 
well with the presence of the pyridoxal phos­
phate and FTTC-reactive sites at residues 497 
and 518 that would leave insufficient distance 
for a membrane-spanning segment, comprising 
about 20 amino acid residues. A cytosolic as­
signment of the glycosylated amino acid residue 
however, which is contradictory to the current 
models of glycosylation of membrane-bound 
proteins, might be possible since it has been 
demonstrated recently that the Na.K-ATPase 
catalytic subunit does contain N-linked carbo­
hydrate moieties located at the cytosolic face of 
the cell membrane [64]. 
The transmembrane organization after the 
large cytosolic domain is uncertain and hydro-
phobicity plots predicted up to six additional 
transmembrane segments [40,41,65]. At the end 
of the large cytosolic domain there is a hydro­
phobic domain that is long enough to contain 
two transmembrane segments. On basis of the 
recently suggested binding sites Cys823 and 
Cys*" of the luminal-acting inhibitor omepra­
zole [52], it is very probably that there are 
indeed two transmembrane passages, M5 and 
M6, in this region, i.e. from residue 797 to 820 
and from residue 824 to 844 [40]. Hydrophibi-
city analysis revealed that another four putative 
transmembrane segments, M7 to MIO, probably 
span between residues 859 and 884, 923 and 
942, 964 and 989 and 991 and 1020 [40,65]. 
This 10 α-helical model for the structure of the 
HJC-ATPase catalytic subunit would account 
for a luminal localization of the omeprazole-la-
belled residues Cys"0 and Cys"3 [52] and for 
the cytoplasmic C-terminus [53]. Moreover, 
this model would also fit with a cytosolic dis­
position of two potential sites of phosphory­
lation by cAMP-dependent protein kinase at 
residues 363 and 953 in case these sites are 
functional regulatory sites [41]. 
Theß-subunil 
Until recently, the possibility that 
Η,Κ-ATPase consists besides of a catalytic 
a-subunit also of other subunits was not 
examined. This was mainly due to the bet that 
SDS-PAGE of purified gastric Η,Κ-ATPase 
preparations principally gave one protein band 
with an apparent molecular mass of about 100 
kDa, which was reported to comprise 75% or 
more of the total amount of protein [6,66,67]. 
This mass is lower than the mass deduced from 
its cloned cDNA [40], but may be due to the 
higher electrophoretic mobility of membrane-
bound proteins, as consequence of having rela­
tively high contents of hydrophobic amino acid 
residues [68]. 
One of the first observations suggesting 
that the functional unit of Η,Κ-ATPase is not 
a monomer of the catalytic subunit, but instead 
a heterodimer of the catalytic subunit and 
another protein, was made with radiation inac-
tivation studies of frozen Η,Κ-ATPase [69]. It 
was demonstrated that the Mg-ATP-dependent 
formation of a beta-aspartyl phosphate ex­
hibited a target size of 133-147 kDa and that 
the target size of the protein migrating on 
SDS-polyacrylamide gels at 94 kDa was 92-143 
kDa. This was clearly larger than a monomer 
and clearly smaller than a dimer of the cata­
lytic subuniL 
Further indications for an additional sub-
unit were provided by a crosslinking analysis of 
CttE, solubilized Η,Κ-ATPase, which exhibited 
ATPase and phosphatase activities, and ligand 
affinities comparable to the native enzyme [70]. 
Glutaraldehyde treatment of soluble protein 
fractions resolved on a linear glycerol gradient, 
revealed no active fraction enriched in mono­
melic (Μ,=94 kDa) НДС-ATPase. Instead, 
K*-ATPase activity was only obtained in frac­
tions enriched in particles of M,=175 kDa. 
This size also suggested that the functional 
Η,Κ-ATPase unit is a heterodimer of a cata­
lytic subunit and an additional subunit, since 
the apparent molecular mass of 175 kDa is 
probably too small to be a homodimer of the 
catalytic subunit. 
Several groups then independently pro­
vided evidence for the existence of an exten­
sively glycosylated B-subunit of gastric 
НДС-ATPase that has an apparent molecular 
mass of 60-90 kDa. Okamoto et ai [71] used 
wheat germ agglutinin affinity column chroma­
tography and immunoprecipitation procedures 
to demonstrate that the catalytic subunit of 
porcine Η,Κ-ATPase is tightly associated with 
a glycoprotein of 60-80 kDa. This noncovalent 
association was confirmed by co-purification of 
the 60-80 kDa transmembrane glycoprotein in 
case of performing a purification of 
НДС-ATPase by a modified J^rgensen SDS-
extractkm procedure [72]. This co-purification 
of a glycoprotein was also observed before by 
Nandi et al. [73]. Deglycosylation of this 60-80 
kDa glycoprotein by endoglycosidase F 
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revealed that it had five asparagine-linked 
oligosaccharide chains and an apparent core 
molecular mass of 32 kDa, which was approxi­
mately the same size as that of the 
Na,K-ATPase B-subunit. As in case of 
Na.K-ATPase, densitometric scans of SDS-gels 
of purified gastric Η,Κ-ATPase revealed an 
approximate stoichiometric ratio of 1:1 for the 
catalytic a-subunit/60-80 kDa glycoprotein. 
Hall et al. [63] identified in a separate 
study the same glycoprotein in Η,Κ-ATPase 
vesicles isolated (тот porcine gastric mucosa. 
A stoichiometric ratio of 1.2:1.0 was found for 
the deglycosylated protein (35 kDa)/catalytic 94 
kDa protein. Furthermore, compelling evidence 
that this glycoprotein is the Η,Κ-ATPase 
B-subunit was provided by N-terminal sequence 
analysis of three protease V8-obtained peptides 
of the 35 kDa core protein. These peptides 
showed 30% and 45% homology with the 
Na,K-ATPase Bl- and fl2-subunit respectively. 
With the use of oligonucleotide probes 
based on the amino acid sequences of these 
protease V8-obtained peptides and of cyanogen 
bromide fragments of the porcine Η,Κ-ATPase 
B-subunit, cDNA clones for the rat [12,25] and 
rabbit [74] Η,Κ-ATPase B-subunit were then 
isolated. 
In parallel with these studies it was 
reported that, besides the Η,Κ-ATPase α-sub-
unit [75], a 60-90 kDa glycoprotein is one of 
the main parietal cell antigens associated with 
autoimmune gastritis and pernicious anemia 
[76]. This 60-90 kDa antigen showed to be a 
conserved molecule, comprising a 34 kDa core 
protein extensively glycosylated with N-linked 
oligosaccharides. By analogy with the approach 
of cDNA cloning of the rat and the rabbit 
Η,Κ-ATPase B-subunit, the cDNA encoding 
the porcine Η,Κ-ATPase B-subunit was then 
isolated [77]. 
The B-subunits from rat [12Д5], pig [77] 
and rabbit [74] have a molecular weight of 
about 33 kDa and comprise 290 to 294 amino 
acid residues. With 82% interspecies homology, 
the B-subunit is not as well conserved as the 
a-subunit, having 98% interspecies homology. 
Also the homology with the Na.K-ATPase 
В1-subunit [78-80] and B2-subunit [81,82], 
being 33% and 42% respectively, is much lower 
than the homology between the Η,Κ-ATPase 
and Na,K-ATPase a-subunits. The hydropathy 
profile predicts that the Η,Κ-ATPase B-subunit 
contains a short polar cytoplasmic amino ter­
minus followed by a single membrane-spanning 
segment and an extensive extracellular region 
including 6 or 7 potential N-glycosylation sites. 
Two of these sites (residues 161 and 193) are 
conserved relative to the predicted N-linked 
glycosylation sites of the Na,K-ATPase Bl-sub-
unit and B2-subunit, which have 3 and 8 to 9 
potential sites respectively. It is likely that 
most of the potential glycosylation sites have 
carbohydrate attached, since four or five degly­
cosylated products were observed during 
enzymatic deglycosylation of the porcine 
Η,Κ-ATPase B-subunit [71,76]. There are 6 
cysteine residues in the presumed extracellular 
domain that are highly conserved between the 
Η,Κ-ATPase B-subunit and the Na.K-ATPase 
Bl- and B2-subunlts. These cysteine residues in 
the Na,K-ATPase Dl-subunit have been 
demonstrated to form three disulfide linkages 
[83,84]. Hence, it is assumable that the 
Η,Κ-ATPase B-subunit also contains three 
disulfide bonds that are similar to those of the 
Na,K-ATPase Bl-subunit. In summary, these 
structural similarities strongly indicate that 
besides the Η,Κ-ATPase and Na,K-ATPase 
O-subunits, the Η,Κ-ATPase and Na,K-ATPase 
B-subunits also derived from a common ances­
tral ATPase. 
The identification of the Η,Κ-ATPase 
B-subunit raises important questions regarding 
the functional significance of this subunit. By 
analogy with the until now identified function 
of the Na,K-ATPase B-subunit [85], a possible 
function of the Η,Κ-ATPase B-subunit could be 
a stabilization of the a-subunit during biogene­
sis, subsequently leading to a functional 
enzyme in the plasma membrane. The highly 
conserved C-terminus of the Η,Κ-ATPase 
B-subunit (95% for the last 20 amino acid resi­
dues) could play a role in exerting this function 
as has been demonstrated for Na,K-ATPase 
recently. Expression of deletion mutants of the 
Na,K-ATPase B-subunit revealed that deletion 
of as few as 11 amino acid residues from the 
C-terminus of the B-subunit results in a mole­
cule that does not appear to assemble with the 
Na,K-ATPase a-subunit [86]. However, trans-
fection of polarized Madin Darby Canine Kid­
ney (MDCK) cells with a cDNA encoding the 
rat Η,Κ-ATPase a-subunit resulted in the 
арреагепсе of the apparently complete a-sub­
unit in the apical membrane of the stably 
transfected cells [87]. Nevertheless, it is pos­
sible that the Η,Κ-ATPase B-subunit is not 
necessary for plasma membrane insertion of 
the Η,Κ-ATPase a-subunit, since the stabilizing 
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role of the НД-ATPase ß-subunit might be 
taken over by the endogenous NaJC-ATPase 
D-subunit of these cells. If the protein that is 
expressed is these cells is functional is not 
known. One important conclusion that can be 
drawn from these transfection experiments is 
that putative determinants involved in targeting 
Η,Κ-ATPase and NaJC-ATPase to their proper 
membrane destinations are not located on their 
respective B-subunits. 
Molecular organization 
The recent identification of the 
Η,Κ-ATPase B-subunit and the demonstration 
that the ratio for the HJC-ATPase catalytic 
Ot-subunit/B-subunit is about 1:1 [62,71] might 
bring new insight into the structural and func­
tional assembly of Η,Κ-ATPase in situ. 
Earlier work using radiation inactivation 
analysis of frozen Η,Κ-ATPase has revealed 
that the target size for the K^-ATPase activity 
ranges from 232 kDa to 270 kDa [69,88]. In 
lyophilized samples however, a target size of 
444 kDa was found for this enzyme activity 
[89]. In all of these irradiation studies a 
smaller target size was measured for the 
K*-p-nitrophenylphosphatase (K*-pNPPase) 
activity. For the phosphoenzyme formation and 
for the destruction of the catalytic subunit 
Rabon et al. [69] measured target sizes of 
133-147 kDa and 92-143 kDa respectively. 
With the use of reconstituted Η,Κ-ATPase 
these authors obtained for the passive Rb* 
exchange and for H* transport target sizes of 
233 kDa and 388 kDa respectively. 
A glutaraldehyde crosslinking analysis of 
CI2E, solubilized Η,Κ-ATPase revealed that 
only particles of N^=175 kDa exhibited 
K*-ATPase activity [70]. This size suggests that 
the functional Η,Κ-ATPase unit is a hetero-
dimer of the catalytic a-subunit and the B-sub­
unit, since the molecular mass of 175 kDa is 
probably too small to be a homodimer of the 
catalytic subunit 
Soumarmon et al. [90,91] determined in an 
octylglycoside solubilized Η,Κ-ATPase prepara­
tion by gelRltration and glycerol gradient cen-
trifugation molecular masses between 390 kDa 
and 420 kDa for the holomeric enzyme. 
Thus the picture that emerges at this point 
is that in the membrane probably a diproto-
meric (aB)2 structure (a is 114 kDa, В is 60-80 
kDa) is responsible for the active transport 
process. On the other hand the minimal struc­
ture for K+-ATPase activity, K*-pNPPase acti­
vity, passive transport and phosphorylation is 
either an aß-protomer or another larger oligo-
meric structure. 
Conformations ofHJC-ATPase 
The widely accepted model, how the class 
of P-type ATPases transports Ions across the 
membrane, starts from the existence of two 
enzyme conformations called E, and E^ which 
have different affinities for the ions to be 
transported. Generally, E, represents the con-
formation that has high affinity for ions at the 
cytoplasmic side and Ej is the conformation 
with high-affinity ion-binding sites at the extra-
cellular side. In case of НДС-ATPase the exis­
tence of these two conformations has been 
demonstrated by several indirect and direct 
approaches. 
The existence of the Ej and Ej states of the 
phosphorylated protein, i.e. the high- and 
low-energy phosphoenzyme intermediate, has 
been demonstrated by the ATP/ADP exchange 
reaction [92,93] and by the "O exchange 
between inorganic phosphate and water [94]. 
Indirect evidence for the existence of dif­
ferent conformations of Η,Κ-ATPase has been 
gained by site-selective reagents. For example, 
Schrijen et aL [67,95] demonstrated that Mg2* 
increased exposure of an essential arginine 
residue near the ATP-binding site and Mg2* 
caused an increase in the number of reactive 
sulfhydryl groups on the enzyme. 
A direct prove for different conformational 
states of Η,Κ-ATPase has been provided by 
limited trypsin digestion of Η,Κ-ATPase as the 
primary cleavage sites showed to be confor-
mationally dependent [34]. In the ATP-depen-
dent E! conformation proteolytic digestion 
gave peptide fragments of M
r
=67 kDa and 35 
kDa, whereas in the K*-dependent E; confor­
mation fragments of M
r
=42 kDa and 56 kDa 
were obtained. Both the 67 kDa and 42 kDa 
peptide fragments contained the residue Asp386 
that is phosphorylated during ATP hydrolysis. 
The existence of a putative third conformation 
was demonstrated by tryptic digestion in the 
presence of Mg2*, revealing a digestion pattern 
unlike ATP or K\ Recently it has been 
demonstrated that the tiyptic-cleavage sites for 
the E, pattern are at Lys47 and probably at 
Lys*68, while the tryptic-cleavage site for the E2 
pattern is at Arg455 [56]. 
With the aid of three different fluorescent 
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reporter groups attempts to observe confor­
mational changes directly within or near the 
nucleotide domain have been reported. Jackson 
et al. [49] demonstrated that covalent labelling 
of Η,Κ-ATPase with fluorescein isothiocyanate 
(FTTC) inhibited the K*-ATPase activity while 
largely sparing the associated K*-pNPPa&e 
activity. The inhibition of the former activity 
was prevented by ATP suggesting that the 
ligand binds at or near to the ATP-binding 
site. Saturation of the high-affinity luminal K* 
site or binding of vanadate in the presence of 
Mg1* induced a low fluorescence state that was 
defined as the Ει conformation. Rabon et aL 
[96] have shown recently that Na* ions 
reversed the K*-induced fluorescence quench 
and somewhat enhanced fluorescence in the 
absence of K* ions, demonstrating that under 
that condition about 70% of Η,Κ-ATPase 
resides in the E, conformation. The apparent 
affinity of the Na* ions for the high fluores­
cence E, conformation increased upon eleva­
tion of pH, which is consistent with compe­
tition between protons and Na* ions. 
Conformational changes within or near the 
ATP-binding site of Η,Κ-ATPase have also 
been demonstrated with the reversible fluores­
cent probes TNP-ATP [97,98] and eosin [99]. 
TNP-ATP binding to ЦК-ATPase enhanced 
the fluorescence fivefold and was suggested to 
be due to binding to a hydrophobic region of 
the protein. K* ions caused a rapid fluores­
cence quench, while Mg2* rapidly and com­
pletely reversed the K* quench and then 
caused a slow fluorescence quench. This fluo­
rescence quench induced by K* and Mg2* was 
caused by a change in the enhancement factor 
of bound fluorophore and was not due to a 
change in the amount of bound fluorophore. 
These cofactor-induced fluorescence quenches 
could be explained by assuming three different 
conformational states, which relationship to E, 
and Ej was not established. 
Contrary to the observations with 
TNP-ATP however, Mg2* enhanced eosin fluo­
rescence, whereas K* ions decreased the fluo­
rescence enhancement of Mg2* and caused a 
fluorescence quench in absence of added ions 
[99]. The fluorescence enhancement caused by 
Mg was explained by an increase in the num­
ber of eosin-binding sites. Faller [98] on the 
other hand, has tempted this explanation and 
argued that only an increase in enhancement 
factor (i.e. movement of the fluorophore to a 
more hydrophobic region of the protein) ex­
plains the Mg2* induced fluorescence increase. 
Recently Rabon et al. [100] reported on a 
new conformational probe of Η,Κ-ATPase. 
This fluorescent quinoline derivative MDPQ 
showed to be a reversible luminal K*-site inhi­
bitor of both K*-ATPase and K*-pNPPase 
activity. High-affinity MgATP binding induced 
a conformational change with fluorophore 
movement into a more hydrophobic environ-
ment. 
The conformational changes so far 
described are probably all relatively small local 
changes In the structure of ЩС-ATPase. This 
has been confirmed by Mitchell et aL [101] 
who demonstrated by Fourier transform infra­
red spectroscopy that a gross change in the 
protein secundary structure does not occur 
upon a conformational change from E, to Ej. 
Circular dichroism measurements however 
[102,103], indicated an increase in alpha helical 
structure upon addition of ATP to 
Η,Κ-ATPase in the presence of Mg2* and K*. 
HNETICS OF HK-ATTASE 
Overall reaction 
Gastric Η,Κ-ATPase catalyses the 1:1 ex­
change of H* for K* upon hydrolysis of ATP, 
which results in vivo in a pH difierenoe of 
more than 6 between the cytoplasm and the 
lumen [4-6]. Several reaction schemes have 
been developed to account for the hydrolysis of 
ATP and the transport of H* and K* 
[14,104-107]. The basis of all these schemes is 
the Albers-Post scheme originally postulated 
for the mechanism of anion of Na,K-ATPase 
[108,109]. 
The scheme in Fig. 2 describes the various 
reactions of Η,Κ-ATPase. In this scheme, 
which requires several steps related to binding 
of substrate and cationic ligands, E, and Ej 
represent conformations of the enzyme with 
high-affinity cation-binding sites facing the 
cytoplasm and the lumen respectively. Phos-
phoenzyme forms are represented as Ε-P in 
case of covalent bound phosphate, and E · Ρ in 
case of bound phosphate. The existence of the 
latter form has been established by measure-
menu of "O exchange between P, and H20 
[94]. The scheme accounts for the sequential 
transport of 2 H* ions from the cytoplasm to 
the lumen and for the transport of 2K* ions in 
the opposite direction [110-112]. 
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Flg. 2. Ej-Ej reaction cycle of НДС-ATPase, aooonting for the transport of two H* and two K* iras 
per molecole of ATP hydrolysed 
The ATPase reaction proceeds from 2Η·Ε 1 ·ΑΤΡ through гН-Е,-? and 2Η·Ε2-Ρ to гК'Е,. Details 
of the reaction cycle are described in the text 
The reaction starts with the binding of 
ATP to the H+ liganded form of the enzyme, 
2H · E,. In the presence of K*, this binding is 
to the К''-liganded enzyme form, Ζ Κ Έ , or 
2K»Ej, or to an occluded form between these 
two forms. The existence of such an occluded 
form has not yet been demonstrated, but its 
detection with filtration or column techniques 
similar to those used previously to measure 
occluded transported cations for Na.K-ATPa&e 
[113] will be very difficult, because of the rapid 
dissociation of K4 from the enzyme [96]. 
Subsequent binding of Mg2* to 2 Η Έ , then 
leads to phosphorylation at an aspartyl residue 
[46,114]. The major phosphoenzyme then 
formed is a K* -sensitive intermediate 
(2H · EyP), whereas a minor part (20%) exists 
as an ADP-sensitive intermediate (ΖΗ'Ε,-Ρ) 
[92,93]. With the conformational change from 
г Н ' Е г Р to гН'Ег-Р the transport of two 
protons from the cytoplasm to the lumen very 
probably occcurs [115]. The next step is the 
displacement at the luminal side of 2 H* ions 
and the subsequent binding of 2 K* ions, which 
then leads to a rapid biphasically dephospho-
lylation of the phosphoenzyme I K ' E ^ P to 
ІК-Ег [104,105]. Finally, the conformational 
change from 2Κ·Ε 2 to 2Κ·Ε„ which reflects 
the transport of 2 K* ions from the luminal to 
cytoplasmic side, completes the transport cycle. 
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This step in the reaction cycle of H,K-ATPase 
has been studied in both native and reconstitu­
ted gastric vesicles as а Κ+/Κ* exchange reac­
tion, using "Rb in lieu of K* as a tracer 
[116-118]. Contrary to Na.K-ATPase [119,120], 
the rate of K+/K* exchange by Η,Κ-ATPase is 
not stimulated by ATP or ADP, and is nearly 
equivalent to the overall rate of hydrolysis. 
This also indicates, as mentioned before, that a 
rate-limiting K* occlusion as defined for 
Na,K-ATPase [121] is not very probably to 
occur. 
Phosphorylation from ATP 
In the presence of Mg2 + gastric 
Η,Κ-ATPase can be phosphorylated by ATP at 
aspartyl residue 386 [46,114]. The mixed-anhy­
dride that is formed, is acid-stable and 
hydroxylamine-sensitive [122]. The initial step 
is the reversible binding of ATP to the protein 
with a pseudo first-order rate constant, in the 
absence of K* and at pH 7.4, of 1400 min"1. 
This is followed by a Mg^-dependent transfer 
of the terminal phosphate of ATP to the cata­
lytic a-subunit with a rate constant of 4400 
min"1 [114]. Increasing H + concentrations on 
the cytoplasmic side accelerate the phosphory­
lation rate, whereas increasing K* concentra­
tions on this side inhibit the phosphorylation 
rate [104-106,123]. Normally, the rate of forma­
tion of phosphoenzyme greatly exceeds the 
overall room temperature rate constant of 
about 200 min', but at high KVATP ratios the 
displacement of K* from the cytoplasmic side 
of the enzyme by ATP becomes rate-limiting 
for overall ATP hydrolysis [104]. 
Recently it has been established by substi­
tution of Mg2* by CaI+ that, prior to phospho­
rylation, the divalent cation binds at a cytosolic 
site with a stoichiometry of about 1 mol per 
phosphorylation site [124,125]. These experi­
ments demonstrated also that the phosphory­
lation rate is sensitive to the nature of the 
divalent cation bound. With Mg2* bound, the 
phosphorylation rate is about 20 times faster 
than with Ca2* bound. The divalent cation 
dissociates after dephosphorylation, suggesting 
that it is tightly bound to the phosphoenzyme 
during the reaction cycle. It was also demon­
strated that the type of divalent cation that 
occupies the divalent cation site required for 
phosphorylation is important for the step 
2K-EJ-P to гК-Ег'Р to гК-Е, [124,125]. 
With Mg2* bound, the 2К«Ег-Р conformer is 
K*-sensitive, whereas with Ca2* bound, the 
intermediate is K*-insensitive. 
A subject of discussion is the maximal 
phosphorylation capacity of Η,Κ-ATPase that 
reaches a maximum of 1.5 nmol.mg"1 [104,126]. 
Under the conditions used for the determina­
tion of the phosphoenzyme intermediate, the 
rate of phosphorylation is more than 100 times 
that of dephosphorylation [104], so that the 
phosphorylation capacity can be used as an 
index of the number of functional pumps pre­
sent With a protein correction factor of 1.42 
[127] this maximal phosphorylation capacity 
increases to 2.1 nmol.mg"1, which corresponds 
to 0.3 phosphorylation site per Η,Κ-ATPase 
aB-protomer (147 ГОа). This value suggests 
that a large fraction of the enzyme is either in­
active or that only a fraction of the sites may 
be phosphorylated at any one time. Recently 
however, phosphorylation capacities of 2.1 and 
2.8 nmol.mg"1 have been measured [125,128]. 
The latter value is obtained in the presence of 
the nonionic detergent СцЕ, and correponds to 
almost 0.6 phosphorylation site per αθ-proto-
mer, suggesting that each Η,Κ-ATPase o-sub-
unit can be phosphorylated at the same time. 
Characteristics of ATP hydrolysis 
Gastric Η,Κ-ATPase catalyses the hydro­
lysis of ATP in the presence of Mg2* and K*. 
This K*-ATPase activity of the enzyme has a 
high specificity for ATP. Compared to ATP, 
the K*-stimuIated hydrolysis of GTP, CTP and 
ADP occurs at a rate of only 12, 15 and 0.7%, 
whereas ITP and ß,J -methylene ATP are not 
hydrolysed at all [6]. For the stimulation of the 
ATPase activity various cations can act as K* 
surrogates with the following order of affinity: 
Ή* > K* > Rb* > N H / > Cs+ > > Na*. U* 
[6,67,122]. 
Steady state kinetics demonstrated that K* 
affects biphasically the K*-ATPase activity 
[104,106]. Low concentrations of K* stimulate 
ATP hydrolysis with a K^ between 0.2 and 5 
mM, whereas high concentrations of K* inhibit 
ATP hydrolysis with a Κα, of about 20 mM. 
The Kft, values for both the stimulatory and 
inhibitory K*-sites are dependent on pH and 
ATP concentration used. Pre-steady state ex­
periments with inside-out-oriented and 
ion-tight Η,Κ-ATPase vesicles showed that the 
rapid biphasic dephosphorylation of the phos­
phoenzyme is induced by luminal K*, giving 
evidence that the stimulatory K* site faces the 
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lumen [104,105]. The inhibitoiy К* site is 
shown in intact vesicles to be cytoplasmic and 
to reduce the rate of enzyme phosphorylation 
by ATP [104,105]. Lorentzon et al. [123] 
demonstrated that this inhibitory K* site is 
potential-sensitive, suggesting that there is a 
charge-carrying step in the K* limb of 
Η,Κ-ATPase. 
In the absence of K* the enzyme exhibits a 
basal Mg2+-ATPase activity that can be 
reduced, but not completely removed, upon 
further purification of the enzyme by free-flow 
or zonal electrophoresis [66,89]. Wallmark et 
al. [104] demonstrated that the rate of spon­
taneous breakdown of phosphoenzyme corres­
ponded very good to the Mg^-ATPase activity 
at low ATP concentrations, implying that this 
activity was not due to a contaminating 
Mg2*-ATPase with a reaction path independent 
of the phosphoenzyme. This conclusion was 
confirmed by Reenstra et al. [129] in a study 
on the nonhyperbolic ATP dependence of 
ATPase activity and phosphoenzyme formation 
of Η,Κ-ATPase, and by Mendlein and Sachs 
[130], who observed that the K'-site inhibitor 
SCH 28080 inhibits both the K+-ATPase and 
Mg2*-ATPase activity of gastric Η,Κ-ATPase, 
inhibiting the latter activity by a K*-like pre­
vention of phosphoenzyme formation. Recently 
however, Van der Hijden et al. [131] demon­
strated with the ATP-analog /in-Benzo-ATP 
that Η,Κ-ATPase also contains a Mg2*-stimu-
lated hydrolytic activity with a reaction path 
independent of the formation of phospho­
enzyme. An answer to the question whether 
this latter activity is due to another enzyme or 
due to an intrinsic reaction of Η,Κ-ATPase, 
comparable to the hydrolysis of p-nitrophenyl-
phosphate, was not given in this study. 
A prominent feature of Η,Κ-ATPase is the 
nonhyperbolic ATP dependence of the phos­
phorylation reaction and the ATPase activity. 
Depending on the pH and K* concentration 
used, two affinities for ATP in the ATPase 
reaction are observed with k^ varying from 0.4 
to 74 дМ and from 50 μΜ to 1.1 mM respecti­
vely [103,104,129,132,133]. Brzezinski et al. 
[107] explained the nonhyperbolic ATP depen­
dence of the K*-ATPase reaction by assuming 
that ATP can react with one nucleotide site on 
the enzyme in both the E, and Ej state, but 
with a lower affinity in E? On the other hand 
Reenstra et al. [129] presented evidence that 
ATP can also bind to the phosphoenzyme, be 
it Ε-P or Ε·Ρ„ which then leads, besides the 
K -^stimulated breakdown, to an additional 
breakdown of phosphoenzyme. The existence 
of a low-affinity, second nucleotide site on the 
phosphoenzyme (probably E,-P) was also 
demonstrated by Helmich-De Jong et al. 
[93,134] who observed inhibition of the 
depbosphoiylation rate by millimolar nucleo­
tide concentrations in the presence of micro-
molar Mg2* concentrations. These authors also 
presented evidence that increasing Mg2* con­
centrations reduce the inhibitoiy effect of 
nucleotides on the depbosphoiylation rate, i.e. 
millimolar Mg2* together with nucleotides 
enhance the depbosphoiylation process. 
The kinetically deduced existence of two 
classes of substrate sites may also account for 
the molar ratio between ATP-analogs and inhi­
bitors on the one hand and phosphoenzyme on 
the other hand. This ratio has been reported to 
be 2:1 for the ATP analogs adenylyl imido 
diphosphate (AMP-PNP) [135] and 
2',3'-0-(2,4,6-Trinitrophenylcyclohexa-
dienyIidine)-ATP (TNP-ATP) [97], and also 2:1 
for the ATP-site directed fluorescent inhibitors 
eosin [99] and FITC [49,50] and the transition-
state inhibitor vanadate [126]. 
Hydrolysis of p-nitrophenylphosphate 
Like Na,K-ATPase, gastric Η,Κ-ATPase 
exhibits also a p-nitrophenylphosphatase 
(pNPPase) activity. This phosphatase activity is 
dependent on Mg2* and K*, or one of its con­
geners with the same order of selectivity as for 
the ATPase activity, yielding a specific activity 
of 61-84% of the maximal ATPase activity 
[4,136,137]. Phosphorylation by pNPP has not 
been demonstrated neither transport is cata­
lysed by this substrate. Like in the ATPase 
reaction the effect of K* on the pNPPase acti­
vity is biphasic Contrary to the ATPase 
reaction however, the K* stimulatory site for 
the phosphatase activity is at the cytoplasmic 
side of the membrane, and shows a lower affi­
nity than for the ATPase activity, whereas the 
K* inhibitory site is also located at the cyto­
plasmic side [66,106,138]. For the phosphatase 
activity an additional luminal K* stimulatory 
site may also be involved [139], as has been 
demonstrated with the carboxyl activating 
reagent ethoxy carbonylethoxy-dihydroquinoline 
(EEDQ) [140]. Therefore the enzyme form for 
this phosphatase activity may be either 2Κ·Ε1, 
2Κ·Ε2 or an occluded form between these two. 
It is disputable however, if the luminal K* 
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stimulatory site for the pNPPase reaction is 
identical with the K* stimulatory site for the 
ATPase reaction. Experiments with the hydro­
phobic amine SCH 28080 that inhibits the 
enzyme competitively with K*, with either 
pNPP or ATP as substrates, indicate that for 
both substrates the K* stimulatory site is iden­
tical [141,142]. Ray and Nandi on the other 
hand [139], observed that spermine competes 
with K* for the K+-pNPPase reaction without 
affecting the К+-АТРа5е activity, suggesting 
that the K* stimulatory sites for both sub­
strates are distinct. A difference between the 
K* stimulatory sites of the pNPPase and 
ATPase activity was recently also indicated by 
the different effects a dibenzoyi derivative of 
Scopadulcic acid, an ingredient of a Paraguayan 
traditional medicinal herb, has on both activi­
ties [143]. The catalytic sites for pNPP and 
ATP seem to be essentially different as has 
been demonstrated by a noncompetitive inhibi­
tion of the pNPPase activity by ATP and ADP 
[133], and by the observation that FTTC-modi-
fied enzyme is inhibited with respect to the 
ATPase but not the pNPPase [49]. 
Phosphorylation from inorganic phosphate 
In the presence of Mg2+ gastric 
Η,Κ-ATPase can also be phosphorylated by P, 
with a Ru, of about 50 μΜ [144,145]. With 
respect to acid-stability, K'-sensitivity and 
maximal phosphorylation level that can be 
obtained, the phosphoenzyme formed with 
inorganic phosphate is identical with the phos­
phoenzyme formed with ATP [145]. The reac­
tion can be considered as the reverse of the 
dephosphorylation reaction of Ej-P to E2 plus 
P,. This reversibility has also been demon­
strated by measurements of "О exchange 
between P, and H 2 0 [94,146]. One of the 
characteristic features of phosphorylation by 
inorganic phosphate is the rate of phosphoryla­
tion that is, in the absence of K*, about two to 
three orders of magnitude lower compared to 
phosphorylation by ATP. Without having an 
effect on the phosphorylation level, low con­
centrations of K* increase the phosphorylation 
rate (K
a
,=0.2 mM), whereas at higher concen­
trations of K* (1^5=2.4 mM) the phosphoryla­
tion level decreases [145]. The Κ,^  value for 
accelerating the phosphorylation rate cor­
responds rather well to the K^ values required 
for the fluorescence quench of FITC-labcIled 
enzyme (1^=0.28 mM) [49], for the slow 
phase of the dephosphorylation rate at the 
luminal site ( 1 ^ = 0 . 2 mM) [104], and for the 
rate of "O exchange between P, and Η,Ο 
( 1 ^ = 0 . 3 mM) [146], indicating that it is the Έ^ 
conformer that is phosphorylated. 
TRANSPORT BY Η,Κ-ATPASE 
The H*IATP stoichiometry 
Gastric Η,Κ-ATPase produces in vivo a pH 
gradient of б pH units. Thermodynamical con­
siderations would therefore preclude a HVATP 
stoichiometry greater than 1 [147]. With the 
use of isolated gastric vesicles or reconstituted 
gastric Η,Κ-ATPase many reports have been 
published concerning the correlation between 
the transport of H + and the hydrolysis of ATP. 
The in vitro values obtained for the H7ATP 
stoichiometry however, varied from 4 to 1 
[6,110-112,147,148]. The reported H7ATP 
stoichiometries of 1, are underestimated 
because of neglecting ATP hydrolysis by 
Mg2*-ATPase activity and K+-ATPase activity 
of broken Η,Κ-ATPase vesicles [147,148]. On 
the other hand, the measured HVATP stoi­
chiometries of 2 [110-112] are compatible with 
the pH gradient of 4.5 pH units obtained in 
gastric Η,Κ-ATPase vesicles [149,150]. The 
difference between the expected H7ATP stoi­
chiometry in vivo and the HVATP stoichio­
metry measured in vitro, therefore suggests that 
the coupling between transport of H + and K+, 
and ATP hydrolysis might not be tight. 
Ion selectivity 
Various effects of Na* have been observed 
on the kinetics of gastric Η,Κ-ATPase and 
suggested the existence of Na+-bmding sites on 
the enzyme. Na* inhibits the phosphorylation 
rate, whereas it does not accelerate the dephos­
phorylation rate [104,114]. The inhibition of 
the phosphorylation rate is increased by an 
alkaline pH at the cytoplasmic side [106]. The 
KOJ for ATP at pH 7.0 increases from about 
0.1 μΜ in the absence of Na* to 3.0 μΜ in the 
presence of 100 mM Na*, with a concomitant 
decrease of the steady-state phosphorylation 
level by 18% [151]. At alkaline pH, Na* also 
inhibits both the K*-ATPase and K*-pNPPase 
activities as well as the transport of H* 
[106,152]. The transport activity is inhibited by 
Na* binding to the cytoplasmic side and is 
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strongest at alkaline pH and only slight at 
neutral or acidic pH. These observations sug­
gested very strongly a competition between 
Na* ions and H* ions, which may be recog­
nized as hydronium ions [153], on 
cytoplasmically oriented sites on the enzyme. 
Another indication that Na* ions may substi­
tute for protons at the cytoplasmic side was 
provided by the observation that "RbCl-loaded 
gastric vesicles showed an extravesicular 
Na+-stimulaied "Rb efflux [116]. 
This competition between protons and Na* 
ions has been confirmed recently by Polvani et 
al. [154] who observed an ATP-dependent °№ 
influx into inside-out-oriented Η,Κ-ATPase 
vesicles at extravesicular alkaline pH that is 
stimulated by intravesicular K*. At extra-
vesicular neutral pH no °Na influx was ob­
served. The competition between Na* ions and 
protons on the E1 conformer is also pointed 
out by a recent study on the effect of Na* ions 
on the conformational state of FTTC-labelled 
Η,Κ-ATPase [96]. Whereas at pH 6.4 equili­
brium titrations showed that Na* ions stabilize 
the E] conformation with an apparent dis­
sociation constant of 62 mM, an apparent dis­
sociation constant of 10.2 mM was observed at 
pH 8.0, consistent with competition between 
protons and Na* ions. 
Besides the competition between Na* ions 
and protons at the cytoplasmic side, compe­
tition between Na* ions and K* ions at the 
luminal side of the enzyme is also observed. 
Experiments with NaCl-loaded proteolipo-
somes containing reconstituted Η,Κ-ATPase 
showed an ATP-dependent proton uptake, re­
quiring internal K*, after dilution of the 
proteoliposomes into KCl, but not NaCl, 
medium [118]. This indicated that a Na*/K* 
exchange, Na* outward and K* inward, must 
have occurred before ATP was added, thereby 
Na* ions interacting with the intravesicular 
K*-binding sites. Ditmars et al. [155] measured 
in gastric vesicles, loaded with 500 mM NaCl 
and diluted in Na*-free medium, an 
ATP-dependent proton uptake, suggesting an 
active transport of Na* ions from the luminal 
to the cytoplasmic side. Furthermore, a stria 
competition between Na* and K* ions is also 
observed with equilibrium titrations of the 
cations and FITC-labelled Η,Κ-ATPase, 
showing that Na* ions bind to and stabilize the 
high fluorescence E, form of the enzyme while 
K* ions stabilize the low fluorescence Ej form 
[96]. 
Electrogenicity of ion transport 
Gastric Η,Κ-ATPase is an electroneutrai 
ion pump, which exchanges protons for K* 
ions. The electroneutrality of the pump is 
demonstrated not only in vivo [156], but also in 
vitro [6]. This indicates that in the consecutive 
transport cycle of the enzyme either the trans­
porting step of both protons and K* ions is 
electroneutrai, or that the transporting step of 
each ion is electrogenic, resulting in an overall 
electroneutrai countertransport. The first men­
tioned possibility would occur if there is bind­
ing of protons and K* ions to negatively 
charged binding sites. Such a mechanism has 
been suggested recently for NaJC-ATPase 
where two carboxyl residues should be involved 
in the cation-binding sites, resulting in an elec­
troneutrai transport of two K* ions and an 
electrogenic transport of three Na* ions [157]. 
For Η,Κ-ATPase, however, it has become clear 
that the transport cycle includes equal and 
opposite charge movements [115,123]. 
Lorentzon et al. [123] demonstrated with gas­
tric vesicles that the K*-transporting step of 
Η,Κ-ATPase, i.e. г К · ^ to 2Κ·Ε, or even E,, 
is potential-sensitive and therefore must be 
charge carrying. The electrogenicity of the 
H*-transpor 
ting step was proven by Van der Hijden et al. 
[115]. Upon phosphorylation of НД-ATPase, 
that was adsorbed to a black lipid membrane, 
with a photolabile analog of ATP they ob­
served a transient capacitive charge movement 
In the presence of K* they observed no pump 
currents, demonstrating also that the K* limb 
of the transport cycle is electrogenic too. 
The electrogenicity of both the H*- and 
K*-transporting steps implicates that the cat­
ion-binding sites must be neutral, i.e. do not 
contain negatively charged amino acid residues. 
For the H*-binding site the involvement of a 
carboxyl residue would actually be very unlikely 
because of the low luminal pH of about 1, 
requiring an extreme low pK, value of the 
carboxyl group. By using the histidine deriva-
tizing reagent diethyl pyrocarbonate (DEPC), it 
has been demonstrated that an essential his­
tidine group with a pK, of about 7 is involved 
in the binding of protons at the cytoplasmic 
side [158]. For the luminal K*-binding site it 
has been demonstrated with the carboxyl acti­
vating reagent N-ethoxycarbonyl-2-ethoxy-l,2-
dihydroquinoline (EEDQ) that a carboxyl 
group is involved in K* binding, but this amino 
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acid residue has a pK, of about 7, showing that 
it is in a nonaqueous environment. Le. in a 
hydrophobic domain [140]. 
ІЛРШ DEPENDENCY OF НДС-ATPASE 
Gastric H.K-ATPase is embedded in a lipid 
bilayer consisting of cholesterol and phospho­
lipids. The composition of the phospholipid 
fraction is little different from the purified 
Na.K-ATPase membranes [159] and consists of 
33% phosphatidylcholine, 22% phosphatidyl-
ethanolamine, 11% phosphatidylserine, 8% 
phosphatidylinositol and 25% sphingomyelin 
[102,160]. The requirement of phospholipids 
for enzyme activity has been studied by diges­
tion with specific phospholipases [102,160-162]. 
Studies with phospholipase A
z
 [102,161] 
demonstrated that the K'-ATPase activity is 
much more sensitive to phospholipase diges­
tion than the K*-pNPPase activity. Besides this 
inhibitory action on the hydrolytic activities of 
НДС-ATPase, it was demonstrated that in case 
of phospholipase A2 treatment the ATP-in­
duced conformational changes, as indicated by 
circular dichroism spectra, were inhibited too 
[102]. Schrijen et al. [160] however, observed 
that during phospholipase С treatment the 
K*-pNPPase activity is lowered in parallel with 
the K+-ATPase activity. Moreover, they 
demonstrated a parallelism between the 
lowering of the phospholipid content and of 
the K*-ATPase activity during treatment with 
phospholipase C, both in time and in final 
level. 
In studies with specific phopholipases the 
asymetry of composition of the lipid bilayer 
was also suggested [102,162]. The requirement 
of specific phospholipids, which are essential 
for enzyme activity however, has not been esta­
blished. For example, Saccomani et al. [102] 
demonstrated that readdition of various phos­
pholipids, after phopholipase A2 treatment, 
results in a restoration of the K*-ATPase acti­
vity. On the other hand, Nandi et al. [161] 
observed a restoration of the K*-ATPase acti­
vity with addition of phosphatidylcholine and 
not with phosphatidylethanolamine. Also 
Schrijen et aL [160] did not observe a specific 
phospholipid requirement. 
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SOLUBILIZATION AND RECONSTITU­
TION 
Although by density gradient centrifugation 
and subsequent free-flow electrophoresis [66] 
or zonal electrophoresis [89] gastric 
НДС-ATPase can be isolated rather purely, 
solubilization experiments have been under­
taken to further purify active H,K-ATPase. 
Solubilization of НДС-ATPase was also carried 
out in order to identify molecular associations 
of the active enzyme, and for reconstitution 
experiments. Soumarmon et al. [90] first re­
ported a non-degradative solubilization of the 
НДС-ATPase by n-octylglucoside. Extracted 
НДС-ATPase displayed the same enzymatic 
properties as the native enzyme and in glycerol 
gradient centrifugation it equilibrated as a 
single peak corresponding to an apparent 
molecular mass of 390 kDa. Takaya et al. [163] 
succeeded in solubilizing НДС-ATPase, which 
had been purified before by sucrose density 
gradient centrifugation, with Emulgen, with 
apparent preservation of the enzyme activity. 
Further purification of the solubilized enzyme 
by polyethylene glycol fractionation and Sepha-
rose chromatography steps however, did not 
result in an increase of the specific enzyme 
activaty, indicating an inactivation of the 
enzyme activity during purification. On 
SDS-polyacrylamide gel the purified, but inacti­
vated, enzyme showed a single band with an 
apparent molecular mass of 94 kDa. Recently 
Rabon et al. [70] reported the solubilization of 
an active НДС-ATPase with the nonionic deter­
gent СцЕ» The retention of enzyme activity 
showed to be dependent upon pH, K* concen­
tration, nucleotide concentration and tempera­
ture. Optimal retention of enzyme activity was 
obtained at pH 6.1 and 2 mM ATP. The good 
stability of the soluble'enzyme (tH for ATPase 
activity of 6 h between 4 and 11 °C) enabled 
the authors to study the subunit associations of 
functional Η,Κ-ATPase. By means of glutar-
aldehyde crosslinking analysis of QjE, solu­
bilized Η,Κ-ATPase it was then demonstrated 
that functional porcine gastric Η,Κ-ATPase is 
organized as a structural dimer. 
Solubilization of an active Η,Κ-ATPase is 
also a prerequisite for reconstitution of the 
enzyme into liposomes. With these 
Η,Κ-ATPase proteoliposomes it is then 
possible to study the transport characteristics 
of pure Η,Κ-ATPase, without interference of 
residual protein contamination usually present 
in native vesicular HJC-ATPase preparations. 
Rabon et al. [118] first reported the reconstitu­
tion of chelate or n-octylglucoside solubilized 
Η,Κ-ATPase into phosphatidylcholine/choles-
terol liposomes. The enzyme was reconstituted 
asymmetrically into the proteoliposomes with 
70% of the pump molecules having the cyto­
plasmic side extravesicular. In the presence of 
intravesicular K*, the proteoliposomes exhibi­
ted a MgATP-dependent H* transport, as 
monitored by acridine orange fluorescence 
quenching. Moreover, as seen with native 
Η,Κ-ATPase vesicles, reconstituted 
Η,Κ-ATPase also catalysed a passive Rb+/Rb+ 
exchange, which rate was comparable to the 
rate of active Rb* efflux. This suggested that 
the K'-transporting step of Η,Κ-ATPase is not 
severely limited by a K'-occluded enzyme form, 
as observed for Na,K-ATPase. Skrabanja et al. 
[164] also described the reconstitution of 
chelate solubilized Η,Κ-ATPase into phospha-
tidylcholine/cholesterol liposomes. With the 
use of a pH electrode to measure the rate of 
H* transport they observed not only an active 
H* transport, which is dependent on intravesi­
cular K*, but also a passive H*/K* exchange. 
This passive transport process, which exhibited 
a maximal rate of 5% of the active transport 
process, could be inhibited by vanadate and the 
specific inhibitor omeprazole, giving evidence 
that it is a function of gastric Η,Κ-ATPase. 
The same authors demonstrated, by separation 
of non-incorporated Η,Κ-ATPase from recon­
stituted Η,Κ-ATPase on a sucrose gradient, 
that Η,Κ-ATPase transports two protons and 
two K+ ions per ATP hydrolysed [112]. 
INHIBITORS OF ЦК-ATPASE 
The search for specific inhibitors of gastric 
Η,Κ-ATPase has a dual purpose. First, with the 
help of suitable inhibitors it is possible to get 
insight into the molecular mechanisms of 
Η,Κ-ATPase, and second, a specific inhibitor 
might be clinically useful for inhibition of 
gastric acid secretion in antiulcer therapy. 
There are many ligands and groupspecific 
reagents that have been demonstrated to alter 
the properties of Η,Κ-ATPase, and which are 
clinically not useful. For example, there is a 
variety of chemicals that have been used in 
studies on structure-function relations of 
Η,Κ-ATPase and that inhibit the enzyme in 
vitro by modification of its amino [49,67,158], 
sulfhydryl [95,165,166] or carboxyl groups 
[140]. 
Another approach that has gained atten­
tion in recent years in investigating structure-
function relationships of gastric Η,Κ-ATPase, 
is the use of monoclonal antibodies that speci­
fically modify a particular reaction step of the 
enzyme. Asano et al. [167] raised a monoclonal 
antibody that inhibited in gastric vesicles 
K+-ATPase activity, K*-pNPPase activity and 
chloride conductance that had been induced 
before with the S-S cross-linking reagent 
Cu2*-o-phenanthroline [168,169]. The inhi­
bitory effects of the antibody on both the 
hydrolytic reactions and the chloride conduc­
tance led the authors to the conclusion that 
the СГ-channel in gastric vesicles is part of the 
function of Η,Κ-ATPase. This hypothesis was 
challenged by Benkouka et al. [170] who 
described a monoclonal antibody with similar 
inhibitory effects on hydrolytic reactions of 
НДС-ATPase, but which did not inhibit the by 
Cu2*-o-phenanthroline induced chloride con­
ductance. Recently monoclonal antibodies 
against gastric Η,Κ-ATPase have been reported 
that completely inhibit the K+-ATPase activity 
and not the K*-pNPPase activity [171,172]. 
Both monoclonal antibodies exhibited an 
pH-dependent inhibitory effect on the ATPase 
reaction that was maximal at alkaline pH. The 
pattern of inhibition of one of these antibodies 
was uncompetitive with respect to K*, indi­
cating that it bound to the K'-bound enzyme 
(Ε,^Κ) [172]. This antibody recognized on 
Western blot the catalytic subunit of the 
enzyme, which made determination of the 
epitope possible [56]. 
There are several antisecretory drugs such 
as fenoctimine [173], nolinium bromide [174], 
the antidepressant trifluoperazine and the Ca2* 
antagonists verapamil and TMB-8 (8-(N-N-
diethylamino)octyl-3,4,5-trimethoxybeiizoate) 
[175] that interfere with gastric Η,Κ-ATPase. 
The mechanism of interaction with 
НДС-ATPase is different for the respective 
drugs. Fenoctimine has been demonstrated to 
be not specific as it inhibits also other mem­
brane ATPases and inhibition of НДС-ATPase 
is the result of a fenoctimine-induced disrup­
tion of the microsomal membrane [173,176]. 
Nolinium bromide on the other hand, inhibits 
Η,Κ-ATPase by acting as a K*-compelitive 
inhibitor, although with low affinity [177,178]. 
Conflicting results exist about the mechanism 
of action of the Ca2* antagonists. Several 
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groups have reported that these drugs are 
K+-competitive inhibitors of H,K-ATPase 
[175,179], whereas other groups ascribe the 
antisecretory activity of these compounds in 
varo to a nonspecific, i.e. a protonophoric or 
detergent-like, action [180,181]. 
Characteristic for Η,Κ-ATPase and other 
P-type ATPases is the inhibition by vanadate, a 
transition-state analog of phosphate [126]. 
Inhibition by vanadate is thought to occur 
since vanadium in the 5+ oxidation state can 
assume the trigonal-bipyramidal geometry of 
pentacoordinate phosphorus. It therefore can 
occupy the phosphate-binding site and prevent 
the phosphorylation of the enzyme. Besides the 
phosphorylation reaction, the Mg2*-ATPase, 
the К+-АТРа5е and the proton transport acti­
vity, also the K+-pNPPase activity of 
Η,Κ-ATPase is inhibited by vanadate. Maximal 
inhibition of these activities is reached at a 
vanadate binding stoichiometry of 3 nmol.mg"1 
protein, whereas a maximum of 1.5 nmol.mg'1 
protein acid-stable phosphoenzyme is formed. 
Faller et al. [126] interpreted these conflicting 
data by assuming ATP-competitive vanadate 
binding at a high- and low-affinity catalytic site. 
The substituted benzimidazoles constitute a 
new class of specific and irreversible inhibitors 
of Η,Κ-ATPase. To this class of inhibitor 
be long omeprazo le (5-methoxy--
2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-
methyl]sulfinyI]-lH-benzimidazole) as main 
representative [182], Ro 18-5364 [183], lanso­
prazole [184], E3810 [185], HOE 731 [186] and 
BY1023/SK&F 96022 [187]. The substituted 
benzimidazoles were initially reported to inhi­
bit acid secretion both in vivo and in vitro 
[188]. A correlation between inhibition of acid 
secretion and blockade of gastric Η,Κ-ATPase 
was then strongly suggested by Fellenius et al. 
[189] who observed that Η,Κ-ATPase in vitro is 
inhibited by the substituted benzimidazole 
picoprazole, a precursor of the clinically used 
omeprazole. With omeprazole it was then de­
finitely demonstrated that inhibition of 
НДС-ATPase is correlated with inhibition of 
gastric acid secretion [190]. The mechanism of 
inhibition by omeprazole was investigated and 
has been reviewed recently [18,191]. 
Characteristic for omeprazole is its low pK, 
of approximately 4 that leads to trapping 
within the acid canaliculus of the parietal cell. 
There the compound is rapidly transformed to 
an active and permanent cationic inhibitor of 
Η,Κ-ATPase [192,193]. The active inhibitor 
thus formed reacts with essential sulfhydryl 
groups on the luminal face of the enzyme 
resulting in inhibition of K*-ATPase and 
K*-pNPPase reactions (ICj, = 8 μΜ at pH 6.0) 
[194-196]. This acid-induced transformation of 
omeprazole into an active inhibitor compound 
makes omeprazole a highly specific drug. Un­
der conditions, in which no pH-gradient is 
generated, a stoichiometry of 10 to 20 mol of 
inhibitor per mol phosphoenzyme is observed 
at complete inhibition of the enzyme [194,196]. 
Both in vitro and in vivo studies however, de­
monstrate that in case of acid accumulation, 
complete inhibition of the K+-ATPase activity 
is reached at a stoichiometry of 2 mol of inhi­
bitor per mol phosphoenzyme [197-199]. Re­
cently Mercier et al. [52] have suggested, after 
sequencing omeprazole-labelled tryptic-digest 
fragments of Η,Κ-ATPase, that the reactive 
cyteine residues of the catalytic a-subunit are 
Cysm and CysTO. Morii et al. [200] on the ot­
her hand, proposed that omeprazole specifical­
ly reacts with Cys322. 
An important class of reversible 
Η,Κ-ATPase inhibitors, exemplified by SCH 
28080 (3-(cyanomethyl)-2-methyl-8-(phenyI-
methoxy)imidazo[l,2a]pyridine) are the sub­
stituted imidazo[l,2a]pyridines. These com­
pounds were initially reported as effective inhi­
bitors of acid secretion [201,202]. Studies in 
isolated guinea pig fundic mucosa indicated 
that the antisecretory activity involved a direct 
action on the parietal cell distal to the 
histamine or cholinergic receptors and at a site 
beyond the formation of cAMP. Scott and 
Sundell [203] then demonstrated that SCH 
28080 inhibits the K*-ATPase activity of iso­
lated Η,Κ-ATPase, suggesting that this com­
pound may exert its antisecretory activity via a 
direct inhibition of Η,Κ-ATPase. Subsequent 
investigations confirmed this hypothesis and 
showed that SCH 28080 is competitive with the 
activating cation K+ for both the ATPase and 
the pNPPase reactions, having a K, between 
0.02 and 0.12 μΜ for the ATPase and 0.28 and 
2.4 μΜ for the pNPPase reaction 
[130,141,142,204,205]. It was also demonstrated 
that the potency of SCH 28080, which is a 
protonatable weak base (pK, = 5.6), increased 
at low pH, commensurate with the proportion 
of SCH 28080 in the protonated form, indi­
cating that the protonated form is the 
luminally active inhibitory species [142,206]. 
Binding of SCH 28080 is to the Ej and EjP 
conformeis of Η,Κ-ATPase with higher affinity 
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to the phosphorylated form, and a binding 
stoichiometry of 2.2 mol of SCH 28080 per 
mol of catalytic phosphorylation sites is obser­
ved [130,141,207]. The mechanism by which 
SCH 28080 inhibits Η,Κ-ATPase suggests that 
SCH 28080 could be used as probe for the 
luminal K* transport site. For this reason 
recently two photoaffinity derivatives of SCH 
28080 have been synthesized that show a quali­
tatively similar interaction with Η,Κ-ATPase to 
that of SCH 28080 [54,208]. The photoaffinity 
derivative m-ATIP (8-(3-azidophenylmethoxy)-
l,2,3-trimethylimidazo[l,2a]pyridinium iodide), 
showed a level of incorporation required to 
produce complete inhibition of ATPase activity 
of 1.9 times the number of catalytic phospho­
rylation sites [208]. This stoichiometry cor­
responded to the stoichiometry for the binding 
of SCH 28080 to Η,Κ-ATPase [207]. Tiyp-
sinisation and sequencing of Η,Κ-ATPase 
labelled with the light-sensitive derivative 
mDAZIP (2,3-dimethyl-8-[(4-azidophenyl)-
methoxy]imidazo[l,2a]pyridine), which however 
exhibited a maximal amount of specific label­
ling similar to the number of phosphorylation 
sites, showed that the site of labelling is 
contained within the region between residues 
10S and 155 [55]. This suggested that the label­
ling site is located within or close to the pro­
posed extracellular loop between trans­
membrane segments Ml and M2. 
AIMS OF THIS STUDY 
The main purpose of this study is to gain 
more information about the structural and 
functional aspects of gastric Η,Κ-ATPase. For 
this goal mainly an immunological approach 
has been applied. 
Chapter 2 describes the production of a 
monoclonal antibody directed against the cata­
lytic a-subunit of Η,Κ-ATPase. This antibody 
specifically inhibits the K+-ATPase activiiy of 
the enzyme, whereby the inhibitory mechanism 
of the antibody is elucidated. 
In Chapter 3 the determination of the 
epitope for the inhibitory monoclonal antibody 
is described. This is performed by identification 
of immunoreactive proteolytic-digest fragments 
of the catalytic a-subunit obtained by limited 
tryptic and papain digestion of gastric 
Η,Κ-ATPase. The identification of selective 
tiyptic cleavage sites allowed to correlate the 
time courses of the biphasic inactivation of the 
K*-ATPase activity, which has been observed 
previously in our laboratory during tiyptic 
digestion in the presence of both K* and ATP, 
with the appearance of well-defined peptide 
fragments on SDS-polyacrylamide gels. 
The production and the characterization of 
other monoclonal antibodies and polyclonal 
antisera directed against gastric Η,Κ-ATPase is 
described in Chapter 4. Especially, the features 
of several in this study produced inhibitory 
anti-H,K-ATPase monoclonal antibodies are 
compared with characteristics of reported inhi­
bitory anti-Na,K-ATPase antibodies. 
Chapter 5 describes a mechanistic study on 
the effect of free fatty acids and detergents on 
gastric Η,Κ-ATPase. In this chapter a proce­
dure for a rapid isolation of a highly purified 
Η,Κ-ATPase preparation is described. With 
this preparation a steady-state phosphorylation 
level could be reached that suggests that each 
catalytic a-subunit of gastric Η,Κ-ATPase can 
be phosphorylated at the same time. 
In Chapter 6 the initial results of the hete­
rologous expression of the catalytic a-subunit 
in the baculovirus expression system are 
presented. 
In Chapter 7, finally, our findings and their 
implications are summarized and discussed. 
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A monoclonal antibody against pig gastric H +/K+-ATPase, which 
binds to the cytosolic E, · K+ form 
Tom J.F. Van Uem ', Wilbert H.M Peters 2 and Jan Joep H H.M De Poni ' 
' Department of Bioctiemsin ana τ Division of Caslrotnlestitial aiul Uoer Diseases, L'mrertin <>/ Nijineцеп \ijim'¡íeiitliit \etlhrUinJs) 
(Received IS SeplemtKr 1989) 
Key words ATPase, Η ' / К * - Munotlonjl unlihody. (Itc^gjMriL mutosu) 
Monoclonal antibodies were raised against a purified membrane fraction from hog gastric mucosa coiitaiiiing 
Η */К*·ATPase. The properties of one of these monoclonal antibodies (5B6) »ere further evaluated On iinniunoblol 
it recognized the 95 kDa peptide of the Η ^/K^-ATPase-rich membrane fraction. The К "'-ATPase jitivity «as 
inhibited by 65% under standard assay conditions (pH 7.0) At pH 6.0 and 8.0 this enzyme activilv »as inhibilcd by 40% 
and 100%, respectively. The maximal inhibition in inside-out vesicles was also 65% at pll 7.0 The inliibilion »as 
uncompetitive with respect to K* and noncompetitive with respect to ATP. Mg2+-ATPase activity and К'"-dependent 
¿»-mtFophenylphosphatase activity were not influenced. The monoclonal antibody lowered the steady -slate phosphoryla-
tion level at pH 6.0, 7.0 and 8.0 by 30%, 40% and 60% respectively. The rale of the K*-Miniulatcd depliosphurylalion 
step was not inhibited These findings demonstrate that 5-B6 recognizes the К, · К + dephosphoeiuyme at the о losolic 
side. 
Introduction 
The H',/K+-ATPase of the gastric mucosa catalyzes 
the exchange of H* and K* upon hydrolysis of ATP 
which results in a pH difference of more than 6 between 
the cytoplasm and gastric lumen [1,2] The catalytic 
subuna of this membrane-bound enzyme is related to a 
number of other cation transport ATPases, including 
the Na VK+-ATPase and the Ca2 '-ATPase 13,4] These 
enzymes belong to the class of P-lype ATPases as they 
all have a stable phosphoenzyme intermediate m the 
enzyme cycle [5,6) Recently the ammo acid sequences 
of the catalytic subunits of rat and hog gastric H*/K'-
ATPase have been deduced from the nucleotide se­
quence of their cDNA [3,7] and the molecular weight of 
the protein was calculated to be 114000 in either case 
Abbievialions H V K + - A T P a s e (EC 3 6 1 ЗА) nugnebium-dependent 
hydrogen юл trampomng and polauium-slimulaled adenouni: ιπ-
pho&phatavï, К'-ATPase К'-dependent adembine Inphobphalau 
M g ' ' - A T P a s e , M g 1 '-dcpendenl adenosine inphosphaljsc, ELISA 
enzyme-linked inununosorheni assay PBS phosphate buffered Sdirne 
Tween 20 polyoxyelhylene sorbilan monotaurale 
Correspondence J J H H M de Pont. Depanmenl of Biothenmlry 
University of Nijmegen P O Box 9101 6500 HB Nijmegin The 
Netherlands 
There is a 60% homology between the prinurv se­
quences of the utalytii subunits of II '/K "-A 1 Pase 
and N a V K '-ATPase [3] Hsdropathy .tnalysis revealed 
that the H'/K'-ATPase suhuntt probably has etghl 
transmembrane domains as is the lase for N a ' / K ' -
ATPase and Ca : '-ATPase [1] Besides these structural 
similarities, the H'/K'-АІРаье also has many func­
tional aspects in common with other P-type ATPases 
Phosphorylation is on an aspartate residue [4] and hy­
drolysis of ATP is inhibited by vanadate [H] The ex­
istence of two conformational slates I-, and E, which 
have reciprocal affinities for H' and К ' at cytosolic 
and luminal side, respectively, has been proved by 
limited proteolytic digestion [9] and by fluorescent 
probes [10.11] Cycling of the enzyme between these two 
conformational slates, during ATP hydrolysis, gives rise 
to the translocation of H ' to the lumen and of К ' to 
the cytosol 
So far relatively little is known about the structure of 
the enzyme It is not known, for example, which part of 
the enzyme is localized at the luminal and which at the 
cytosolic side, which amino acids contribute to the 
binding sites for ions and inhibitors as omeprazole [12] 
and SCH 28080(13] 
Monoclonal antibodies against the H */K '-ATPase 
could be used as probes to iiivosiigale (he structure and 
function of the enzyme They could clarify whether the 
gastric enzyme is an oligomer of ideniical or nontdenti-
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cal 114 kDa subumti [14] and whether H has any 
immunological similarity to the NaVK*-ATPase [IS] 
Monoclonal antibodies against the subunit of the pig 
gastric H VK*-ATPase are already available [16-18]. 
These monoclonal antibodies have been used for histo­
logical studies on H VK*-ATPase [16] and to suggest 
that the CI" channel is part of the function of H*/K+-
ATPase [18] 
In order to get more information about structure and 
function of H+/K*-ATPase we prepared monoclonal 
antibodies against the enzyme In this paper we describe 
the characteristics of one of these monoclonal antibod­
ies which inhibits the gastric H VK-+-ATPase 
Materiali and Metbodn 
Preparation of gasine H */K *-ATPase 
Isolation of the HVK+-ATPase has been earned out 
according to the procedure previously reported by 
Skrabanja et aL [19] with some modifications Stomachs 
of freshly slaughtered pigs were transported to the 
laboratory on ice. After flushing with tap water the 
fundic region was placed during 30 mm ш homogemza-
uon buffer containing 230 mM sucrose and 20 mM 
Tns-HCI (pH 7 4) Mucus was removed by wiping the 
tissue with paper towels and the mucosa was scraped 
off from the underlying muscular layer The scraped 
material was placed m homogemzation buffer and ho­
mogenized with a Braun teflon-glass homogemier by 
three up-down strokes of the rotating pestle (250 
rev /mm) The homogenate was centnfuged for 30 mm 
at 20000 x g The resulting supernatant was centnfuged 
for 60 mm at 100000 x g The pellet was resuspended in 
homogenization buffer and centnfuged on top of a 
discontinuous gradient of 7% (w/v) Ficoll-250 mM 
sucrose m 20 mM Tns-HCI (pH 7 4) over 37% (w/v) 
sucrose ш 20 mM Tns-HCI (pH 7 4) After 60 nun 
ccntnfugation at 150 000 X g the 250 mM sucrose/7% 
(w/v) Ficoll-250 mM sucrose interface containing the 
vesicular HV K + -ATPase fraction and the 7% (w/v) 
FicoU-250 mM sucrose/37% (w/v) sucrose interface 
containing the open membrane H VK+-ATPase frac­
tion were diluted in 20 mM Tns-HCI (pH 7 4) and 
centnfuged for 60 mm at 150000 X g The final pellets 
were resuspended in 20 mM Tns-HCI (pH 7 4) and 
frozen at - 2 0 e C 
Hybndoma production 
The antigen was H+/K*-ATPase punfled from hog 
stomach and emulsified in complete Freund's adjuvant 
Several 6-week-old female BALB/c mice were im­
munized intrapentoncally with 200 μg of enzyme. After 
3 weeks, sera were drawn for evaluation of titer against 
gastnc H VK*-ATPase One mouse was selected on the 
basis of the highest titer and boostered by tail vein 
injection of 100 jig antigen in 0 3 ml of 0 9% (w/v) 
NaCl on three subsequent days On the fourth day the 
spleen was removed and spleen cells (5 101) were (иъеі 
with mouse Sp2/0 myeloma cells (2 IO7) in the pres­
ence of 40% (v/v) polyethylene glycol 4000 flic cells 
were washed and cultured in RPMl 1640 medium (Dutch 
modification. Flow Laboratories, Irvine, Scotland) sup­
plemented with 20% (v/v) fetal Laif serum (Flow 
Laboratories), 2 mM glutamine, 50 μΜ 2-mercapto-
ethanol, 1 mM sodium pyruvate and 50 mg/l genlamy-
cin After 3 hours a solution containing hypoxanlhme, 
aminoptenn and thymidine (final concentrations 01 
mM, 0 4 μΜ and 16 μΜ) was added to the medium and 
cells were plated out 
Production and partial purification о/ monoclonal antibod­
ies 
Hybndomas producing antibodies were cloned by 
limited dilution and injected (5 10 6 cells) intrapen­
toncally into BALB/c mice pruned with pnstane (0 S 
ml ι ρ ) 2-4 weeks before. After 10 days antibody-nch 
ascites fluid was obtained every 2-3 days and centn­
fuged for 10 nun at 2000 x g to remove cell debris The 
supernatant was precipitated with ammonium sulfate 
(pH 7 4, adjusted with Tns) at 50% saturation The 
12000 X g precipitate was resuspended in a volume of 
20 mM Tns-HCI (pH 7 4) equal to the onginal volume 
of the ascites, dialyzed against 100 volumes of 20 mM 
Tns-HCI (pH 7 4) at 4 " С with three changes of the 
dialysate and stored at - 2 0 ° С The subclasses of the 
monoclonal antibodies were determined with subclass-
specific antibodies according to Ouchterlony [20] 
EUSA 
Reagents per well and incubation tunes were as 
follows 0 5
 Mg of gastnc H VK
+
-ATPase m 50 pi PBS 
was immobilized by ovenught evaporation in wells of 
flat-bottomed, 96-well microtiter plates (Costar, Cam­
bridge, MA, U S A ) Blocking was done by incubating 
with a solution of 1% (w/v) gelatin in PBS for 2 h at 
room temperature whereafter the plates were washed 
with PBS containing 0 05% (v/v) Tween 20 Incubation 
for 1 h at room temperature with antibodies from 
hybndoma culture media was followed by washing with 
PBS/TWeen and subsequent incubation with peroxidase 
conjugated rabbit-anti-mouse immunoglobulins (Dako-
patts, Denmark) diluted 1 800 in PBS with 1% gelatin 
After washing a substrate solution containing 0 8 mg/ml 
S-ammosalicylic acid in 50 mM phosphate buffer (pH 
6 0) and 0024% (w/v) hydrogen peroxide was added 
Absorption at 492 nm was measured after 30 nun using 
a Titertek Muluscan plate reader (Flow Laboratories) 
Gel electrophoresis and immunoblotlmg 
Purified Н+/К+-АТРазе was electrophoresed on 10% 
(w/v) SDS-polyacrylamide slab gel according to Laem-
mil [21] The separated proteins were transferred to 
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nitrocellulose by electroblotting [22] The blots were 
incubated first for 2 h with PBS-1% (w/v) gelaUn-0 05% 
(w/v) Tween 20 (Buffer I) to block nonspecific reactive 
sites, then for 16 h with 1 100 dilutions of monoclonal 
antibody 5-B6 in Duffer 1 After washing five limes in 
PBS-0 05» (w/v) Tween 20 (Buffer II) the blots were 
incubated for 1 h with I 250 dilutions of rabbit-anti-
mouse immunoglobulin (Dakopalls, Denmark) in Buffer 
1, washed again with Buffer II and incubated for another 
hour with 1 250 dilution of mouse peroxidase-antiper-
oxidase immunoglobulin (Dakopatts, Denmark) in 
Buffer I Finally the blots were washed with Buffer II 
and substrate solution (60 mg 4-chloronaphthol, 60 μΙ 
30% (w/v) hydrogen peroxide, 20 ml methanol, 100 ml 
PBS) was added 
A TPase and p-mtrophenylphosphatase assay 
K.*-ATPase activity and К +-/>-mtrophcnylphospha-
tase activity of the enzyme were determined according 
to Schnjen et al [23] Gasine HVK*-ATPase, 100 μ\ 
with a concentration of 60 μ% protein/ml, was prein-
cubated for 10 mm at 37° С with 100 μΐ of a diluted 
monoclonal antibody solution with concentrations as 
indicated in the figures Dilutions of enzyme and mono­
clonal antibody were made in 30 mM iimdazole-HCI 
(pH 7 0) The reaction was started by adding 200 μ\ 
medium containing 10 mM NajATP or 10 mM p-
nitrophenyl phosphate, 10 mM Mg2*, 0 2 mM ouabain, 
30 mM mudazole-HCl (pH 7 0) and 40 mM KCl or 40 
mM chohne chloride. Stopping of the reaction and 
further treatment of the samples were earned out as 
described before [24] The К *-ATPase and K+-;>-
nilrophenylphosphatase activities were obtained from 
the difference in activity with KCl and choline chlonde, 
respectively Protein was determined according to Lowry 
et al [25], using bovine serum albumin as standard 
Radiaactiue ATPase assay 
Abquots of 50 μ\ enzyme (0 08 mg/ml) were prein-
cubated for 10 mm at 37° С with 50 μΐ monoclonal 
antibody solution at vanous concentrations and 50 μΐ 
medium containing 60 mM iimdazole-HCI (pH 7 0), 0 4 
mM ouabain and 80 mM KCl or 80 mM choline 
chlonde The reaction was initiated by adding 50 μΐ of a 
solution containing [γ-33Ρ]ΑΤΡ and Mg 1 * at a ratio of 
0 S and at various concentrations The reaction was 
slopped by adding 800 μ I 5% (w/v) trichloroacetic 
acid/10% (w/v) Noni After centnfugation /or 10 mm 
at 1500 X g (Heraeus Christ) 200 μΐ of the supernatant 
was counted in a Packard 2200CA liquid scintillation 
analyzer 
Enzyme phosphorylation and dephosphorylation 
The phosphorylation and dephosphorylation reac­
tions were earned out as described by Helmich-de Jong 
et al [26] Ahquots of 50 μΐ Η */YL '-ATPase (0 3 
mg/ml) were preincubated for 10 nun at room tempera­
ture with 50 μΐ monoclonal antibody solution at various 
concentrations and 4 mM MgCI, The phosphorylation 
reaction was started by adding 100 μ| 10 μΜ [γ-
"PJATP After 10 s at 20°C the réaction was slopped 
by adding S ml 5% (w/v) tnchlorojcetit. and/O 1 M 
Η,ΡΟ4 
The effixl of the monoilonal ашіЫхІу on the rale of 
the potassium stimulated dcphnsphorylaiion was studied 
at 0 - 4 ° С Phosphorylation was first initiated by adding 
50-μΙ ahquots of 10 μΜ (γ-1 2Ρ]Al Ρ 10 μΜ MgCI2 io 
50 μΐ ahquots of Η*/К '-ATPase (0 2 mg/ml) After 10 
s dephosphorylation was starled by adding ATP (final 
concentration 1 mM), KCl at various loncenlralions 
and monoclonal antibody The reaction was stopped 
by adding S ml 5% (w/v) tnchloroacetit. aud/0 1 M 
H J P O J Further processing was curried oui as described 
by Schuurmans Stekhoven et al [27] 
Residu 
Preparation of monoclonal untibodie\ 
By ELISA screening of the produced hybndomas six 
monoclonal antibodies were obtained which showed a 
positive reaction against the purified hog gasine 
H VK+-ATPase Four of them inhibited llie К '-ATPase 
activity One of them, called 5-B6, gave the strongest 
inhibition and was further characterized 
Double immuno-diffusion with Ig subclass specific 
anti mouse immunoglobulins showed that 5-B6 is of 
subclass IgG, By Western blot analysis of ihe purified 
H+/К+-ATPase membrane fraction, 5-Bo recognized a 
95 kDa peptide (Fig 1) fhere was no cross reactmly 
with rabbit kidney NaVK'-ATPase 
Effect on И*/К* АТРше 
The gastric HVK*-AlTase preparation contains 
К
+
-ATPase, K'-p-nilrophenylphosphaiase as well as a 
Mg2+-ATPase activity The effect of monoclonal anti­
body 5-B6 on these enzyme activities was studied with a 
non-inhibitory monoclonal antibody, directed against 
H VK'-ATPase and also partially purified as control 
Fig 2 shows the inhibition of К4-ATPase activity 
with various amounts of 5 B6 {0 04 to 150 μg/ ml) and 
with three different H V K '-ATPase concentrations (5 
15 and 50 ng/ml) in the reaction mixture The maximal 
inhibition obtained was 65% for all three H ' / K ' 
ATPase concentrations used Variation of the prein­
cubation time had no effect on the degree of inhibuion 
Activities of К''-p-nitrophenylphosphaiase and Mg 1 ' -
ATPase were not influenced (data not shown) 
The maximal extent of inhibition of К ' -ATPase 
activity by S-B6 varied with the pH in the reaction 
mixture (Fig 3) At pH 6 0, 7 0 and Я 0 the maximal 
inhibition of the К '-A TPase aciivii) was 40%, 65% and 
100%, respectively The half-inaxnnal inhibitory con 
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Fig. 1. Western blol of pig gastric H'/K^-ATPase stained with 
monoclonal antibody 5-B6 (A) Amido Black staining of proteins on 
nitrocellulose after electroblotting of a 10% SDS Polyacrylamide gel. 
Lane 1, S /ig gastric microsomal membrane proteins. Lane 2, 5 μι 
purified Η VK'-ATPase. Molecular mass markers are 94, 67, 43, 30 
and 20.1 kDa (B) Western blot stained with the anti-H */К *-ATPase 
monoclonal antibody 5-D6 Lane 1. 3 Mg gastric microsomal mem­
brane proteins. Lane 2,1 Mg punned И VK 'ATPase 
Fig 2. Inhibition of IC*-ATPase activity of H*/K*-ATPase by 
monoclonal antibody S-B6. Density gradient purified and leaky 
Η VK*-ATPase vesicles. 5 (ig/ml (Δ). 15 Mg/ml (Q) and 50 (ig/ml 
(o), were preincubated with different concentrations of monoclonal 
antibody 5-B6 at 37°C for 10 min. K*-ATPase activity at pH 7 0 was 
determined as described in Materials and Methods (representative of 
three experiments). The 100% activity in the absence of 5-B6 was 64.1 
μ mol Ρ, per mg per h. 
Fig. 3. Inhibition of К'ATPase activity of Η'/К'ATPase by 
monoclonal antibody 5-B6 as a function of pH. 15 Mg/ml leaky 
H'/K'-ATPase vesicles were preincubated with different concentra­
tions of monoclonal antibody 5-B6 in 30 mM mudarle-HCl at pH 
6 0 (О). pH 7.0 (Δ) or pH 8 0 (D) at 37 0 C for 10 min К 'ATPase 
activity was determined as described in Materials and Methods (rep­
resentative of three experiments). The 100% actisity at pH 6 0. 7 0 and 
8 0 was 29 8, 79.8 and 19 3 μ mo! P, per mg per h. respectively. 
centration of the antibody did not change with pH and 
was 15 μg of antibody/ml when 15 /»g/ml H*/K*-
ATPase was used. 
The inhibition of the K+-ATPase activity by 5-B6 
was measured as function of both K* as well as ATP 
concentration. Fig. 4 shows that 20 /ig/ml 5-B6 in an 
assay medium containing 15 Mg/ml HVK+-ATPase 
lowered the K
mJ, value from 80 to 35 /imol P, per mg 
per h. The K
m
 value for К + was lowered from 4.8 to 1.9 
mM. These results indicate that the interaction between 
K+ and 5-B6 is uncompetitive. Variation of the ATP 
concentration at a fixed K* concentration (Fig. 5) 
showed that 20 /ig/ml 5-B6 in an assay medium con-
- 0 6 -0.4 -02 OO Ql 0Л 0 6 0 8 10 U 
Fig. 4. Effect of К * concentrations on the inhibition of К -ATPase 
activity of HVK+-ATPasc by monoclonal amibod> S-B6 15 Mg/ml 
H+/K.+-ATPasc were preincubated with 20 (ig/nil 5-B6 at 37° С for 
10 min. К + ATPase activity was deternuned in assa) media contain­
ing S mM ATP. 5 mM MgCI
 2 01 mM ouabain, 30 mM imidazole-HCI 
(pH 7.0) and KCl concentrations varying between I and 10 mM. P, 
was measured as described in Materials and Methods- · . Control; o. 
S-B6 (representative of three experiments) 
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Fig S Effect of ΛΤΡ concentnuons on the inhibition of K'ATPase 
•clivity of H */K*-ATPasc by monocloiu] anubody S-1A IS ßg/nu 
ИУК'-АТРж were pranciibiled with 20 (ig/ml 5-Bi at 3 7 · С for 
10 nun K+-ATPase activity was delcrmined ac descnbed in Materials 
and Methods with assay media containing 20 mM KCl, 01 mM 
ouabain. 30 mM umdazde-HCl (pH TO), (γ-"PIATT concentrations 
varying between 0 025 and 0 S mM and MgClj ooncenlnuona varying 
between 0 05 and 1 mM, thereby maintaining an ATP/Mg3* rauo of 
1 2 · , Contrpl, Ο. 5-B6 (representative of three capenments) 
taming 15 Mg/ml H */K'''-ATPase decreased the K ^ 
value from 100 lo 25 μ mol Ρ, per mg per h. The K
m 
values did not change. The effect of 5-B6 on the K+-
ATPase reaction with respect to ATP was therefore 
noncompetitive. 
Effects on phosphoemyme 
The effect of monoclonal antibody 5-B6 on the 
steady-slate level of phosphoenzyme in the absence of 
K+ and at pH 6.0, 7 0 and 8.0, respectively, is shown in 
Fig 6. The steady-state phosphorylation level at pH 6.0, 
Λ 
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Fig. 6 Effect of monoclonal antibody 5 B6 on steady-state phos­
phoenzyme levels of HYK.*-ATPase at different pH 75 jig/mJ 
purified Η VK+-ATPase were prancubated in 30 mM imidazole·HCl 
pH 6 0 (о), pH 7 0 (л) and pH 8 0 (О) with various concentrations of 
S-B6 and 4 mM MgCl2 Imlulion of the phosphorylation and de-
lermination of phosphoenzyme levels were earned out as descnbed in 
Materials and Methods The phosphoenzyme levels, in the absence of 
5-B6 (100%), were 075 nmol/mg protein (representative of three 
expenments) 
Ime (гтит) 
Fig. 7 Effect of monoclonal antibody 5-B6 on К+-siiimilaled dephctt-
phorylauon of HVK+-ATPase PhosphoiyUiion at 0 e C of 100 
Mg/ml Η VK+-ATPase was earned out as descnbed in Maien^ls and 
Methods After 10 s dephosphorylaiion of the phosphoenzyme was 
slaned with addition of cold ATP (final concentration 1 mM), S-B6 
(final concenirauon 100 pg/ml) and KCl to a final concentration of 
0 1 mM (•) or 1 mM (A) Blank symbols represent control values; 
Stopping of the phosphorylation reaction and deierminution of phos­
phoenzyme levels were earned out as described in Mwtenah .ind 
Methods. The phosphoenzyme levels, in the absence of 5-B6 (\(Ά\% 
values), were 0 92 nmol/mg protein (represemabve of three experi­
ments) 
7.0 and 8.0 was concentration dependenily reduced to a 
maximal extent of 30%, 40% and 60%, respectively The 
half-maximal inhibitory concentration of 5-B6 in all 
cases was 30 /ig/ml with 75 Mg/ml Н*/К.+-АТРале 
used 
When the effect of S-B6 on the steady-state phospho­
rylation level was studied without preincubating with 
5-B6 (the monoclonal antibody was added at the same 
lime as phosphorylation was started) the s.ame extent of 
inhibition was seen (data not shown) These results 
indicated a very rapid binding of monoclonal antibody 
to gastric HVK+-ATPase. 
TABLE I 
Inhibttion of K* A TPase aetwity by S-B6 m iruide oui and in leaky 
votela 
80 μ g/ml Н+/К+-АТРа$е (specific aciivny 85 μ mol Ρ,/mg per h) 
was prancubated for 15 mm at room temperature with 10 μΜ 
nigencin (inside-out vesicles) or with 0 3% (w/v) saponin (leaLy 
vesicles) The К+-ATPase reaction was starled by adding 100 μΐ 
enzyme aoluuon to 300 μί isotonic assay medium with а Γιηαί con­
centration of 100 jig/ml 5-B6 The values are given as percentages 
relative to K*-ATPase activity with control mouse IgG Each value is 
the average of three separale deierminalions, each of which is done in 
duplicate. 
Perccntdge residual 
К
+
-АТРа« aciivily 
1 Inside-out vesicles 
2 Leaky vesicles 
34±7 
28±4 
30 
61 
The effect of 5-B6 on the К'-stimulated dephospho-
rylation rale is shown in Fig. 7 In this experiment 
dephosphoiylation was initiated after 10 s by adding 
cold ATP (final concentration 1 mM) along with the 
indicated concentrations of KCl and S-B6 The mono­
clonal antibody did not affect the rate of the К ^stimu­
lated dephosphoiylation, nor the second phase in the 
dephosphorylation, which is interpreted as interconver-
sioD from Ε, · Ρ to Ej · Ρ [28] 
Sidednas of mhibmon of gastric H*/K*-ATPase by 
S-B6 
For determination of the sidedness of binding of 
monoclonal anubody 5-B6 on gastric Η */K+-ATPase 
freshly isolated inside-out vesicles were used. Table I 
shows that the maximal level of inhibition of К *-ATPase 
activity was identical in inside-out vesicles as well as m 
leaky HVK+-ATPase vesicles These results indicate 
that S-B6 binds to the cytosoUc side of gastric Н*/К + -
ATPase. 
Discussion 
In the present study, the interactions of monoclonal 
anubody 5-B6 with HVK+-ATPase have been investi­
gated To clarify interpretation of the interactions of 
5-B6 with H VK+-ATPase the following enzymatic 
mechanism of gasine H */YL '-ATPase has to be consid­
ered (Fig. 8) [28-30] In this mechanism, which requires 
several steps related to binding of substrate and cauonic 
hgands, E, and Ej represent conformational states of 
the enzyme with cation binding sites facing the cytosobc 
and luminal side, respectively. 
When considering the phosphorylation reaction, the 
E, conformation can interact competitively with either 
H* or K*. The E, K* form relatively slowly reacts 
with ATP, forming an E, ATP · K+ complex At higher 
H + concentrations K* may also be displaced from the 
Ε,-Η*· 
Γ 
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Fig. I A ramón cycle at H'/K'-ATPut. Et «nd E, repiaail 
coofaniuuoOAl ilâlet of the enzyme with cauon binding siles feeing 
the суимоі end lumen, respectively I repiesenls the inhibilocy mono· 
clonel enubody 5-B6. 
enzyme and E, H* is formed This form reacts with 
ATP and the E, ATP K* with H* lo a fc, ATP H' 
complex which is subsequently phosphorybled (step 1 ) 
The Ε] Ρ form then generated, is ADP-sensnive [26] 
and converts spontaneously to E2P with concomitant 
transport of H + (step 2) [31] This form has a high 
affinity for K* at the luminal side and is rapidly hydro-
lyzed (step 3) [28] The E 2 K* form then converts to 
the E, K+ form with consequent countertransport of 
K+ (step 4) [32] 
The monoclonal antibody 5-B6, which binds to the 
95 kDa peptide in the purified Η */K '-ATPase frac­
tion, inhibited the K+-ATPast activity in a concentra­
tion dependent way The maximal extent of inhibition 
was pH dependent and was maximal at pH 8 0 Line-
weaver-Burk plots showed that inhibition of the K*-
ATPasc by 5-B6 at pH 7 0 was nontompetaive with 
respect to ATP and uncompetitive with respect to K* 
Since the stimulation of the ATP hydrolysis by Κ+ is 
mediated through an mercase of the dephosphoiylation 
rate of E 2 P, these findings would suggest an interac­
tion of 5-B6 with the Е 2 К
+
 or the E, K+ form A 
distinction between these two dephospho-forms can not 
be made since the Ej K+ to Ε, К * conversion is not a 
rale-limiting step in the enzyme cycle at the high 
ATP/K.* ratio used [28] The finding however, that 
5-B6 recognizes an epitope on the cytosolic side, would 
favour binding of 5-B6 to the Ε, · К * form The varying 
degree of maximal inhibition of the К'-ATPase activity 
at different pH can be explained by the influence of 
[Η*] on step 1 and step 3 of the enzyme cycle [29-30] 
An alkaline pH mercases the rate of the К'-stimulated 
dephosphorylation and stabilizes the Ε, K ' form of 
the enzyme which has low affinity for ATP [29] This 
results m an accumulation of the E, K ' form during 
ATP hydrolysis and therefore increases the maximal 
extent of inhibition An acidic pH on the other hand, 
stabilizes the aad-stable pbosphoenzyme by reducing 
the affinity for luminal K.' and increases the rate and 
extent of phosphorylation As a consequence, the maxi­
mal extent of inhibition by 5-B6 decreases. 
The finding that the K'-i-nitrophenylphosphatase 
activity is not inhibited by 5-B6 is consistent with 
binding of S-B6 to the E, K ' form, since hydrolysis of 
p-rutrophenylphosphale requires a dephosphoenzyme 
with a cytosobc K ' stimulation site (E, K ' ) [30] or a 
luminal К ' stimulation site (E] K ' ) [ 3 3 ] 
An alternative explanation might be that S-B6 binds 
lo a form of the enzyme which is intermediate between 
E, K ' and Ej K ' This form E(K' ) would represent 
an enzyme form which occludes K ' Such a form has 
not yet been demonstrated for H ' /K '-ATPase in con­
trast to N a ' / K '-ATPase [34,35] where such a form 
easily can be found 
The steady-state phosphorylation level of H */K *-
ATPase was reduced by S-B6 in a concentration depen-
31 
62 
dent way. The maximal extent of reduction was also pH 
dependent. A reduction of the steady-state level of 
phosphoenzyme does not indicate whether inhibition of 
formation, or stimulation of breakdown has occurred. 
Since S-B6 neither accelerated the spontaneous (data 
not shown) and the К'-stimulated dephosphorylation 
nor influenced the interconversion from Ε, · Ρ to E2-P, 
it seems possible that binding of 5-B6 prevents the 
phosphoenzyme formation. Normally, the steady-state 
level of phosphoenzyme does not change with pH, as 
does the rate of phosphorylation in the absence of K+ 
[29]. In the case of reduction of the EP level by 5-B6 
however, an alkaline pH might cause an inhibition of 
the phosphorylation rate by S-B6 through stabilizing an 
enzyme form which inhibits or slows down phospho­
rylation. This is probably an E, form without H + 
bound to it. An acidic pH on the other hand would 
favour the Ε, · Η + form, and as a result a smaller 
maximal extent of reduction of EP level by S-B6 would 
be reached. The difference in the maximal extent of 
inhibition of the К+-ATPase activity, and of reduction 
of the steady-state phosphoenzyme level at each pH 
value, can be explained by the absence of the E, • K* 
form during phosphorylation and for which 5-B6 has a 
greater affinity than for the E, form without H* bound 
to it. Therefore the enzyme conformation differs in the 
E| • K+ or E, and E, • H* in such a way that effective 
binding with monoclonal antibody 5-B6 is selective for 
the E, • K.+ form. 
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Determination of the epitope for the inhibitory monoclonal 
antibody 5-B6 on the catalytic subunit of gastric Mg2+-dependent 
H+-transporting and K+-stimulated ATPase 
Tom J F. VAN UEM, Herman G Ρ SWARTS and Jan Joep H H M. DE PONT* 
Department of Biochemistry, University of Nijmegen, Ρ Ο Box 9101, 6500 HB Nijmegen, The Netherlands 
The monoclonal antibody S-B6, directed against (he a-subumt of pig gasine H*,K*-ATPasc (Mg*'-dependent H' · 
transporting and K'-stimulatod ATPase), was shown to be a potent inhibitor of the K*-ATPasc activity, thereby binding 
to the cytoplasmic side of the x-subumt of the enzyme (Van Hem, Peters &. De Pont (1990) Biochim Biophys Acta 1023, 
56-62) In order to define the epitope for 5-B6 on pig gastric H'.K'-ATPase more precisely, the a-subunu of the eiuyme 
was subjected to limited proteolysis followed by chemical cleavage Restncted proteolysis with papain followed by 
sequence analysis yielded an immunoreactive fragment of 27 kDa beginning at Ser"' This fragment was water-soluble and 
possessed the fluorescein isothiocyanate-reaction site Limited tryptic digestion in the presence ol K' gave nse to an 
immunoreactive 56 kDa fragment beginning at lie"*, thus restricting the location of the epitope Irom Ile'" tu the C-
terminal end of the 27 kDa fragment (around residue 620) Further degradation of the 27 kDa fragmenl by means of 
formic aad cleavage at Asp-Pro bonds resulted initially in the formation of two non-immunoreaclive fragments of 17 kDa 
and 11 kDa, indicating that the epitope for 5-B6 has lo be localized around the chemical cleavage sites Asp"' and/or 
Asp*1* Companson of the pnmary structure of the a-subunils of gastnc H*,K*-ATPase and non immunoreactive rat 
kidney Na*,K*-ATPase shows almost no similanty for the sequence containing these formic acid cleavage »tes (Thr*"-
Leu-Glu-Aip-Pro-Arg-Asp-Pro-Arg11*), whereas the adjacent sequences are nearly 100υα identical These findings 
strongly suggest that the epilope for 5-B6 includes (part of) this sequence 
INTRODUCTION 
Gastnc HMf-ATPase (Mg'^-dependent HMransporting and 
K*-slimulalcd ATPase) is an intnnsic membrane protein complex 
responsible for gastnc aad secretion (1) The enzyme belongs lo 
the class of P-type ATPases [2,3] and catalyses in vitro an 
ekclroneutral exchange of 2 K* ions and 2 H* ions per molecule 
of ATP hydrolyscd (4,5) Recently it has been demonstrated that, 
m addition to the catalytic a-subumt of 114 kDa (6-8), the 
enzyme contains a glycosylated /f-subuml with a core protein of 
33 kDa [9-13] 
The hydropathy profile of the a-subumt of H*,K*-ATPase 
strongly suggests the presence of eight transmembrane segments 
with the W-terminus facing the cytoplasm (6] Evidence for the 
actual folding of the a-subumt resembling the predicted one 
comes from studies on specific chemical modifications al the 
extracellular or cytoplasmic side With the use of tightly sealed 
mside-out-onented vesicles it was shown that Lys'" reacted with 
the impermeant reagent pyndoxa! 5'-phosphate, indicating its 
location on a cytoplasmic domain of the enzyme [14] AddiUonal 
evidence that this residue faces the cytosol comes from the 
observation thai ATP prevents its chemical modification by 
pyndoxal S'-phosphate ATP also prevents FITC (fluorescein 
isothiocyanate) labelling of Lys*" ( 15), indicating Ih« cytoplasmic 
onentation of this important recognition site on the a-subumt of 
P-type ATPases 
The monoclonal antibody 5-B6, directed against the a-subumt 
of pig gasine H*,K*-ATPase, is a potent inhibitor of the K*-
ATPase activity of the enzyme [16] By using inside-out-onented 
vesicles containing native pig gastnc Η *,K·-ATPase we were 
able to show that 5-B6 recognizes the cytoplasmic side of the a-
subumt [16] In order to determine tbe epitope for 5-B6 
(apparently probing a functional domain on the a-subuml), 
identification of immunoreactive and non-immunoreactivc pep­
tides, obtained by limi led tryptic digestion [17] or papain 
digesuon [18] of gasine Η*,К'ATPase, was undertaken This 
approach made it necessary to identify the specific cleavage sites 
on the a-subumt The localization of the tryptic sues enabled us, 
moreover, to correlate the time course of formation of tryptic 
fragments of the α-subunil with the concomilam biphasic in-
activation of the K*-ATPase activity of the enzyme as previously 
found by us (17] Chemical fragmentation of a soluble fragmenl 
of the a-subumt, which was obtained by papain digestion (18), 
and an amino acid-by-amino acuì companson with the non-
immunoreactivc Na*tK+-ATPasc was earned out to characteruc 
the epitope 
The results of our expenments show that (he epitope includes 
(part of) the amino aad sequence from residue 504 to 512 This 
finding is fully consulent with the proposed folding of the a-
subunit, with a large cytoplasmic domain from amino acid 
residue 359 lo 796 [6], and suggests that the recently found 
carbohydrate moiety at Asn*** [9] faces the cytosol 
EXPERIMENTAL 
Prepantioo of gaKrk Η',Κ'-ATPase 
Membranes ennched in H*,K*-ATPasc were isolated from the 
gastnc mucosa of freshly slaughtered pigs as desenbed previously 
by us [16] Prolan was determined by {he Lowry method with 
BSA as standard 
LabeOiog of Н%К*-АТРам with FITC 
FITC-labelling of gastnc H*,K.*-ATPase was earned out as 
desenbed by Jackson 4 al [19] Briefly, gasine Η',Κ'-ATPase 
ЛЬЬГС ИІЮОІ used НМС'-АТРыс (EC Э 6 I 36), Mg"-depeiidenl H'-lransporting and K' slunulated ATPase, I-ITC Duomxin uothKa.yanatt 
Caps. 3-(cyclobexylanuno)-1 propaocsulphonic acid 
* To whom cormpondence ibould be addressed 
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was incubated at a prolan concentration of 3 mg/au ID а 
reaction medium containing 100 тм-Tns/HCl buffer, pH9 2, 
2 mu-EDTA and 5 /IM-FITC (duneihylformaimde solution). 
After incubation for 30 mm at 22 eC in the dark, a 10-Told excess 
of ice-cold 20 тм-Tns/HCl buffer, pH 7 2, containing 4 тм-
lysinc hydrochlonde was added The modified H*,K+-ATPase 
was spun down (100000 g for 1 h), washed with tbe same buffer 
and resuspended lo S mg/ml in 20 тм-Тп$/НС1 buffer, pH 7 2, 
in which 0 25 и-sucrose was included 
Tryptk digestion of Н+,К+-ЛТРв$е 
Treatment of H*,K*-ATPase wilh trypsin was earned out as 
described by Helnuch-De Jong etui [17] Peptide fragments 
charactenslic for the E, conformation (67 and 35 kDa) were 
obtained by tryptic digestion of 1 25 mg/ml H+,K+-ATPase for 
30 mm at 37 eC in a medium containing 50 m м-imidazole/HCl 
buffer, pH 7 0, 5 mM-Na,ATP, 100 тм-choline chlonde, 2 тм-
EDTA and 100 /ig of trypsm/ml Digestion under similar 
conditions, but in the presence of 100 тм-KCl and 30 μ& of 
trypsm/ml gave peptide fragments (56 and 42 kDa) charactenslic 
for the E
a
 conformation of the enzyme Tryptic digestion was 
stopped by precipitation with 5 % (w/v) trichloroacetic acid The 
pellets were washed with 30% (w/v) sucrose and resuspended in 
the sample buffer for SDS/PAGE described by Laemmh [20] 
Papaia digestion of Η',K*-ATPase 
Limited papain digestion of native and FITC-labelled H*,K.*-
ATPase was carnal out by the procedure of Saccomam & 
Mukidjdm [IS] Before use, papain (6 units/ml) was activated 
for 20 mm al 22 0C m a solution containing 20 ты-cysteme 
hydrochlonde and 2 тм-Tns/EDTA, pH 7 0 The solution was 
kepi under a stream of N, After activation, papain (0 6 unit/ml) 
was incubated at 37 "С with native or FITC-labelled enzyme 
(1 0 mg/ml) The digestion was slopped after 30 mm by adding 
lodoacelic and (20-fold molar excess over cysteine hydro­
chlonde) Tbe digested sample was cenlnfuged (100000 χ for I h) 
and the supernatant, containing a soluble FITC-labelled 27 kDa 
peptide of the catalytic subunit, was dialysed against deionized 
water and freeze-dned Finally, this peptide fragment was 
resuspended in 20 тм-Tns/HCl buffer, pH 7 2, and concentrated 
to a protein concentration of 10 mg/ml with Centneon 30 
microconcenlralors (Amicon) 
Cleavage of the 27 kDa fragment with fonale add 
Selective chemical cleavage of the 27 kDa fragment, obtained 
by papain digestion of FITC-labelled H+,K+-ATPase, at Asp-Pro 
bonds was achieved by treatment of the peptide fragment with 
70 0 0 (v/v) formic acid for 48 h at 37 0C [21] After incubation, 
samples were freeze-dned and resuspended in sample buffer for 
Tncine gels [22] 
Gel electropboresis and Western blotting 
The SDS/polyacrylamide slab gels utilized were prepared and 
used according to the procedure of Laemmh [20] and were either 
10ΟΟΟΓ8-15Ο/
Ο
 gradient gels To separate the peptide fragments 
after chemical cleavage of the 27 kDa peptide, Tncine gek [22] of 
16 5% with 3 % cross-linker were used After electrophoresis, 
the gels were soaked for 5 min in transfer buffer [10 тм-
Caps/NaOH buffer, pH 110, containing 10% (v/v) methanol] 
and subsequently electroblolled for I h at 50 V to poly(vinylidene 
difluondc) membranes (Immobilon Transfer, Millipore) [23] 
After elcclroblolling, the Immobilon membranes were nosed 
twice with deionized water Subsequent blocking of non-reactive 
sites, incubation with monoclonal antibody 5-B6 and secondary 
antibodies and staining were earned out as desenbed before [16] 
T. J. F. Van Uem, H. G Ρ Swans and J J H H M De Pont 
W-Termiiul seqoeacc aulysls 
Tbe ^-terminal sequences of proteolytic fragment;» of H\K.'-
ATPase were delcmuned by automated Edman degradation in 
an Applied Biosystems 475A gas-phase Sequenalor Therefore 
proteolytic fragments of the enzyme were separated on à Laemmh 
gel that had been aged for 24 h and pre-run with ¡.ample buffer 
in the presence of 0 001 % (v/v) thioglycolhc acid in the upper 
running buffer Electroblottmg to un Immobilon me m brant, was 
as above, except for addition of 0 001% (v/v) thioglycolhc 
acid in the transfer buffer The Immobilon membrane was 
washed in deionized water, stained with 0 I % (w/v) Coomassie 
Blue R-250 in 50% (v/v) methanol and then detained in 50", 
(v/v) methanol/10% (v/v) acetic acid The membrane was 
finally nnsed with deionized water, air-diied, and the peptide 
bands (40 prool for each peptide) of interest were cut out for N-
termmal sequence analysis 
RESULTS 
Spedficlty of monoclonal antibody 5-B6 
The monoclonal antibody 5-B6, which we described bel ore 
[16], is an antibody that spet. ι fica 11 y inhibits the К+-ATPase 
activity of gastric H*,K.*-ATPase membrane fragmenls Since 
the antibody also inhibits the enzyme in msidc-oul-oncntcd 
membrane vesicle preparations the antigenic determinant must 
be at the cytoplasmic side 
Fig I demonstrates the specificity of antibody 5-B6 for the a-
subumt of gasine H\K+-ATPase The Immobilon membrane:» 
presented contain punned membrane samples from pig Η',Κ.*-
ATPase (lane 1), rat H*,K*-ATPdse (lane 2) and rabbit kidney 
Na\ К'-ATPase (lane 3) The blot on the lei I was blamed with 
Coomassie Blue The blot on the nghl was stained with 
monoclonal antibody 5-B6 1· " evident that antibody 5-B6 
reacts equally well with the 95 kDa a-subunit of both pig and rat 
gasine H\K*-ATPase, but not wilh ihe 95 kDa a-iubunit ol 
Na+,K+-ATPase The same results were obtained m an enzyme-
linked immunosorbent assay (work nol shown) 
Lñnlted trypsin and papain digestion 
The first step in the determination of the 5-B6 epitope on the 
catalytic subumt of gasine H*,K.*~ATPase was made by carrying 
out limited tryptic and papain digestions of gastric H\K. -
ATPase, as described by Helmich-De Jong et al [17] and 
Saccomam & Mukidjam [18] These experiments were earned 
out m order to determine which of the obtained peptide fragmentь 
contains the binding site for antibody 5-B6 
We have previously shown that (he products formed upon 
tryptic digestion of gasine Η\K.+-ATPase depend on the 
conformational state of the enzyme [17] Thus in (he presence ol 
ATP two fragments are produced with apparent molecular 
masses of 35 and 67 kDa, whereas in the presence of K+ the 
α-subunit is split into fragments of 42 and 56 kDa The 
phosphorylation site, Asp,M, is present in both the 42 kDa and 
the 67 kDa fragment The presence of Asp"' in the 42 kDa 
peptide means that (his fragment must be the ^ -terminal cleavage 
product of thea-subumt On the other hand lhe67 kDa fragment 
can originate from the C-termina I as well as from the V-terminal 
part of the α-subunit, since m both саьсъ il will overlap Asp9" 
However, on the basis of structural analogy with the a(l)-subunii 
of Na*,K*-ATPase [24] we then concluded that the 67 kDa 
tryptic-digest fragment of HMC'-ATPase was musi probably on 
the C-terminal part, with Arg"7* us the putative cleavage site 
Although two of six ammo acid assignments were unccnjin 
(represented in Table I by X), we uncquivocali) conhrm in the 
present study the C-terminal ongin ol ihe 56 kDa produci by 
1991 
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1 
¥ìt 1· Wirtin Ы»І шиішіші «Г iMtfk Н*Л*-АТРтЁШ by аомсіомі 
«Mitotfy 5-BC 
Pig НМС+-АТРме (Une I. 3 i^g), rat HMC*-ATP»ie (Une 2, 3 >.g) 
and rabbit kidney Na*.K+-ATPa*e (Une 3. 5 /ig) were ran on a 10 % 
Laenunli gel and ihcn transTerred to Immobilon membranes. The 
blot on the ІеП (e), containing also molecular-mass marker proteins 
оГ 94, 67. 43. 30 and 20.1 kDa. was stained with Coomassie Blue. 
The blot on the right (b) was stained with antibody S-B6. 
±668 35 kDa 
42 kO· R4SS 
6 3 7 8 27 к 0« ± 0 3 0 
1 1 
Trypsin (ATP) 
Trypsin (K ) 
Papain 
Fig. 2. Tryptic- and p a f U Щ/ЯЕт sites «ι tb· caialytk ыіЬиші af 
Н*Д*-АТРме 
The Figure shows a linear polypeptide map of the catalytic subuoit 
of the pig enzyme. Besides Asp1**, which is phospboryUled during 
catalysis (P). and Lys*1·, which can be modified by FITC. the 
specific tryptic-digestion sites in either the presence of ATP or in the 
presence of K* as well as the digestion sites of papain are shown. 
The indicated molecular masses of Ihe frugments are the apparent 
molecular masses observed on SDS/PAGE gels. 
ТаЫа 1. /V-Termlaal s 
gastric HMt< -ATPase 
of proteolytic-digest fragments from pig 
The sequences were determined by automated Edman degradation 
and aligned to the pig ΙΓ,ΚΛ-ATPasc amino acid sequence [7]. X 
represents uncertain amino acid assignments where less than ID pmol 
of amino add phcnylthiohydan torn derivative was detected. 
Fragment Residue JV-Terminal sequence 
X M E I N D X Q L S V 
E M E I N D H Q L S V 
X V I X D A 
I V I G D A 
X T X V I X X D 
S T S V I C S D 
means of automated Edman degradation of the AMerminal part 
of this fragment and comparison with the known sequence of pig 
gastric H*,K+-ATPase. The 56 kDa fragment starts at lie4*·, 
indicating that in the presence of K* trypsin preferentially cleaves 
the a-subunit of H*,K*-ATPase at Arg"· (tryptic-cleavage site 
Tl of NaMC+-ATPase). Interestingly, the /V-terminal sequence 
of the 67 kDa fragment aligns with an ^-terminal sequence of 
the a-subunit of HMC*-ATPase starting at Glu", Our results 
demonstrate that in the presence of ATP the a-subunit of H*.K.+-
ATPase is preferentially split at Lys47 (tryptic-cleavage site T2 on 
Na*.К*-ATPase) and not at Arg'" (tryptic-cleavage site T3 on 
Na^.K.^-ATPase). Fig. 2 summarizes these findings in a linear 
polypeptide map of the catalytic subunit of H',K*-ATPasc. This 
map shows besides the tryptic-cleavage sites also the 
phosphorylation site and the FITC-reaction site. In this map the 
position of the third tryptic-cleavage site, which gives rise to the 
35 kDa fragment, is presumed to be at Lys*M. This would be the 
site trypsin preferentially attacks, since there are two basiCamino 
acid residues (Arg*47 and Lys··") next to each other. Indications 
for such a preference are given by the finding that the tryptic-
cleavage sites Τ1 and T2 of Na+,К*-ATPase also have such a pair 
of basic amino acid residues [24]. The Na+,K*-ATPase however, 
has only one basic amino acid residue in the comparable sequence 
near to residue 650, which would explain why this enzyme has no 
restricted tryptic-cleavage site in this region. 
Prolonged papain digestion of gastric И+,К *-ATPase produces 
a soluble 28 kDa peptide fragment that has both the 
(A) I' 
• t 
• 
. 67 
iS>6 
Fig. 3. Wcstcrn-Uot i l i U l a g of prolcolytlc-dlfcst frafHcats of gastric 
Η',Κ'-ATPase» by wonodonal antibody 5-Bt 
Pig gastric tr,K*-ATPase (Une 1) was digested with trypsin in the 
presence of K* (Une 2) or ATP (Une 3) and with papain (Une 4) as 
described in the Experimental section. Samples were run on a 10 "
u 
Laenunli gel and transferred to Immobilon membranes. The blot on 
the left (a) was stained with Coomassie Blue, and molecuUr-mass 
markers are 94, 67, 43, 30 and 20.1 kDa The blot on the right (ύ) 
was stained with monoclonal antibody S-B6. 
phosphorylation and the FITC-reaction site [18]. Because of 
these characteristic sites, and because of its solubility, the 
fragment is believed to originate from the putative large cyto­
plasmic domain between the fourth and the fifth transmembrane 
segments of the catalytic subumt. Since the exact cleavage sites 
for this papain digestion were also not known, the Л'-terniinal 
sequence of this soluble peptide fragment (27 kDa in our 
experiments) was determined. The Λ/-term ina I sequence is 
presented in Table I. Although four of eight amino acid residues 
could not be assigned, the ЛЧегпііпаІ sequence could be aligned 
with certainty beginning at Ser37*. The apparent molecular mass 
indicates that the fragment extends lo about residue 620. This 
correlates nicely with the findings obtained by Saccomam & 
Mukidjam [18], who observed that the fragment contains both 
the phosphorylation site Asp3"· and the FITC-reaction sue 
Lys11· The location of the 27 kDa papain-digcst fragment is also 
shown in the linear polypeptide map of Fig. 2. 
The binding of monoclonal antibody 5-B6 to the specific 
proteolytic-cleavage peptide fragments of the a-subunit of H^.K4-
ATPase is shown in Fig. 3. In this experiment pig gastric H'.K*-
ATPase (lane 1) was digested with trypsin in the presence of K' 
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Fig 4 Formic add d a n s e of tbc FlTC-bMU 27 kDa fragment 
The purified and FITC-labelkd 27 kDa fragment obteincd after 
papain digestion of pig Н\КЛАТРа« (lane 1) waj treated with 
formic uud for 48 h (lane 2) as doenbed in the Experimental 
section The samples were separated on a Тгкіпс gel and 
eleelroblotted on to an Immobilen membrane Pand (ci) shows a 
Coomassie Blue stain of the Tríeme gel The lane on the far left 
shows molecular mass markers of 94, 67,43, 30, 20 1 and 14 4 kDa 
Panel (i) shows the F1TC labelling of the fragments Panel (c) shows 
an immunostaining of the fragments with monodonaJ antibody 
5 B6 
СЭ7 27 kDa ±620 
^ 1 k Papain 
17 kDa FITC 9 kDa 2 kDa 
Fit- 5. Formic add-deavace altea OB the 27 kDa fracneat 
The Figure shows a linear polypeptide map of the catalytic subunit 
of pig H+IK* ATPase wil h the papain-digesüon sites and the forane 
acid-cleavage sites The indica ted molecular masses of the fragments 
are apparent molecular masses on Tncine gd 
(lane 2) or ATP (lane 3), and with papain (lane 4) as described 
in the Expenmental section Samples of the native enzyme, the 
trypsin-treated enzyme and the punned soluble 27 kDa peptide 
obtained after papain digestion were separated on SDS/PAGE 
gels and electro blotted on to Immobilon membranes The blot 
on (he left, which also contained the low-molecular-mass 
marken, was stained with Coomassie Blue The blot on the right 
was incubated with monoclonal antibody 5-B6 Tbc antibody 
recognized the undigested 95 kDa a>subuiut as well as the C-
tcrminal 56 kDa fragment, the N-terminal 67 kDa fragment and 
the soluble 27 kDa fragment Taking into account the location of 
the 56 kDa, 67 kDa and 27 kDa fragments on the linear poly-
peptide map of Fig 2, this implies that the sequence beginning at 
lie4" and ending near to amino acid residue 620 contains the 
commonly shared antigenic determinant of these fragments 
Ckarage of the 27 kDa fragment with formic add 
A more exact localization of the epitope on the sequence He4" 
to about ammo acid residue 620 was earned out by further 
fragmentation of the punned 27 kDa fragment by specific 
chemical cleavage of Asp-Pro bonds with formic acid as desenbed 
in the Expenmental section The 27 kDa fragment contains three 
of these bonds, al position Asp**7, Asp*10 and Aspu* Complete 
fragmentation of the punned 27 kDa fragment with formic acid 
will therefore lead to four peptide fragments On Tncine gels, 
however, the small 0 3 kDa fragment that results from cleavage 
at AspMT and Asp410 cannot be detected Identification of the 
fragments obtained is facilitated by using FITC labelling of 
Lys1" The results of chemical cleavage with lormic acid of the 
FITC-labelled and punned 27 kDa fragment and blaming with 
monoclonal antibody 5-B6 are shown in Hg 4 In this experiment 
the FITC-labelled 27 kDa fragment (lane I) was treated with 
formic aad for 48 h and the fragments obtained (lane 2) were 
separated on a Tncine gel The Coomassie Blue-stained gel (Hg 
4a) shows that the chemical cleavage resulted in Lomplete 
disappearance of the 27 kDa fragment and in the appearanu. of 
a 17 kDa, an 11 kDa and a weakly stained 9 kDa fragnuni 
Treatment of the 27 kDa fragment with lormic acid for dilferenl 
times demonstrated an initial cleavage of the fragment mio a 
17 kDa and an 11 kDa fragment whereafter the II kDa fragment 
was degraded to a 9 kDa fragment (resulti not shown) This 
phenomenon and the fact that only the 11 kDa and the 9 kDa 
fragments are FITC-labelled (Hg 4b) demonstrate an initial 
cleavage of the 27 kDa FITC-labelled fragment at Asp"T and/or 
Asp410, which results in an JV-lerminal 17 kDa fragment and an 
II kDa FITC-labelled C-lemunallragment Subsequent tied vage 
at Asp*" results in degradation of the II kDa UTC-la belled 
fragment to a 9 kDa FITC-labelled fragment Although the 
calculated molecular mass of 14773 Da of the У -termina I frag­
ment (residue 379 to 507 or 510) is smaller than the apparent 
mass of 17 kDa determined by Tncine gel eleUrophorebis, (he 
other calculated molecular masses of 11 kDa (residue 507 or 510 
to about 620) and 9 kDa (residue 507 or 510 to 603) are in good 
agreement with the observed apparent masses (12220 and 
10487 Da respectively) A summary of this cleavage by formic 
acid of the FITC-labelled 27 kDa fragment ь shown in a linear 
polypeptide map in Fig 5 
When an eleclrophoretic blot of this Tncine gel was stained 
with monoclonal antibody 5 B6, only the 27 kDa FITC-labelled 
fragment was recognized (Fig 4<) Chemical modihcaiion of the 
epitope by formic acid leading to a loss of tmmunoreaclmiy is 
nol very likely, since in the case of shorter lreaIment ût the 
27 kDa fragment with formic acid the remaining 27 kDa frag-
ment is still recognized by the monoclonal antibody (results not 
shown) The fact that there is no staining with (he 17 kDa or 
11 kDa fragment suggests that the epitope includes the amino 
acid sequence that is initially split by formic acid Asp*0T-Pro1UB 
and/or Asp'^-Pro*11 Cleavage in this region apparently leads 
to destruction of the epitope and thus to loss of immunoreauivity 
It cannot, however, be excluded that suitable folding of another 
site is inhibited when the two formic acid-den ved fragments arc 
separated 
fine speclfidty mapping of the epitope 
Since antibody 5-B6 showed no cross-reactivity with rabbit 
kidney Na*,K*-ATPase, the determination of the epitope could 
be obtained by an amino acid-by-ammo aad comparison in the 
region of AspMT and Asp»10 of H',KT-ATPases and Na'.K*-
ATPase The aligned sequences of pig H *, К •-ATPase, rat HT,KT-
ATPase and rat al Na*,К.*"-ATPase (this species is closest to 
rabbit on the evolutionary scale) are presented in Fig 6 The pig 
sequence begins at Asn"3, the residue that is most likely 
glycosylated [9,25], and ends at Lys*", the re&idue that reacts 
with FITC [15] Besides this site of cova lent modification. Fig 6 
also shows the location of the lysine residue that is specifically 
modified with pyndoxal 5'-phosphate [14] The analogous lysine 
residue of lamb kidney Na\K*-ATPase has recently also been 
demonstrated to be reactive towards pyndoxal 5 -phosphate [26] 
Examination of these aligned sequences revealed one stretch of 
residues, ammo acids 504-512 of the pig sequence, which is 
identical in the rat enzyme, but which is nearly completely 
different in Na*,К*-ATPase Since the adjacent sequences show 
nearly 100% identity, it is very likely that the binding site for 
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Topology of gasine HMC+-ATPasc 
PIP FITC 
Pig H\K' ATPm 493 N S T N K F O L S I H T L E D P R D P R H V L V M K 
Rat H* К' A T P M · 4«2 N S T N K F g L S I H T L E O P R D P R H I L V M K 
R« N.* K ' - A T P M 478 N S T N K y O L S I H k n p n a s e P K H I L V M K 
Fig. 4. "ii|Mlii cos^rtaa Ьм«гмв tke catalytic іиІиіИі of pig шшЛ rat H*JL '-ATPase· шва rat al Ν Ι ' , Κ - Α Τ Ρ Μ * 
Data an from Maeda el a/ P], Shull A Lmgrel (6) ind ShuU et α/ 127] Residues Üut are noi ккоіісві ait uiduilcd by lower-case lellen The 
pyndou] 5 -phosphate (PLP)- and FITC-rcacuoD ates and the forane sod-deavage sita are also ihown 
anubody 5-B6 includes (part of) this essential sequence from 
residue 504 lo 512 
DISCUSSION 
Efttope of aatíbody 5-B6 oa the eatalydc шЬовІі 
Tbc first step in the detemnnauon of the anligemc binding site 
on the a-subunit of gasine H*K*-ATPasc was earned out by 
identifying immunoreactive proteolytic peptide fragments of the 
a-subunit of the enzyme This approach made identification of 
the restricted proieolyiic sites on Н*,К'-АТРа$е necessary The 
tryptic-cleavage sites that have been identified were for the 
condition where ATP was present Lys" and probably Lys"", 
and for the condition where K+ was present Arg4** The 
identification of Ser"· as the ^-terminus of the 27 kDa soluble 
fragment obtained by papain digestion showed that this fragment 
is almost identical with a soluble proteotytic-digest fragment of 
the catalytic subunit that was recently isolated by Tai ei al [25] 
They earned out a limited trypuc digestion of FITC-labelled 
H+,K*-ATPiise in the presence of an amphiphihc detergent The 
soluble 27 kDa peptide fragment obtained this way showed not 
only (he FITC-binding site but also concanavahn A-brnding 
activity Its ^-terminal sequence began at AsnM* of the rat 
HMt'-ATPasc Although the iV-1 emu nal sequence of the 27 kDa 
fragment obtained in the present study is different, both sequence 
déterminations demonstrate that a large part of the putative 
cytoplasmic domain, which is proposed to start at Lys*** and to 
end at Glu™ [6], indeed has a cytoplasmic disposition 
The binding of antibody 5-B6 lo proteolytic-digest fragments 
of 67 kDa, 56 kDa and 27 kDa made it possible to limit the 
epitope lo a sequence beginning at He4*· and ending near to 
residue 620 Further chemical cleavage of the 27 kDa fragment 
with formic aad then showed that there was loss of 
immunorcactivity upon the primary cleavage of Asp-Pro bonds 
at residue 507 and/or 510 An ammo acid-by-amino acid 
companson between the region of initial formic acid cleavage in 
H+,K.+-ATPase and the similar region in non-immunoreactive 
Na*,K**ATPase showed large differences, in contrast with the 
adjacent regions of both enzymes The sequence companson 
revealed a stretch of nine ammo acid residues beginning at Thr**4 
and ending at Arg*11 that is, except for Pro*11, completely 
different in rat kidney Na Mt'-ATPase Because of its 
hydrophilicity (Thr-Leu-Glu-Asp-Pro-Arg-Asp-Pro-Arg) - it is 
assumable lhat this sequence has the potency to function as a 
strong antigenic determinant These data, taken together, seem 
to justify the conclusion lhat the epitope of antibody 5-B6 
comprises the complete or pari of the sequence from residue 504 
to 512 
This sequence is located at the cytoplasmic side of the calai y lie 
subunil, as has been demonstrated by the inhibitory action of 
antibody 5-B6 on the К*-ATPase activity of insidc-out-onented 
Н*,К"-АТРазе vesicles (16) Therefore the topological disposition 
of this sequence brings new light on the discussion about (he 
udedneas of the AMinked carbohydrate moiety at Asn4 M, which 
shows concana va b η A-binding attivity [9,25} Hall et id [9] 
detemuned by concanavalm A/colloidal-gold binding to post-
embedded inside-ou(-onen(ed Н*,К*-АТРаьс vesicles that 72'Ό 
of the reactivuy towards concanavalm A was on the inlenor of 
the veside membranes It was therefore concluded thai Asn4 M 
has an extracellular location As there was a discrepancy in the 
topological disposition of Asn4" and Lys4,T, the residue lhat 
binds pyndoxal 5 -phosphate and that is protected by ATP (14), 
it was suggested thai there is a mem bra netspanning segment in 
the putative cytoplasmic domain lhat enables extracellular 
glycosylalion to occur only four ammo aad residues away from 
Lys*". However, a membrane-spanning segment, which will 
have an α-helix structure, should be at least about 20 amino acid 
residues long The fact thai the sequence from residue 504 lo 
residue 512 faces the cytoplasmic side therefore suggests lhat ihe 
carbohydrate moiety at Asn4·· is located at the cytoplasmic side 
This topological disposition would be in much belter agreement 
with the cytoplasmic disposition of Lys4" and Lys*1*, chemical 
modification of which with pyndoxal 5 -phosphate and FITC 
respectively in both cases is prevenled by ATP Moreover, a 
cytoplasmic assignment of this glycosylated amino acid residue, 
which would be contradictory to the lurrenl model* of 
glycosylalion of mem bra ne-bound proteins, has recently also 
been demonstrated for the catalytic subunil of Na*,K*-ATPase 
[28] 
Tryptic cleavage of H Jt-ATPase 
Digestran of gasine H+,K*-ATPase by trypsin is known to 
occur at restricted sites [17] The more precise identification of 
specific uyplic-deavage sites, desenbed in the present study, 
makes it possible to correlate the time courses of the Ыphasic 
mactivation of the КЛ-ATPase activity, which is observed dunng 
tryptic digestion in the presence of both K* and ATP [17], with 
the appearance of well-defined peptide fragments on SDS/PAGE 
gels Dunng the initial rapid phase of trypiic maciivation of the 
ΚΛ-ATPasc activity, neither the K+-slimulated /»-mlrophenyl 
phosphatase activity nor the phosphurylaiion capacity of I he 
enzyme was inactiva led It was therefore concluded that it is (he 
interconversion from Ε,Ρ into E,P that is interrupted dunng this 
rapid phase [17] 
In the presence of ATP, which induces the E, conformation, 
tryptic cleavage occurs at Lys" and probably at LysM* The 
latter residue is part of a highly conserved sequence in P-iype 
ATPases [29] that forms part of the ATP-binding domain [30] 
Although ihe second tryptic-cleavage site at L) :»**· is not definitely 
determined, there are two arguments for ilm site, as follow* (1) 
Tryptic cleavage at this site will result m (he observed fragments 
with apparent masses of 35 and 67 kDa, ihe lailerconlainingthe 
asparuc aad residue that is phosphorylaled by ATP (17] (2) 
High ATP concentrauons proteci against trypiic ι пас u vat ion 
[17] Such a shielding effect of miele о udes has also been 
demonstrated for the chymolryptic-clca\ age tile and the lr>piit.-
deavage site T3 on Na*.К*-ATPase [31] Tryptic cleaxage at 
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these two Iryplic-clcavage siles in the E, СОПГОПІЫІІОП оГ the 
enzyme explains the observation that the K*-ATPuse activity is 
inhibited in a biphasical manner [17]. Since the time course of 
fonnation of the 33 kDa and 67 kDa fragment corresponds to 
the rate of the slow phase of inactivation of the K'-ATPase 
activity [17], it can be concluded that Iryptic cleavage ut Lys'" is 
responsible for the slow phase of inactivation of the К'-ATPase 
activity, i e inactivation of phosphorylation capacity and K'-
stimulated /7-nitrophenyl phosphatase activity 
Since the sum of the masses of the 35 kDa and 67 kDa 
fragments virtually equals the apparent mass of 95 kDa of the 
undigested a-subunit, the initial rapid phase of inactivation of 
the K'-ATPasc activity should be caused by splitting offa small 
fragment from the z-subumt. Although this initial tryptic cleav­
age can not be seen on the SDS/PAGE gels because of poor 
resolution [17), the presence of this site is confirmed in the 
present study by the finding that the AMenninus of the 67 kDa 
fragment begins at Glu" Therefore the rapid phase of in­
activation of the lC*-ATPase activity, caused by interrupting the 
inlerconversion from Ε,Ρ into E,P [17], very probably can be 
asenbed to cleavage at Lys". This would be in agreement with 
Na*,K+-ATPase, where cleavage of the tryptic-clcavage site T2 
at the ЛМегтшш of the catalytic subunit, corresponding to the 
Lys47 of pig HMC'-ATPase, also affects the conformational 
transition from Ε,Ρ to Ε,Ρ as well as the transition from E, to 
^ [ 2 4 ] 
We thank Dr W W De Jong for his valuable suggestion to apply Ihe 
formic acid cleavage method and Dr Ρ H G M Willems for his help in 
the piepaiaUon of this manuscnpi 
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CHAPTER 4 
Immunochemical studies of gastric Η,Κ-ATPase using 
monoclonal and polyclonal antibodies. 
Tom J.F. Van Uem, Herman G.P. Swarts and 
Jan Joep H.H.M. De Pont 
Department of Biochemistry, University of Nijmegen, 
P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. 
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The abbreviations used are: 
Η,Κ-ATPase (EC 3.6.1.36), magnesium-dependent hydrogen ion transporting and potassium-stimulated 
adenosine triphosphatase; K*-ATPase, K*-dependent adenosine triphosphatase; K+-pNPPase, 
K*-dependent p-nitrophenylphosphatase; Mg^-ATPase, Mg24'-dependent adenosine triphosphatase; 
ELISA, enzyme-linked immunosorbent assay; PBS, phosphate-buffered saline; Tween 20, 
polyoxyethylene sorbitan monolaurate; HRP, horseradish peroxidase; WGA, wheat germ agglutinin; 
SDS, sodium dodecyl sulfate; PAGE, Polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluo-
ride; CAPS, 3-[cyclohexylamino]-l-propanesulfonic acid; Ig, immunoglobulin. 
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Immunochemical studies of gastric Η,Κ-ATPase using 
monoclonal and polyclonal antibodies. 
Tom J.F. Van Uem, Herman G.P. Swarts and Jan Joep H.H.M. De Pont 
Department of Biochemistry, University of Nijmegen, P.O. Век 9101, 6500 HB Nijmegen, The Nethertand» 
SUMMARY 
Polydona! antisera and monoclonal antibodies directed against native pordne HJC-ATPase have 
been characterized with respect to their effects on the enzyme's activity and location of antigenic 
binding sites. The polyclonal antisera contained antibodies that bound to the core protein of the 
B-subunit and antibodies that recognized binding sites on the N-tenninal half of the a-subaniL No 
binding of polyclonal antibodies to the C-terminal half of the a-subnnit was observed. The polyclonal 
antibodies did not influence the activity of gastric HJC-ATPase. 
Of the monoclonal antibodies obtained, only antibody 5-B6 (Van Uem, Peters & De Pont (1991) 
Biochim. Biophys. Acta 1023, 56-62) both inhibited the IC-ATPase activity and recognized on Western 
blot the a-subnnit. The antibodies 1-F11 and 4-D10 ediibited an identical inhibitory effect on the 
KVATPase activity as antibody 5-B6, but did not bind in the Western blot assay. Experiments studying 
the effect of combinations of these three inhibitory antibodies on the If-ATPase activity, together 
with competitive ELISA aperiments, revealed that two different cytoplasmic epitopes exist for these 
antibodies. The mecfaanism of inhibition of the anti-HJC-ATPase antibodies is compared with that of 
inhibitory anti-NaJC-AITase monoclonal antibodies. 
INTRODUCTION 
Gastric Η,Κ-ATPase1 is a membrane-
embedded transport protein that forms the 
final link in the process of gastric add 
secretion [1-3]. The enzyme belongs to the 
class of phosphoenzyme-forming or P-type 
ATPase« [4], and catalyses in vitro an 
electroneutral exchange of 2 K+ and 2 H* per 
molecule of ATP hydrolysed [5,6]. In addition 
to a catalytic a-subunit of 114 kDa [7-9], the 
enzyme also consists of a heavily glycosylated 
ß-subunit of 60-80 kDa that has a core 
molecular mass of 33 kDa, and which functions 
are unknown [10-15]. 
Although cloning of the cDNAs of both a-
and D-subunit has brought a wealth of 
structural information important questions 
about the actual folding of the subunits 
through the membrane, the location of 
functionally important domains and spatial 
relationships between different regions of the 
primary structures are still unanswered. 
Antibodies directed against НДС-ATPase, and 
which even spedfically modify a particular 
reaction step of the enzyme, might provide 
clues answering these questions. To investigate 
the structure-function relationships monoclonal 
antibodies and polyclonal antisera were raised 
against the native pordne enzyme. One of the 
monoclonal antibodies, named 5-B6, has re­
cently been described [16]. It inhibited the 
K+-ATPase activity of the enzyme in a pH-
dependent way but not the K*-pNPPase 
activity. The pattern of inhibition was 
uncompetitive with respect to K*, indicating 
that it bound to the K*-bound enzyme form 
Ej'K*. The antibody 5-B6 recognized on 
Western blot the catalytic a-subunit, which 
made localization of the cytoplasmic epitope 
consisting of amino acids 504 to 512 possible 
[17]. 
In this report several other monoclonal 
antibodies and polyclonal antisera against 
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porcine HJC-ATPase, which were also obtained 
by immunization with the native enzyme, are 
characterized with respect to their effects on 
HJC-ATPase activity and location of antigenic 
binding sites. 
MATERIALS AND METHODS 
Preparation of gastric HJC-ATPase 
Membranes enriched in H.K-ATPase were 
isolated from the gastric mucosa of freshly 
slaughtered hogs as described previously by us 
[16]. The HJC-ATPase preparations that were 
used had at ЗТС a specific activity of 60-90 
μπιοί Ρ, released per mg protein per min. 
Protein was determined according to Lowry et 
al. [18], using bovine serum albumin as stan­
dard. 
Production of monoclonal antibodies 
Monoclonal hybridoma cell lines secreting 
anti-H,K-ATPase antibodies, as detected by 
ELISA-screening with native H.K-ATPase, 
were obtained by the fusion of Sp2/0 myeloma 
cells with lymphocytes of female BALB/c mice 
immunized with native Η,Κ-ATPase, according 
to the procedure reported by us before [16]. 
Subsequently, hybridoma cells producing 
anti-H,K-ATPase antibodies were injected 
intraperitoneally into BALB/c mice primed 
with pristane and the antibody-rich ascites fluid 
collected 2-3 weeks later. The immunoglobulins 
were isolated from the ascites fluid by pre­
cipitation with ammonium sulfate, adjusted 
with Tris to pH 7.4, at 50% saturation and 
subsequent dialysation against 20 mM Tris-Ha 
(pH 7.4) at 40C with three changes of the 
dialysate. Characterization of the immuno­
globulin subclasses was done with antisera 
against mouse IgG,, IgG^ IgGj,, IgGj, IgM 
and IgA, according to Oucbterlony [19]. Some 
of the IgG, antibodies were further purified by 
affinity chromatography on a Staphylococcus 
Aureus protein A-Sepharose CL-4B (Phar­
macia) column according to the manufacturer's 
instructions. Therefore ammonium sulfate pre­
cipitated antibodies were dialysed against a 
solution containing 3 M Nad and 1.5 M 
glycine, adjusted to pH 8.9 with 5 M NaOH, 
and then loaded on the protein A-Sepharose 
column. The fraction containing IgG, anti­
bodies was eluted with αϊ M citric add 
adjusted to pH 6.0 with 5 M NaOH, where­
upon citrate was removed by gel filtration on 
an Econo-Pac 10 DG (Bio-Rad) column 
equilibrated with a 50 mM Tris-HQ and 0.02% 
(w/v) sodium azide (pH 7.4) solution. 
Production of antisera against HJC-ATPase 
Lyophilized gastric HJC-ATPase, having a 
specific activity of 90 /imol P, released per mg 
protein per min, was resuspended in 0.25 M 
sucrose-20 mM Tris-HCI (pH 7.4), emulsified 
in Freund's complete adjuvant (75 ßgfmi) and 
injected subcutaneously at twenty sites (0.1 ml 
each) along the back of New Zealand White 
rabbits. Then booster injections with the same 
amount of antigen in Freund's incomplete ad-
juvant were administered biweekly, starting five 
weeks after immunization. Sera samples for 
determination of antibody titers were taken 
from the ear marginal vein on the days of 
booster injections. Antibody binding to 
HJC-ATPase was detected by ELISA-screening 
with native HJC-ATPase. 
Enzyme-linked immunosorbent assay (ELISA) 
0.5 μ% of gastric HJC-ATPase in 50 μΐ 10 
mM phosphate-buffered saline (PBS) was 
immobilized on polystyrene wells of 
flat-bottomed 96-well microtiter plates by 
overnight evaporation. Blocking was done by 
incubating with 200 μΐ of buffer A (1% (w/v) 
gelatin in PBS) for 2 h at room temperature, 
whereafter the plates were washed five times 
with buffer В (0.05% (v/v) Tween 20 in PBS). 
Incubation for 1 h at room temperature with 
100 μΙ of hybridoma culture supernatant or 
antiserum (diluted with buffer A) was followed 
by five times washing with buffer В and 
subsequent incubation with 100 μΐ of HRP-
conjugated rabbit-anti-mouse or HRP-
conjugated swine-anti-rabbit immunoglobulins 
(Dakopatts, Denmark) diluted 1:800 in buffer 
A. After five times washing with buffer В 
bound antibody was detected using 100 μΐ of 
o-phenylenediamine substrate solution (0.4 
mg/ml o-phenylenediamine and 0.012% (w/v) 
hydrogen peroxide in 100 mM dtrate-
pbosphate buffer (pH 5.0)). After 10 min 
incubation the reaction was terminated with 
100 μΙ of 2 M HjSO, and the absorbance of the 
reaction solution was measured at 490 nm 
using a Titertek Multiscan plate reader (Flow 
Laboratories). Tiler values were defined as the 
reciprocal values of dilutions of antiserum, 
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ascites or antibody-containing media that give 
50% maximal binding in ELISA. 
Labelling of monoclonal antibodies with 
horseradish peroxidase (HRP) 
For competition binding studies carried out 
in order to determine whether the isolated 
monoclonal antibodies are directed towards 
different or identical antigenic sites of 
Η,Κ-ATPase, partially purified immuno­
globulins (ammonium sulfate precipitation and 
dialysis) were labelled with HRP according to 
the manufacturer's instructions (Sigma, SL 
Louis, MO, USA). Briefly, 2 mg HRP was 
dissolved in 500 μΐ distilled water, whereafter 
100 μΐ 0.1 M NaI04 was added and the mixture 
thoroughly mixed (all reactions were carried 
out in the dark and at room temperature). 
After 20 min the activation was stopped by 
dialysis for 16 h against 1 mM acetic acid. The 
activated-HRP solution (0.7 ml) was then 
thoroughly mixed for 2 h with 0.5 ml 
immunoglobulins (5.6 mg/ml) and 5 /il 0.1 M 
NaHCO, (pH 9.5). Finally, the coupling 
reaction was stopped by adding 0.5 ml of a 
2.4% NaiHPO* 0.8% NaCl, 4% glycine and 
21.3% sucrose (pH 7.6) solution and after 1 h 
the HRP-labelled immunoglobulins were 
frozen at -20°C. 
Spectrophotometric ATPase andpNPPase assay 
The ATPase and pNPPase activities of 
gastric Η,Κ-ATPase were determined at ЗТС 
in a total volume of 400 μΐ, according to 
Schrijen et al. [20]. The reaction mixtures 
contained 30 mM imidazole-HCl (pH 7.0), 5 
mM MgClb 0.1 mM ouabain, 20 mM KCl or 
20 mM choline chloride and 5 mM Na2ATP or 
5 mM pNPP, respectively. The K*-ATPase and 
K*-pNPPase activities were obtained from the 
difference in activity with КО and choline 
chloride. The Mj¿*-ATPase activity was 
obtained in the absence of K* and calculated 
as the difference between activity at 37°C and 
0°C The effects of polyclonal and monoclonal 
antibodies on these catalytic activities were 
determined after prior incubation of 5-10 μg of 
Η,Κ-ATPase in 30 mM imidazole-HCl (pH 
7.0) with varying amounts of serum or purified 
antibodies at ЗТ'С for 10 min, followed by the 
addition of reaction media to initiate the 
hydrolytic reactions. 
Radioactive ATPase assay 
In order to determine the effect of 
monoclonal antibodies on the ATP-dependency 
of the K*-ATPase reaction, Η,Κ-ATPase was 
preincubated at 370C for 10 min with varying 
amounts af purified antibodies, followed by the 
addition of reaction medium giving a total 
volume of 200 μΐ and final concentrations of 30 
mM imidazole-HCl (pH 7.0), 0.1 mM ouabain, 
20 mM KCl or 20 mM choline chloride and 
various concentrations of [gamma-32P]ATP, 
specific activity 0.5-5 Ci.mol ' (Radiochemical 
Centre Amersham, UK) and Mg2* at a ratio of 
0.5. The reaction was terminated by adding 800 
μΐ 5% (w/v) trichloroacetic acid/10% (w/v) 
Norit. After 10 min the mixture was 
centrifuged at 1500 g (Heraeus Christ), where­
after 200 μΐ of the supernatant was counted in 
a Packard 2200CA liquid scintillation counter. 
Tiyptic digestion of Η,Κ-ATPase 
Treatment of Η,Κ-ATPase with trypsin was 
carried out as described by Helmich-De Jong et 
al. [21]. Peptide fragments characteristic for the 
Ε,-conformation (67 and 35 kDa) were 
obtained by tryptic digestion of 1.25 mg/ml 
Η,Κ-ATPase for 30 min at 37°C in a medium 
containing 50 mM imidazole-HCl (pH 7.0), 5 
mM NajATP, 100 mM choline chloride, 2 mM 
EDTA and 100 μg of trypsin/ml. Digestion 
under similar conditions, but in the presence of 
100 mM KCl and 30 μg of trypsin/ml gave pep­
tide fragments (56 and 42 kDa) characteristic 
for the Ej-conformation of the enzyme. Tryptic 
digestion was stopped by precipitation with 5% 
(v/v) trichloroacetic acid. The pellets were 
washed with 30% (w/v) sucrose and 
resuspended in sample buffer for SDS-
polyaciylamide gel electrophoresis described by 
Laemmli [22]. 
Papain digestion of Η,Κ-ATPase 
Limited papain digestion of Η,Κ-ATPase 
was carried out according to Saccomani and 
Mukidjam [23]. Before use, papain (6 units/ml) 
was activated for 20 min at 22°C in a solution 
containing 20 mM cysteine-HCl and 2 mM 
Tris-EDTA (pH 7.0). The solution was kept 
under a stream of nitrogen. After activation, 
papain (0.6 unit/ml) was incubated at УТС 
with Η,Κ-ATPase (1.0 mg/ml). The digestion 
was stopped after 30 min by adding iodoacetic 
acid (20-fold molar excess over cysteine-HCl). 
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The digested sample was cemrifuged (100,000 
g, 1 h) and the supernatant, containing a 
soluble 27 kDa peptide of the catalytic subunit, 
was dialysed against deionized H20 and 
lyophilized. Finally, this peptide fragment was 
resuspended in 20 mM Tris-HQ (pH 7.2) and 
concentrated to a protein concentration of 10 
mg/ml using a Centricon 30 microconcentrator 
(Amicon). 
Enzymatic degfycosylation of H,K-ATPase 
Deglycosylation of N-linked carbohydrates 
on HJC-ATPase was performed by incubation 
of 0.S mg/ml Η,Κ-ATPase in a medium con­
taining 100 units/ml peptide-N-glycosidase F 
from Flavobacterium meningosepticum 
(N-Glycosidase F, Boehringer Mannheim 
Biochemica), 25 mM imidazole-HCl (pH 7.4), 
5 mM EDTA, 0.5 mM DTE and 0.5% (w/v) 
n-octylglucoside for 16h at 37 e C The reaction 
was terminated by the addition of SDS-PAGE 
sample buffer. 
Gel Electrophoresis and Western Blotting with 
anti-H,K-ATPase antibodies and wheat germ 
agglutinin (WGA) 
The 10% SDS-polyacrylamide slab gels 
utilized were prepared and used according to 
the procedure of Laemmli [22]. After elec­
trophoresis the gels were soaked for 5 min in 
transfer buffer (10 mM CAPS-NaOH (pH 
11.0), 10% (VA') methanol) and subsequently 
electroblotted for 1 h at 50 V to PVDF 
membranes (Immobilem Transfer, Millipore) 
[24]. After electroblotting the PVDF 
membranes were rinsed twice with deionized 
water. Subsequent blocking of non-reactive 
sites, incubation with primary and secondary 
antibodies, and staining was carried out as 
described before [16]. 
Probing of the membranes with the 
HRP-conjugated lectin WGA (Sigma, St. 
Louis, MO, USA) was performed as follows. 
Membranes were blocked for 2 h with 1% 
(w/v) gelatin and 0.05% (w/v) Tween 20 in 
phosphate-buffered saline, pH 7.4, incubated 
for 1 h with 1:300 dilution of HRP-conjugated 
WGA and finally s ta ined with 
4-chloro-l-naphthol as the chromogenic 
substrate for HRP. 
RESULTS 
Binding of polyclonal antisera to Η,Κ-ATPase 
Native porcine HJC-ATPase was injected 
Into two rabbits (HK73 and HK74) and the 
development of the antiserum titers against 
Η,Κ-ATPase was followed by ELISA-screening 
with the native enzyme. Fig. 1 shows the 
development of the antiserum titers of both 
rabbits. About eight to nine weeks after the 
first injection the antiserum titers of both 
animals were maximal. When the titers started 
to decrease both rabbits were bled and the sera 
HK73 and HK74 that were obtained showed 
antiserum titers of 10,000 and 4,600, 
respectively. 
The specificity of the antisera HK73 and 
HK74 and the location of the major antibody 
binding sites were subsequently determined by 
an immunoblot assay. For the latter 
determination limited proteolytic 
fragmentation of the Η,Κ-ATPase catalytic 
a-subunit was carried out. Fig. 2 is a schematic 
diagram of the a-subunit of Η,Κ-ATPase 
showing the locations of the proteolytic frag­
ments obtained by limited tryptic and papain 
digestion [17]. Moreover, in order to determine 
whether the core protein of the B-subunit was 
recognized by the polyclonal antibodies 
enzymatic deglycosylation of gastric 
Η,Κ-ATPase with N-Glycosidase F (an enzyme 
that only hydrolyses N-linked oligosaccharides) 
was also performed [10,11]. Fig. 3 shows a 
typical Coomassie-stained SDS-gel of porcine 
Η,Κ-ATPase samples that were enzymatically 
degtycosylated, and which contain the 33 kDa 
0-subunit as major deglycosylation product. 
The results that were obtained in the 
immunoblot assay with antiserum HK74 are 
presented in Fig. 4. These results are also 
representative for antiserum HK73 that showed 
identical immunological reactions. The 
antiserum HK74 contains antibodies that 
recognize the 95 kDa catalytic a-subunit as well 
as antibodies that bind to the 60-80 kDa 
heavily glycosylated ß-subunit (Fig. 4B, lane 1). 
In addition to the probably strong antigenic 
carbohydrates of the 0-subunit, the 
anti-D-subunit antibodies are also directed 
against the protein moiety, as can be seen in 
Fig 4B, lane 5, where the 35 kDa core protein 
of the D-subunit, which is obtained after 
enzymatic deglycosylation, is also recognized by 
antibodies of antiserum HK74. The antibodies 
directed against the porcine Η,Κ-ATPase 
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Fig. L Development of antiserum titeis in rabbits HK73 (squares) and HK74 (ciides) jmmnnfo^ with 
native ЦК-ATPase 
Rabbits were immunized and boostered with ISO ßg Η,Κ-ATPase each. Days of booster injections are 
indicated by dark symbols. 
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Fig. 2. Scheme of proteolytic-digest fragments of the porcine НДС-ATPase a-subunit 
The scheme [17] shows the locations of selective proteolytic sites and the apparent molecular masses of 
proteolytic-digest fragments of the Η,Κ-ATPase a-subunit obtained by digestion of porcine 
Η,Κ-ATPase either with trypsin in the presence of ATP or K\ or with papain. 
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Fig. 3. Coomassic Bloe-stained SDS-gcl of N-glyoosidase F-treated perdile НДС-ATPase 
Five μg porcine gastric Η,Κ-ATPase (lane 1) was incubated for 16 h with N-glycosidase F (lane 2) or 
with N-glycosidase F and 0.2% (w/v) SDS (lane 3) as described in Materials and Methods. The 33 kDa 
core protein of the B-subunit resulting from enzymatic deglycosylation is indicated with an arrowhead. 
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Fig. 4. Western blot staining of antiserum HK74 with НДС-ATPase 
Porcine gastric Η,Κ-ATPase (lane 1, 0.5 μg) was either digested with trypsin in the presence of ATP 
(lane 2, 0.5 ßg) or K+ (lane 3, 0.5 μg) and with papain (lane 4, 1.0 μg), or treated with N-glycosidase F 
(lane 5, 0.4 μg) as described in Materials and Methods. These samples plus rat gastric Η,Κ-ATPase 
(lane 6, 1.0 μg) and rabbit kidney Na,K-ATPase (lane 7, 1.0 μg) were separated on a 10% Laemmli gel 
and transferred to a PVDF-membrane. (A) Coomassie Blue-stained SDS-gel. (B) Western blot 
incubated with 1:300 dilution of antiserum HK74 and 1:500 dilution of HRP-conjugated 
swine-anti-rabbit immunoglobulins. 
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α-subunit cross-reacted with the rat 
HJC-ATPase α-subunit (Fig 4B, lane 6), but 
showed no cross-reactivity with either the 
catalytic subunit of rabbit kidney Na.K-ATPase 
(Fig. 4B, lane 7) or the catalytic subunits of 
Ca-ATPase of either the sarcoplasmic reti­
culum or the plasma membrane (results not 
presented). 
The location of the major antibody binding 
sites on the H,K-ATPase α-subunit was 
determined by the binding of antibodies in 
antiserum HK74 to proteolytic fragments of 
the α-subunit on immunoblot Of the 
fragments of 67 kDa and 35 kDa, obtained by 
tryptic digestion in the presence of ATP (Fig. 
4A, lane 2), only the N-terminal 67 kDa 
fragment contains strong antibody binding sites 
(Fig. 4B, lane 2). The antiserum HK74 also 
contains antibodies that recognize sites on 
fragments of 42 kDa and 56 kDa, which are 
produced from the α-subunit upon tryptic 
digestion in the presence of K* (Fig. 4B, lane 
3). Since the C-terminal 35 kDa fragment 
contains no antibody binding sites, the 
antibody binding region of the 56 kDa 
fragment comprises maximally about 200 amino 
acid residues, i.e. from residue 456 to about 
668 (Fig. 2). Evidence for a strong antigenicity 
of the central part of the α-subunit is also 
provided by the binding of antibodies of 
antiserum HK74 to the 27 kDa fragment, 
obtained by digestion of the α-subunit with 
papain (Fig. 4B, lane 4). 
Binding of monoclonal antibodies to 
H,K-ATPase 
Two cell fusions, using spleen cells from 
mice that had developed antisera against the 
native Η,Κ-ATPase as shown by ELISA, 
produced several stable monoclonal hybridoma 
cell lines. The screening of the hybridoma cell 
lines producing anti-H,K-ATPase antibodies 
was done using cell culture supernatant 
samples and testing the antibody's ability to 
bind to the native Η,Κ-ATPase in the ELISA 
and to inhibit the K*-ATPase activity of the 
enzyme. Based on strong ELISA reactions 
and/or the inhibitory effects on the K+-ATPase 
activity of Η,Κ-ATPase six monoclonal 
hybridoma cell lines were selected and grown 
as ascites tumors. The properties of the 
monoclonal antibodies produced by these cells 
are summarized in Table I. 
All monoclonal antibodies were shown to 
recognize both native porcine НДС-ATPase and 
native rat Η,Κ-ATPase in the solid surface 
adsorption assay. None of them cross-reacted 
in the ELISA with native rabbit kidney 
Na.K-ATPase. Although the protein A-purified 
antibodies 5-B6, 4-D10 and 1-F11 showed 
nearly identical affinities to native Η,Κ-ATPase 
(the half-values of the maximum binding varied 
between 0.2 and 0.3 nM, using a molecular 
mass for IgG! of 162000), only antibody 5-B6 
did bind to the 95 kDa α-subunit of both 
porcine and rat gastric Η,Κ-ATPase in the 
Western blot assay [16]. Also antibody 5-D6 
did neither recognize the 95 kDa α-subunit nor 
the 60-80 kDa B-subunit by Western blot 
analysis. 
On the other hand, the antibodies 2-F11 
and 2-A7 bound to polypeptides of 
НДС-ATPase in the Western blot analysis. The 
results that were obtained in the Immunoblot 
assay with antibody 2-A7 are presented in Fig. 
5A. The immunological reactions of antibody 
2-F11 paralleled the results from antibody 
2-A7 and are therefore not shown. In Fig. 5A, 
lane 1, it is shown that antibody 2-A7 binds to 
a region between 60 and 100 kDa of the 
purified Η,Κ-ATPase. In order to determine 
whether the catalytic a-subunit is recognized by 
antibody 2-A7, limited digestion of 
Η,Κ-ATPase with papain and with trypsin in 
the presence of either ATP or K* was carried 
out [17]. Fig. 5A, lane 2, shows that antibody 
2-A7 binds to a 95 kDa polypeptide and to a 
60-80 kDa region. It did neither bind to the 67 
kDa nor to the 35 kDa tryptic-digest fragments 
of the α-subunit, which are produced upon 
tryptic digestion of Η,Κ-ATPase in the 
presence of ATP. Of the fragments of 42 kDa 
and 56 kDa, obtained by tryptic digestion of 
Η,Κ-ATPase in the presence of K*, none was 
recognized by 2-A7 (Fig. 5A, lane 3). In this 
case antibody 2-A7 also only stained the 60-80 
kDa region and the 95 kDa polypeptide. The 
soluble 27 kDa fragment, which derived from 
the α-subunit and which was obtained by 
papain digestion of Η,Κ-ATPase, was also not 
recognized by antibody 2-A7 (Fig. 5A, lane 4). 
Since none of the proteolytic-digest fragments 
of the Η,Κ-ATPase α-subunit was recognized 
by antibody 2-A7, it is very likely that the 
immuno-reactive 95 kDa polypeptide is not the 
catalytic α-subunit but instead another 
polypeptide migrating as the a-subunit on 
SDS-gels. 
The intense staining of the 60-80 kDa 
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TABLE I 
Hybridoma cell lines producing anti-HJC-ATPase antibodies 
Screening of the monoclonal hybridoma cell lines was based on ELISA-signals and/or the ability of 
produced antibodies to inhibit K*-ATPase activity of gastric Η,Κ-ATPase as described in Materials and 
Methods. 
Cell line 
5-B6' 
4-D10 
l-FU 
2-F11 
2-A7 
5-D6 
If class 
IgG, 
IgG, 
IgG, 
IgG; 
IgM 
IgM 
Ascites liter 
33000 
45000 
12000 
30000 
13000 
12000 
Purification 
grade 
Protein A 
Protein A 
Protein A 
(NH^jSO, 
ascites 
ascites 
Inhibition 
K*-ATPase 
+ 
+ 
+ 
-
-
-
o-subunit 
Pig 
+ 
-
-
-
-
-
ß-subunil 
Ρ« 
-
-
-
+ J 
+2 
-
The characteristics of monoclonal antibody 5-B6 were previously described [16]. 
The carbohydrate moiety of the porcine Η,Κ-ATPase B-subunit is recognized. 
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ÍN 
Fig. S. Western blot staining of monoclonal antibody 2-A7 (A) and WGA (B) with H,K ATPase 
Porcine gastric Η,Κ-ATPase (lane 1, 0.5 μ£) was either digested with trypsin in the presence of ATP 
(lane 2, 0.5 ßg) or K+ (lane 3, 0.5 μg) and with papain (lane 4, 1.0 μg), or treated with N-glycosidase F 
(lane 5, 0.4 /ig) as described in Materials and Methods. These samples plus rat gastric Η,Κ-ATPase 
(lane 6, 1.0 μg) and rabbit kidney Na,K-ATPase (lane 7, 1.0 μg) were separated on 10% Laemmli gels 
and transferred to PVDF-membranes. The immunoblots were either incubated with (A) antibody 2-A7 
and HRP-conjugated second antibody or with (B) HRP-conjugated WGA 
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region suggested that the Η,Κ-ATPase 
D-subunit is the antigen to which antibody 
2-A7 binds. Therefore, enzymatic 
deglycosylation of Η,Κ-ATPase was performed 
to determine whether the large carbohydrate 
moiety or the 35 k£>a core protein [10,11] of 
the Η,Κ-ATPase B-subunit is the antigen for 
the antibodies 2-A7 and 2-F11. In Fig. 5A, lane 
5, it is shown that with deglycosylated 
НДС-ATPase there is only a faint staining of 
the 60-80 kDa region and the 95 kDa 
polypeptide left. This is presumably caused by 
an incomplete deglycosylation of the 
НДС-ATPase sample. However, it is remarkable 
that there is no staining of the 35 kDa core 
protein, indicating that both antibodies 
probably bind to the carbohydrate moiety of 
the Q-subunit. The cross-reaction with the 95 
kDa polypeptide therefore implies that this 
antigen is also glycosylated. 
The glycoprotein nature of the 95 kDa 
antigen was subsequently tested by 
WGA-binding to Η,Κ-ATPase in the Western 
blot assay. The results of WGA-binding to 
Η,Κ-ATPase samples, which are identical to 
the samples used for determination of the 
antigen of antibodies 2-A7 and 2-F11 (Fig. 
5A), are shown in Fig. 5B. The results 
presented demonstrate that in addition to the 
60-80 kDa B-subunit also the 95 kDa 
polypeptide binds WGA (Fig. 5B, lane 2). 
Interestingly, there was a very weak 
WGA-binding to the B-subunit of rat 
Η,Κ-ATPase (Fig. 5B, Urne 6). The rat 
B-subunit had an apparent molecular mass of 
60-70 kDa. Compared to the 60-80 kDa 
porcine B-subunit the apparent molecular mass 
of the rat B-subunit suggests a lower hetero-
genicity of the carbohydrates of the rat 
B-subunit. The lack of binding of antibodies 
2-A7 and 2-F11 to rat Η,Κ-ATPase in the 
Western blot assay, as shown in Fig. 5A lane 6, 
therefore could be caused by the different 
carbohydrate composition of the rat 
НДС-ATPase B-subunit. 
Effect of antibodies on hydrofytk activities of 
Η,Κ-ATPase 
The screening of monoclonal hybridoma 
cell lines producing anti-H,K-ATPase 
antibodies was not only based on strong 
ELISA-signals, but also on the ability of the 
antibodies to inhibit the K'-ATPase activity of 
gastric Η,Κ-ATPase. In contrast with the 
polyclonal antisera HK73 and №74, which did 
not inhibit the K*-ATPase activity, three of the 
six antibodies presented in Table I were shown 
to inhibit this hydrolytic activity. Besides 
monoclonal antibody 5-B6, the characteristics 
of which «vere previously described [16], the 
antibodies 1-F11 and 4-D10 also inhibited the 
K*-ATPase activity. As in case of antibody 
5-B6, both the K+-pNPPase activity and the 
Mg2+-ATPase activity of gastric Η,Κ-ATPase 
were not inhibited by the antibodies 1-F11 and 
4-D10. 
The mechanism of inhibition of the 
K*-ATPase activity by antibodies 1-F11 and 
4-D10 showed to be identical with that of 
antibody 5-B6. Experiments with freshly 
isolated inside-out-oriented gastric vesicles 
demonstrated that the maximal levels of inhi­
bition of the K*-ATPase activity were Identical, 
whether the vesicles were left closed or made 
leaky with non-inhibitory concentrations of 
saponin. This indicates that both antibodies 
bind to the cytoplasmic side of gastric 
НДС-ATPase (Table II). The maximal extent of 
inhibition of the K*-ATPase activity by the 
antibodies 1-F11 and 4-D10 showed also to be 
dependent on the pH-value of the ATPase 
assay medium. Whereas the maximal level of 
inhibition of the K*-ATPase activity by the 
antibodies 1-F11 and 4-D10 at pH 7.0 was 62% 
and 65%, respectively, levels of 50% and 53% 
at pH 6.0, and 90% and 85% at pH 8.0 were 
reached. For antibody 5-B6 the respective 
values are 40% at pH 6.0, 65% at pH 7.0 and 
100% at pH 8.0 [16]. The inhibition of the 
K*-ATPase activity by the antibodies 1-F11 
and 4-D10 was also measured as function of 
the K* as well as the ATP concentration. Fig. 
6A shows that 25 /ug/tal antibody 1-F11 led to a 
decrease of V
e o
 by 57% and to a decrease of 
the K„ value for K* from 4.8 to 2.5 mM, 
indicating that the Inhibition by antibody 1-F11 
is uncompetitive with respect to K*. With 
antibody 4-D10 identical results were obtained 
(data not shown). The results of the expe­
riments dealing with the ATP-dependency of 
the inhibition of the K*-ATPase activity by 
antibody 1-F11 are presented in Fig. 6B. 
Antibody 1-F11 (40 Mg/ml) inhibited the 
K'-ATPase activity noncompetitive with res­
pect to ATP, as can be seen by the V^, that is 
lowered by 68% and the K, value for ATP that 
is unchanged. With respect to the ATP-
dependency, identical results were observed 
with antibody 4-D10 (data not shown). 
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Effect of combination of monoclonal antibodies 
on IC-ATPase activity cf gastric HJt-ATPase 
Since the Inhibitory monoclonal antibodies 
1-F11, 4-D10 and 5-B6 showed identical 
characteristics with respect to their inhibitory 
effect on the K*-ATPase activity of gastric 
HJC-ATPase, the influence of several 
combinations of these antibodies on the 
K*-ATPase activity was studied in order to 
determine if they bind to the same determinant 
site. Using the maximal inhibitory 
concentration of each of the respective 
antibodies, it was expected that in case an 
identical antigenic site is involved, addition of 
any of the other antibodies would not lead to 
an increase of the maximal level of inhibition. 
Interestingly however, the results presented in 
Fig. 7 provided an demonstration that the 
antibodies can bind independently and that 
separated antigenic sites are involved. 
Combination of antibody 1-F11 either with 
antibody 4-D10 or with the non-inhibitory 
antibody 2-F11 (taken as control) did not 
increase the level of inhibition. On the other 
hand, the combination of antibody 1-F11 with 
antibody 5-B6 increased the maxima] level of 
inhibition up to 100%. This indicates that 
antibody 5-B6 binds to an antigenic 
determinant different from that of antibody 
1-F11, and that antibody 4-D10 shares the 
antigenic determinant with antibody 1-F11. 
Complementary experiments with combinations 
of fixed concentrations of antibodies 4-D10 and 
5-B6 with varying concentrations of the other 
antibodies (Fig. 7) clearly demonstrated the 
presence of two antigenic binding sites for the 
three inhibitory antibodies, I.e. one site for 
5-B6 and one common site for 1-F11 and 
4-D10. 
Competitive ELISA 
In order to determine whether the 
inhibitory monoclonal antibodies bound to 
identical or to different antigenic sites on 
gastric Η,Κ-ATPase, competitive binding 
studies with an ELISA were performed. This 
was done by using a fixed concentration of 
HRP-conjugated antibody with increasing 
concentrations of unconjugated-antibody to 
compete for binding to gastric Η,Κ-ATPase. 
Fig. 8 shows that the unlabelled antibodies 
1-F11, 4-D10 and 5-B6 could compete for the 
binding of their respective labelled 
counterparts. These are the internal controls. It 
b also shown that antibody 4-D10 competes for 
the binding of antibody 1-F11, and that there Is 
neither competition between binding of 
antibody 1-F11 and antibody 5-B6, nor between 
binding of antibody 4-D10 and antibody 5-B6. 
Thus, these experiments are an additional 
demonstration that the three inhibitoiy 
antibodies bind to two separate determinant 
sites. 
DISCUSSION 
In this report the production and charac­
terization of polyclonal antisera and 
monoclonal antibodies against porcine gastric 
Η,Κ-ATPase is described. Both polyclonal anti-
sera and only one of the monoclonal 
antibodies, namely 5-B6 [16,17], which were 
raised to the native enzyme recognized on 
Western blot the catalytic a-subuniL Besides 
the monoclonal antibodies 2-F11 and 2-A7, 
which bind to the carbohydrate moiety on the 
Η,Κ-ATPase B-subunit and to a 95 kDa 
glycoprotein, the other monoclonal antibodies 
did not bind to any of the HJC-ATPase 
polypeptides in the Western blot assay. How­
ever, on the basis of the similarity between the 
mechanism of inhibition of the K*-ATPase 
activity of antibody 5-B6, which does bind to 
the a-subunlt in the Western blot assay, and 
the mechanism of inhibition of the antibodies 
1-F11 and 4-D10, it is veiy likely that the anti­
bodies 1-F11 and 4-D10 also bind to the α-sub-
unit The difference between the reactivity of 
the different inhibitoiy antibodies in the 
Western blot assay can then be explained by 
binding of the antibodies to either a con­
tinuous, as in case of antibody 5-B6 [17], or a 
discontinuous epitope, i.e. binding is either to 
a short amino acid sequence that is preserved 
after SDS-PAGE or to a conformationaUy 
dependent structure. Additional support for 
the existence of two different epitopes for the 
inhibitoiy antibodies is provided by the experi­
ments studying the effect of combinations of 
the antibodies 1-F11, 4-D10 and 5-B6 on the 
K*-ATPase activity of gastric Η,Κ-ATPase, and 
by the competitive ELISA experiments. 
It is interesting to note that, although the 
inhibitoiy antibodies 1-F11, 4-D10 and 5-B6 
bind to different antigenic determinants on the 
Η,Κ-ATPase a-subunit, they all display an 
Identical inhibitoiy effect on the K*-ATPase 
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Maximal level of inhibition of K*-ATPase activity of inside-out-oriented gastric vesicles by 
anti-HJC-ATPase monoclonal antibodies 
The ATPase assay was performed with 20 ßg/ml gastric Η,Κ-ATPase (specific activity 70-95 дтоі 
Р.-п^.К
1) and 100 Mg/ml monoclonal antibody (purified by ammonium sulfate precipitation) as 
described in Materials and Methods. The activity in inside-out oriented closed vesicles was determined 
with 10 μΜ nigericin, whereas the activity in leaky vesicles was determined with 0.3% (w/v) saponin. 
The values are given as percentages inhibition of Ю-ATPase activity. Each value is the average of 
three separate determinations, each of which is done in duplicate. 
Closed vesicles 
Leaky vesicles 
l-FU 4-D10 5-B6 
65 ±9 62 ± 7 69 ± 7 
71 ± 8 67 ± 7 76 ± 11 
A В 
Fig. 6. Effea of K* and ATP concentrations on the inhibition of the K*-ATPase activity of gastric 
ЦК-ATPase by monoclonal antibody 1-F11 
The K*-dependency (A) and the ATP-dependency (B) of the K*-ATPase reaction were measured as 
described in Materials and Methods, using in (A) 15 ßg/ml Η,Κ-ATPase and 0 (circles), 10 (squares) 
and 25 (triangles) jig/ml antibody; in (B) 20 ßg/ml Η,Κ-ATPase and 0 (circles), 15 (squares) and 40 
(triangles) ßg/ml antibody. The antibody 1-F11 used was purified by ammonium sulfate precipitation. 
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Flg. 7. Effect of combmations of monodonal antibodies on the K*-ATPase activity of gastric 
НДС-ATPase 
For the K+-ATPase reaction 15 Mg/ml gastric Η,Κ-ATPase was incubated with (i) 100 ¿ig/ml 1-Fll and 
varying concentrations of 2-Fll (squares), 4-D10 (circles) and 5-B6 (triangles), (ii) 50 ßg/ml 4-D10 and 
varying concentrations of 2-Fll (circles), 1-Fll (squares) and 5-B6 (triangles), (iii) 30 ßg/ml 5-Вб and 
varying concentrations of 1-Fll (circles), 2-Fll (squares) and 4-D10 (triangles). The monoclonal 
antibodies used were purified by ammonium sulfate precipitation, and the assay was performed as de­
scribed in Materials and Methods. 
1-F11 4-D10 6-B6 
Fig. & Competition binding of anti-HJC-ATPase monodonal antibodies 
The effect of increasing concentrations of unlabelled antibody 1-Fll (squares), 4-D10 (triangles) and 
5-B6 (circles) on binding of the HRP-conjugated antibodies 1-Fll, 4-D10 and 5-B6 to native gastric 
Η,Κ-ATPase was tested in the ELISA Incubation with the different combinations of labelled and 
unlabelled antibodies was performed for 2 h, whereafter bound antibody was detected with o-phenyl-
enediamine as substrate for the HRP, as described in Materials and Methods. Values are given as the 
percentage of antibody binding relative to that for a fixed concentration of HRP-conjugated antibody 
binding to НДС-ATPase with no additional antibody added (representative of three experiments). The 
monoclonal antibodies used were purified by ammonium sulfate precipitation. 
54 
activity of the enzyme. As has been demon­
strated for antibody 5-B6 [16], it can be 
deduced from the experiments described in this 
report that the antibodies 1-F11 and 4-D10 
also inhibit gastric Η,Κ-ATPase by stabilizing 
the enzyme's E, · K+ conformation. 
Thus far, only anti-H,K-ATPase inhibitoiy 
monoclonal antibodies have been reported, 
which bind to epitopes on the cytoplasmic side 
of the enzyme. Asano et al. [25] first raised a 
monoclonal antibody, which inhibits in gastric 
vesicles the IC'-ATPase activity, the 
K*-pNPPase activity and a chloride conduc­
tance that has been induced before with the 
S-S cross-linking reagent Сиг*-о-
phenanthroline. Benkouka et al. [26] described 
a monoclonal antibody with similar inhibitory 
effects on hydrolytic reactions of Η,Κ-ATPase, 
but which does not inhibit the by 
Cu^-o-phenanthroline induced chloride 
conductance. Finally, Asano et al. [27] reported 
on a monoclonal antibody, which exhibits 
inhibitoiy effects on gastric Η,Κ-ATPase 
similar to that of antibody 5-B6 [16], but which 
did not bind to the catalytic ce-subunit in the 
Western blot assay. 
Monoclonal antibodies against the struc­
turally and functionally related Na,K-ATPase 
a-subunit have also been described. These 
antibodies inhibit the Na,K-ATPase activity by 
stabilizing either the E, or the E; 
conformation. For example, Schenk et al. [28] 
have isolated an antibody, 9-A5, which inhibits 
the rat kidney Na,K-ATPase activity by stabili­
zing the E, conformation of the enzyme. The 
epitope for antibody 9-A5 was identified as 
being on the cytoplasmic side of the 
Na,K-ATPase a-subunit in a region between 
the amino acid residues Ala269 and Arg4* [29]. 
Ball [30,31] has prepared two inhibitoiy 
anti-Na,K-ATPase monoclonal antibodies, 
which both inhibit the lamb kidney 
Na,K-ATPase activity by stabilizing the Ε,-forai 
of the enzyme. The discontinuous epitope of 
one of these inhibitoiy antibodies, M7-PB-E9 
[30], was localized on the cytoplasmic side of 
the Na,K-ATPase a-subunit in a region 
between Ala2*7 and approximately amino acid 
residue 600 [29]. Urayama et al. [32] have de­
scribed an inhibitoiy anti-Na,K-ATPase mono­
clonal antibody that also stabilizes the Et 
conformation by binding to a discontinuous 
cytoplasmic epitope on the N-terminal half of 
the a-subunit. On the other hand, the 
anti-Na,K-ATPase antibody M45-80 [33], the 
epitope of which is located at the extracellular 
side of the a-subunit, was shown to inhibit the 
NaJC-ATPase activity by shifting the enzyme to 
the Ej conformation. 
On basis of these findings with anti-
Na,K-ATPase antibodies, and since a cyto­
plasmic disposition is the only common feature 
of the epitopes for the just mentioned inhibi­
toiy anti-H,K-ATPase antibodies, it is tempting 
to speculate that the binding of an antibody to 
the cytoplasmic side of the Η,Κ-ATPase 
a-subunit will stabilize the Ε,-form, in case of 
the by us produced antibodies 1-F11, 4-D10 
and 5-B6, the E, · K* conformation. 
Characteristic for the so far identified 
antigenic determinants of inhibitoiy antibodies 
directed against either Η,Κ-ATPase or 
Na,K-ATPase, is their location in the 
N-terminal region of the respective a-subunits 
[17,29,32]. For both enzymes, especially for 
Na,K-ATPase, it has been demonstrated by 
selective proteolytic digestion that the region 
from the N-terminus to the central domain of 
the a-subunits undergoes an integrated 
structural change upon transition from the E, 
to the Ег conformation [213435]. Therefore, it 
might be possible that the inhibitoiy effects of 
the monoclonal antibodies are caused by bind­
ing to those peptide segments that move upon 
conformational transitions. This would make 
the inhibitory antibodies excellent markers for 
moving peptide segments accompanying Ε,-Ej 
transitions. Preliminary experiments in our 
laboratory with a polyclonal antiserum directed 
against a synthetic peptide corresponding to 
the region of amino acid residues 565 to 585 of 
the rat gastric Η,Κ-ATPase a-subunit 
(generous gift of Dr. MJ. Caplan, Yale 
University School of Medicine, New Haven, 
CT, USA), and which cross-reacts with native 
porcine НДС-ATPase (ELISA), showed that the 
antibodies of this antiserum did not influence 
the K*-ATPase activity of gastric Η,Κ-ATPase. 
This would suggest that this region of the 
enzyme is not involved in conformational 
transitions. 
So far, neither an inhibitoiy nor a 
non-inhibitory antibody against the C-terminal 
region of either the Η,Κ-ATPase or the 
Na,K-ATPase a-subunit has been reported. In 
this study it has also been shown, as demon­
strated by the lack of binding of the polyclonal 
antisera HK73 and HK74 to the C-terminal 35 
kDa trypsin-digest fragment of the 
Η,Κ-ATPase a-subunit (Fig. 4B), that the 
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C-terminus of the Η,Κ-ATPase α-subunit is not 
very Immunogenic This suggests that a large 
part of the C-tenninus has a relatively low ex­
posure to the aqueous environment, i.e. is 
probably membrane-inserted. This is supported 
by hydropathy analysis of the primary structure 
of the HJC-ATPase o-subunit, revealing several 
putative transmembrane sequences in the 
region containing the last 250 amino add resi­
dues [7,8]. 
For the near future it will be very 
interesting to produce specific C-terminal 
peptide-antibodies in order to determine which 
peptide segments in this region are exposed to 
the aqueous environment, and whether these 
peptide segments are also involved in con­
formational transitions of the enzyme. 
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The steady-state ATP phosphorylation level and the orientation 
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Effect of free fatty acids and detergents on H,K-ATPase. 
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Key woiib: АТРше, H*/К*-; Pbotpbocylilioa; Delerteni; Orienldlkm; Free Гану and 
The effects of detergents and free fatty adds on the К ^ -activated ATPase activity and on the steady-state 
phosphorylation level of pig gastric Η,Κ-ATPase were studied. Unsaturated free fatty acids inhibited the К ^-activated 
ATPase activity, due to inactlvation of the enzyme (long-term effects) and to a decrease In the К'''-sensitive 
dephosphorylation rate (short-term effects). The degree of inhibition depended on the reaction conditions: the 
protein concentration, the temperature and the ligands used. No effect was observed when saturated- or melhylated 
unsaturated fatty acids were tested. Free fatty acids and the detergent C^E, Increased the steady-state ATP 
phosphorylation level, Indicating the presence of vesicular structures in the Η,Κ-ATPase preparaliuns. At higher 
concentrations these compounds Inactivated Η,Κ-ATPase, which was measured as a decrease in phosphorylation 
capacity. By combining the data from the ATP phosphorylation level In the absence and presence of C i aE, (without 
Inactivation) and the data from the К ^ -activated ATPase activity with and without lonophore the tightness of 
vesicular preparations and the orientation of Η,Κ-ATPase was determined. A rather simple method for the isolation 
of Η,Κ-ATPase is reported, which yields highly purified Η,Κ-ATPase preparations with a ATP phosphorylation 
capacity of 3.9 nmol Ρ per mg protein or 0.57 mol Ρ per mol aß protomer. This number suggests that each 
a-subunit Η,Κ-ATPase can be phosphorylated at the same time. 
Introduction 
Η,Κ-ATPase is an intrinsic membrane protein com­
plex which is responsible for acid secretion (1]- It is a 
member of the class of P-type membrane bound ion-
transporting ATPases. There are numerous structural 
and kinetic similarities between Η,Κ-ATPase and 
Na,K-ATPase. Both enzymes contain a catalytic a-sub­
unit of 114 kDa [23] and 112 kDa [4], respectively, as 
well as a glycosylated /J-subunit with a protein moiety 
of 33 kDa [5-7] and 35 kDa [8], respectively. The 
Abbreviations* C^E,,, octaethyleneglyCDldodecyl monoether; SD&, 
sodium dodecyl sulfate; PAGE, Polyacrylamide gel electrophoresis 
Correspondence. J J Η H.M. de Pont, Department of Biochemistiy, 
University of Nijmegen, PO Bon 9101, 6500 IIB Nijmegen, The 
Netherlands. 
catalytic a-subunit contains the ion- and ATP-binding 
site(s) as well as the ATP phosphorylation site. There 
is one apparent difference. Whereas, with Na.K-ATPase 
it has been established that each a-subuntl can be 
phosphorylated at the same time [9], the maximal phos­
phorylation level found until now with Η,Κ-ATPase 
has been 1.5-2.3 nmole per mg protein, which is less 
then 0.35 mol/mol catalytic subunit [10-13]. 
One of the reasons for this difference might be the 
presence of inaccessible substrale siles in the enzyme 
preparations. With Na,K-ATPase most studies have 
been carried out with a detergent treated kidney 
preparation prepared according to Jergensen (14). In 
these preparations the enzyme is present in membrane 
sheets, so that both sides of the membrane are avail­
able for substrate and ions. Several types of Η,Κ-
ATPase preparations have been described [IS,16], 
which are characterized, with regard to leakiness and 
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orientation, by using lonophores and detergents in the 
K*-activated ATPase assay 
We studied the effect of detergents and free fatty 
acids on the K*-activated ATPase activity as well as on 
the ATP phosphorylation level m various Н.К-АТРаье 
preparations Free fatty acids arc interesting since they 
were reported to be inhibitors of К '''-activated ATPase 
activity [17] Moreover, m a recent study with Na.K-
ATPase we found short-term inhibitory effects as well 
as long term irreversible mactivation effects of unsatu­
rated free fatty acids [18]. In view of the structural and 
functional similarities between the two enzymes it is 
interesting to compare the effects of fatty acids on both 
ATPases 
In the present paper we show that m all H.K-ATPase 
preparations used by us vesicular structures are pre­
sent Detergents and free fatty acids open these struc­
tures leading to increased phosphorylation levels 
whereas at higher concentrations these compounds in­
activate the enzyme By using limited concentrations of 
detergents and lonophores and by measuring the phos­
phorylation level and the K+-slimulated ATPase activ­
ity, we could determine the tightness and orientation of 
Η,Κ-ATPase preparations We show moreover that in 
membrane vesicles, treated by osmotic shock, it is 
possible to obtain ATP phosphorylation levels above 
OS mol per mole of a-subunit, suggesting that in 
Η,Κ-ATPase preparations each α-subunit can be phos-
phorylated at the same time 
Materials and Methods 
Η,Κ-ATPase preparations 
Η,Κ-ATPase, from gasine mucosa, was prepared as 
reported previously [19] with some modifications. 
Stomachs of freshly slaughtered pigs were rinsed with 
tap water, transported on ice and further processed at 
0-4° С The pink fundic region was placed in 0 25 M 
sucrose in 20 mM Tns-HCl (pH 7 0) (homogemzation 
buffer) for 30 mm The tissue was wiped with paper 
towels to remove the mucus and the mucosa was 
scraped from the underlying muscular layer with a 
surgical blade After 10-times dilution with homoge­
mzation buffer, the tissue was homogenized by 3-5 up 
and down strokes at 300 rev /min with a Braun teflon-
glass homogemzer The homogenate was centnfuged 
for 30 mm at 20000 x g The resulting supernatant was 
centnfuged for 30 mm at 100000 χ g The pellet was 
collected and resuspended in the homogemzation 
buffer This microsomal preparation (fraction M) was 
layered on top of a gradient of 7% Ficoll in 0 25 M 
sucrose and 37% sucrose in 20 mM Tns-HQ (pH 7 0) 
and centnfuged for 60 mm at 100 000 X g The mem­
brane fraction at the 7% (w/v) Ficoll and the 37% 
(w/v) sucrose interface (fraction A) was 5-times di­
luted with 20 mM Tns-HCl (pH 7 0), spun down, 
homogenized in homogenualion buffer and stored at 
-20° С The fraction at the 0 25 M sumbe and ΤΊ 
(w/v) Ficoll in 0 25 M sucrose interface (fraction B) 
was collected and stored at 4 ° С Sucrose was removed 
from fraction В by dilution with 20 mM Tns-HCl (pH 
7 0) and centnfugation, whereafter the membranes 
were freeze-dned overnight, resuspended in humoge 
nization buffer and stored ut 4°C (fraction C) Alter­
natively sucrose was removed from Iraction B, where 
upon the resuspended fraction was incubated overnight 
in 20 mM Tns-HCl (pH 7 0) at 4°C and layered un a 
7% (w/v) Ficoll in 0 25 M sucrose cushion lollnwed by 
centnfugation for 60 mm at НКШМ X g The pellet was 
resuspended in homogemzation buffer and stored at 
4°С (fraction D) 
Protein deiennination 
Protein was determined according to the Lmvry el 
al [20] method following trichloroacetic acid precipita 
non [21], or the Bio-Rad protein assay [22] In either 
case bovine serum albumin was used as a standard 
The ratio between the measurements with the Lowiy-
tnchloroacetic acid method and Bio Rad protein assay 
was 150 ±003 (mean ± S Ε , л - 20) All data are 
expressed in Lowry protein values 
Gel electrophoresis 
The Η,Κ-ATPase preparations (10 Mg) were elcc-
trophoresed on 10% (w/v) SDS-polyaciylamide slab 
gel according to Laemmli [23] The protein bands were 
stained with Coomassie blue 
Steady-state ATP phosphorylation lei el 
Η,Κ-ATPase (10-50 Mg/ml) was incubated at 22° С 
for 10 s in 0 1 ml medium containing 1-20 μ Μ |γ-
"PJATP, spec act 0 03-0 3 Ci/mmol (Amersham In­
ternational, U К ), О 1-1 0 mM MgCl2 and either 50 
mM imidazole-acelate (pH 7 0) or 0 25 M sucrose in 20 
mM Tns-HQ (pH 7 0) The reaction was stopped by 
adding 5 ml 5% (w/v) trichloroacetic acid in 0 1 M 
phosphoric acid and filtered over a Schleicher & Schuil 
(Dassel, F R G ) filter (type AE95, 1 2 μπι) After 
washing two times with 5 ml stopping solution the 
filters were analyzed for their 12P-protein content 
Blanks were prepared by denaturing the enzyme prior 
to incubation with stopping solution [24] 
Dephosphorylation studies 
After 10 s phosphorylation (see above) 5 volumes of 
0 6 mM nonradioactive ATP with the ligand to lest 
were added and incubated for another 10 s at room 
temperature The reaction was stopped hy adding 5 ml 
stopping solution The l:P-phosphoenzynie was deter­
mined as described above 
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Hydroxylamme assay 
The sensitivity of the phosphointermediates formed 
by ATP, m the presence or absence of detergent (as 
described above), to hydroxylamme was performed as 
described by Schuurmans Stekhoven et al (25] 
К ^-actuated ATPase assay 
To 0 4 ml medium, containing either (medium A) 20 
mM choline chloride, 5 mM MgC^, 5 mM NajATP, 
0 1 mM EDTA, 0 1 mM ouabain and 30 mM imida-
zole-HCI (pH 7 0) or (medium B) same as A but 20 
mM K+ replacing choline chloride, 20 ^ g H,K ATPase 
was added Osmolanty of the assay medium was kept 
constant at 0 25 osM with sucrose After incubation at 
З С or at 0°C for 10 mm 15 ml 8 6% (w/v) tri­
chloroacetic acid and 1 5 ml ammonium heptamolyb-
date (I 15%, w/v) in 0 66 M sulphuric acid with 9 2% 
(w/v) FeSOj THjO was added The blue phospho-
molybdate complex was analyzed after 30 mm at 700 
nm The aspccific Mg2+-ATPase activity was calculated 
as the difference between activity at 37 ° С and 0 ° С in 
medium A and the К'''-activated ATPase activity as the 
difference in activity at 37 ° С in medium A and В [26] 
p-Nitrophenylphosphatase assay 
К'''-activated ρ nitrophenylphosphatase activity was 
determined under the same conditions as the Re­
activated ATPase activity with p-mtrophenyl phos­
phate as substrate, according to Schnjen et al [26] 
Electron microscopy 
The Η,Κ-ATPasc preparations were pelleted by 
cenlnfugation for 60 mm at 100000 Xg and resus-
pended, at 4 ° C, in 1 5% (w/v) glutaraldehyde in phos­
phate-buffered saline After 30 mm the fixed material 
was centnfuged again for 30 min at 150000 Xg The 
pellets were rinsed with phosphate buffered saline and 
fragments of the pellets were stained with 1% (w/v) 
osmium tetroxide, dehydrated with ethanol and em­
bedded in Epon LXI12 Thm sections were studied in 
a Philips EM410 electron microscope 
Calculation of relatne H А' АТРизе опепишоп m the 
membrane preparation 
In the preparations different structures of mem­
brane bound H,K ATPase can be distinguished leaky 
or ruptured vesicles (open structures. SI), vesicles with 
the ATP-sitc at the outside (S2) and vesicles in which 
the ATP-site is not accessible (SI) (see fig 1) These 
can either be unilamellar vesicles with the ATP-site at 
the inside (S3a) or multilamellar vesicles (S3b) In 
leaky or ruptured vesicles both ATPase activity and 
phosphorylation level are maximal and detergents (at 
low concentrations) as well as lonophores have no 
effect In the S2 vesicles phosphorylation can occur, 
but ATP hydrolysis is not possible since K* is needed 
at the inside of the vesicles With lonophores or deter­
gents the ATPase activity can increase up to Us maxi­
mal level In the S3 vesicles no phosphorylation or 
ATP hydrolysis takes place lonophores have no effect 
but detergents increase both the activity and the phos­
phorylation level to its maximal value 
In this study we calculated, from the ratio of the 
К "''-activated ATPase activity in the presence 
(ATPaseS|+s2) and absence (ATPascsl) of nigenun 
and from the ratio of the phosphorylation level in the 
absence (Е-Р4| + ы ) •lnc' presence (Е-Рч, + Ь 2 , ь , ) of the 
non ionic detergent C^E,,, the Iraclional occurrence 
(ƒ) of SI, S2 and S3 in the Η,Κ-ATPase preparations 
as follows 
/ S 3 " ( E PSI+S2 + b J ~ E P b l + i 2 > / ( E P i l * S ι&ΛΪ 
/«-(ATPaseM.^-ATPasej,) (I - Λ,ΙΛΑΤΡιιί;,, j,) 
/
s
,-(ATPaie>,> (1 -/¡„(/(ΑΤΡίΜ^,^) 
Chemicals 
Free fatty acids (Supelco, Ine Leusden, The Nether­
lands) and nigencm (Sigma, St Louis, MO, U S A ) 
were dissolved in methanol or ethanol (nigencm) and 
diluted to their final concentrations in 3% (w/v) 
methanol or ethanol Ο,,Ε,, octaethyleneglycoldodecyl 
SI S2 3 3 
Fig. 1 Possible orienution of Η К АТРам with us ATP and К* ШеЫ in the dilTerent lipid biU>er membrane slruvtures SI »pen ыгисшгеь. 
S2, closed vesicles with the ATP phusphorylalion site at the oulside S3 closed vesidcs with Ihe ATP site at in Ihe inside unilamellar lS3a> or 
multilamellar vesicles (S3b> 
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monoether, was oblained from Nikko Chemicals, 
Tokyo, Japan. Cholate, from Matheson Coleman & 
Bell, Norwood, OH, U.S.A., was recrystallised in 50% 
ethanol, following destaining with charcoal and dis­
solved as a Tris sail. All other chemicals were of 
analytical grade. 
Resulla 
Effect of free falty acids 
In this study we compared the effect of free fatty 
acids on H.K-ATPase with the results obtained by us 
with Na,K-ATPase [18]. In general the findings were 
rather similar, (i) Both the К'-activated ATPase and 
the IC-activated p-nitrophenylphosphatase activity, as­
sayed with 10 μζ Η,Κ-ATPase per ml during 60 min 
incubation at 37 ° C, were inhibited by oleic acid with 
an / M value of 10 μΜ. (ii) Both higher enzyme con­
centrations (or shorter incubation times needed in or­
der to avoid a too high substrate conversion) and the 
lowering of the temperature decrease the inhibitory 
effect of free fatty acids, (iii) Saturated- or methylated 
fatty acids had little or no effect on the enzyme, 
indicating that both the carboxyl group (charge) and 
the double bound (fluidity) are important for this inhi­
bition process. 
To get more information about the nature of this 
inhibition we studied the effect of free fatty acids on 
the partial reactions of Η,Κ-ATPase. Oleic acid in­
creased the steady-state ATP phosphorylation level 
(Fig. 2A), while there was a decrease in the K*-sensi-
tivily of the phosphocnzyme from II. In mM to 0.4(1 mM 
in the presence of 0.18 mM oleic dcid (Fig. 2B) If 
Η,Κ-ATPase was preincuhuted for 611 mm with oleic 
acid prior to the phosphorylation reaction an enhance­
ment of the phosphorylation level was only observed al 
low concentrations of oleic acid (10-20 μ M). At higher 
concentrations there was u complete inhibition. The 
ί ι / 2 for this inactivation process, also observed with 
Na,K-ATPasc [18], was about S min with 0.1 mM oleic 
acid and could be reduced to 30 min by including 100 
mM NaC in the incubation medium. 
The enhancement of the ATP phosphorylation level 
can be explained by assuming the presence of inacces­
sible ATP-sites, which are set free in the presence of 
fatty acids. Fatty acids apparently act as detergents 
[27]. Therefore we carried out comparative experi­
ments with the detergents С
и
Е
в
, cholate and SDS. 
Effect of detergent on the ATP phosphorylation level 
In Fig. ЗА the effect of the detergents С,, Ец, cholate 
and SDS is shown. They influence the ATP phospho­
rylation level of a freeze dried and resuspended Η,Κ-
ATPase preparation, similarly to free fatly acids. In­
creasing the concentration of detergent in the 
phosphorylation medium resulted, at a Η,Κ-ATPase 
concentration of 50 Mg per ml, first in an enhancement 
of the phosphorylation level. Maximal activation oc­
curred at the following concentrations: SDS at II. I 
mg/ml, cholate at 6 mg/ml and С'12ЕИ at 0.1 mg/ml. 
At higher detergent concentrations a decrease in the 
ATP phosphorylation level was observed. The 
E-P (%) 
1 Ю 
uMotote add 
100 
M 
60 
40 
20 
η 
% E-P hydratyMd 
В 
/ 
Ih 18:1 
S f 
^ 
χ " 
0.1
 + ι 
mMK* 
Fig. 2. Effect of oleic acid on ATP phosphorylation and dcphusphorylalion. (A) H,K-ATPase (10 μί/ηι!) wak prciniubaied for 0 nun 
(O O) or 60 mm ( · · ) al 22 * С m 50 mM iimddzole acetic acid (pli 7 0) with the indicutcd ole IL acid toiKcntnimns, altercai te г ιι 
was phosphorylated for 10 s at 22° С with 2 /iM|y-,2PjATP, 0 I mM MsC12l 50 m M imtd<uolc-accij|e (pH 7 0) further ргосемти ач derribe J 
in Materials and Methods Data are presented as % of the ctmirol (nu preincubation, no oleic acid) (13) After phmphorylaimti 5 volumes of 0 ft 
mM пол-radioactive ATP with ( · · ) and without (O O) 0 IH mM oleic acid (IH.I) m the préseme of the intlmud k' 
concentrations was added and incubated for amHher 10 s. The amount (% of original) of E-P hydrolybed in 10 s LS ptoitcd 
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Fig 3 Effccl of C ^ E , chülale and SDS on the ATP phosphoiylalun level (A) 11 К A T I ' J M ; (5(1 M b / m i l w j s intub 1I1.J for Kl s al 22 Ч »Ul i 2 
м М ly " P J A T P ü I m M MgCI Mi m M imidazole acétale (pH 7 Π) in the presence of the i n d n a l i d d e u r b i n l L4MKi.iilralions ( • · M>S 
• · C p E g О о chiilale) Further processing as described in Materials and Methods (U) H К АТРом: /м, i n i u b j i e d al 22"С with 
( · ) and without (o) 0 I mg С ^ Е д per ml Ü I m M MgCU and SÜ m M imidazolL ULelate ( p l l 7(1) After the indnatLiI preiiHuhulion tune the 
phosphorylation capacity was determined by the addition of 5 μ Ι (y ' 2 P)ATP (40 μ Μ ) to the rcai t ion medium (45 μ Ι ) After II) s the reaUuin 
was terminated and the samples were processed as described in Materials and Methods Data are presented as percentage of the Limlrol 
(EP)% 
phosphorylation experiments were carried out under 
steady-state conditions as the A T P phosphorylation 
level was not influenced by increasing the incubation 
time (up to 1 mm), the temperature ( 0 - 3 7 ° C ) or the 
concentration of either M g 2 + (0 1-1 m M ) or A T P 
( 2 - 1 0 μ Μ ) А Л increase of the incubation time of the 
enzyme with C ^ E , , prior to the phosphorylation exper­
iment resulted, at a fixed C n E . concentration (0 1 
mg/ml), in a rapid decrease in t h i phosphorylation 
level of the enzyme, with a / , / , of jbout 5 mm ( i ig 
3B) This mactivatton process is muih slower than the 
enhancement in phosphorylation level which takes 
place in less than 10 s (Fig ЗА) 
T h e increase of the steady slate A T P phosphoryla­
tion level by C ^ E , , was not due io a decrease in the 
turnover of the phosphotntcrmcdiate since ι lu rate of 
«ctlvlly 
ι η юо 
ид C E , p o r ml 
«ctlvlty Ê-P 
to Ю0 
цд C E . p e r ml 
M юо 
»g C E , per ml 
Fig 4 Effect of C ^ E g on K * activated ATPase activity and A T P phosphorylation capacity of preparation A D and С Phosphorylahon capacity 
( Δ Δ ) H К ATPase (50 μ g / m l ) was incubated with the C p l * concentrations as indicated in the presence nl I m M MgCI 20 μ Μ 
l y , ! P ) A T P and 0 25 M sucrose/20 m M Tris HCl ( p H 7 ü) for 10 s at 22 " С E P is expressed as nniol Ρ per mg protein К a U i v a l i d A l Pase 
activity И К ATPase (50 μ κ / ι η Ι ) was incubated with ( · · ) and without ( o o ) 10 μ Μ п і ь е п и п for UI mm al 17' ÍC m an 
iso-osmotic medium (250 m M ) as indicated m Materials and Methods The activity is expressed as μπιο! Ρ per mg protein per h 
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ATP hydrolysis measured under phoshorylation condi­
tions (low ATP, no K*, 30 s) was also increased by 
C|,ES (data not shown) 
The phosphoenzymes formed in the presence and 
absence of C | ;E„ showed identical behavior towards 
hydroxylamine (data not shown) This indicates that 
under both conditions a carboxyl residue was phospho-
rylated 
The above findings indicate that freeze-dned and 
resupendcd H.K-ATPase preparations still have closed 
structures As the increase in the steady-state ATP 
phosphorylation level was most pronounced in the 
presence of C12E, we reinvestigated with the aid of 
CuE, the properties of the different kinds of H.K-
ATPase preparations that can be isolated from gastric 
mucosa (fractions А, В, С or D, see Materials and 
Methods) 
Effect of С12Eg on the К *-octwated ATPase activity 
Under iso-osmotic conditions the K+-activated 
ATPase activity of these different preparations were 
also influenced by C^E,,, (Figs 4A, 4B and 4C) En­
hancement of the activity occurred at concentrations 
up to 0 03 mg C,2Ee per ml Higher concentrations of 
this detergent decreased the enzyme activity The K+-
activated ATPase activity was inhibited more strongly 
by C|2Ee than the steady-state ATP phosphorylation 
level This was due to the longer incubation period and 
higher temperature involved in the ATPase assay, giv­
ing rise to mactivation, as shown above 
In the presence of the lonophore nigencin (absence 
of detergent), an activation (being maximal at 10 μΜ 
nigérian) of the K+ activated ATPase activity took 
place, indicating the presence of vesicular structures 
with the ATP-site at the outside (K* activation al the 
inside) The increase in К''-activated ATPase activity 
by C l 2 E e was most pronounced in preparation В (Fig 
4B) and can be interpreted as the conversion of closed 
to open structures However, the K*-activated ATPase 
activity in the presence of C|2EB alone did not always 
reach the same level as in the presence of nigencin 
(Fig 4B), indicating that these limited concentrations 
of detergent already caused some enzyme mactivation 
In the presence of nigencin the inhibitory effect of 
C^Eg was enhanced and no activation was observed, 
the activation of H,K ATPase probably being overruled 
by the mactivation process Comparison of Figs 4A 
and 4C with 4B indicate that in the preparations A and 
С the ATPase activity in the absence of lonophore is 
much higher than in preparation В and that the rela­
tive stimulation by lonophore is much less This sug­
gests that fractions A and С contain more open vesicles 
or sheet structures than fraction В Fraction A was 
obtained from the Ficoll/37% sucrose interface, 
whereas fraction В was obtained from the 0 25 M 
sucrose/Ficoll interface, after cenlrifugation ol (hi 
microsomal fraction I ractiun С was ublaiiu.d aflir 
freeze drying of fraction В I his procedure apparently 
opens closed vesicles 
The orientation of H.K-ATPaw in membrane /ire/iara 
lions 
Three different orientations of the H.K-ATPase wiih 
respect to the lipid bilayer can be distinguished open 
structures (SI), closed structures wilh the A IP-site at 
the outside (S2) and closed structures with the А ГР site 
at the inside either unilamellar (S3a) or multilamellar 
(S3b), see Fig I The experiments described in hig 4 
make it possible to calculate the contribution of each 
of the three different orientations for the various 
ATPase preparations In the absence of Ο,,Ε,, the 
ATP-phosphorylation level of SI plus Ь2 could be 
measured In the presence of the detergent probably 
all vesicular structures disappeared, the ΑΊ P-site at 
the inside (S3) became available loo and the ΑΊ Ρ 
phosphorylation level of S1 + S2 + S3 could be mea 
sured In the K*-activated ATPase assay, under stan 
dard conditions, only the activity of SI could he mea­
sured, since the ΑΓΡ as well as the K* site (opposite 
to the ATP-site) must be accessible for this activity In 
the presence of the К ^ -lonophore nigencin the inner 
K+ sites became accessible and the enzyme molecules 
present in S2 vesicles start to contribute to the enzyme 
activity too (SI + S2) As in the presence of low con 
cenlrations of C^E, in combination with IÜ μΜ 
nigencin mactivation of the enzyme activity occurred 
(see previous section) it was not possible to measure 
under these conditions the К * activated ATPase activ 
ity (SI + S2 + S3) 
From the ratio of the K* activated ΑΊ Pase activity 
in the presence (SI + S2) and absence (SI) of nigencin 
and from the ratio of the phosphorylation level in the 
absence (SI + S2) and presence (SI + S2 + S3) of 
C12EB, we calculated the relative amounts ol SI, S2 
and S3 in the H,K ATPase preparations (see Materials 
and Methods) The data in Table 1 show lhat there is a 
large variety in the orientation of Η K-ATPase in 
membrane preparations Fraction A contained when 
assayed under iso-osmotic conditions considerable 
amounts of vesicular structures (36% S2 and 27% S3) 
Preparation В contained 92% closed vesicles with the 
ATP site at the outside (S2) Freeze drying resulted in 
opening of most of the vesicular structures 1 his frac 
lion (C), however, also contained 27'r vesicles with the 
ATP site at in the inside (ЬЗ) Ί he osmotic shock 
treated preparation (fraction D) contained only 25'< 
open structures (SI) and 22c/i vesicles of type S3 
Probably a reorientation occurs during rt suspension of 
the enzyme 
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M 1 
Fjg. S. SDS-PAGE patlern of the various i Ι К ATPase preparations. 
10 /ig prolein was eleclrophoresed on 9 10% SDS-slab gel and 
stained with Coomassie Blue. Lane M. molecular weight markers (in 
kDa) lane I, lOOOOOX; supernatant; lane 2, microsomal fraction 
(fraction M); lane 3, fraction A (37% sucrose/Ficoll interface); lane 
4, fraction В (0.25 M sucrose/Ficoll interface); lane 5, fraction С 
(freeze dryed) and lane 6. osmotic shock preparation (fraction D). 
The morphological apparence of the preparations 
(fractions А, В, С and D) were also investigated by 
electron microscopy (Fig. 6). Fraction A contains a 
mixture of various structures, vesicles, open mem­
branes and endoplasmic reticulum. Fraction В shows 
mostly unilamellar vesicles but some multilamellar 
vesicles can be distinguished. The open membranes 
apparently do not contain much ATPase activity (Fig. 4 
and Table I). Fraction С and D show more vesicular 
structures than fraction B, whereas the biochemical 
analysis indicated that less closed vesicles were pre­
sent. This suggests that a large fraction of these vesi­
cles is not ion-tight. In addition the number of multi­
lamellar vesicles in fraction С and D are clearly higher 
than that in fraction B, which is in agreement with the 
larger percentage of S3 structures. The recentrifuga-
tion of fraction С and D apparently removed part of 
the membranes not containing Η,Κ-ATPase resulting 
in the higher phosphorylation capacity of these frac­
tions. 
Further characterization of the preparation by electron 
microscopy and SDS-PAGE 
The degree of purifity of Η,Κ-ATPase preparation 
can be shown by SDS gel electrophoresis (Fig. 5). In 
lane 6 (fraction D) mainly the a-subunit of Η,Κ-ATPase 
was observed, indicating a higher degree of purifica­
tion, compared to fraction В (lane 4). Parallel with this 
the ATP phosphorylation level increased, from 1.19 to 
2.39 nmol Ρ per mg protein (see Table 1). 
The ATP-phosphorylation capacity of Η,Κ-ATPase 
The data in Table I also show that we are able to 
isolate very highly purified Η,Κ-ATPase. The density 
of the membranes (vesicles) isolated at the 0.25 M 
sucrose and the 7% Ficoll/ 0.25 M sucrose interface 
(fraction B) could be changed by diluting with low 
buffer concentrations, following centrifugation and re-
suspension. The obtained fraction could pass the 7% 
Ficoll/ 0.25 M sucrose cushion and could be collected 
as a pellet (fraction D). The degree of purification is 
TABLE I 
ATPase activity, ATP phosphorylation level and orientation of Η,Κ-ATPase preparations 
Preparation 
η 
A T P phosphorylation level 
(nmol P/mg protein) 
Control 
«-CaBgtU mg/ml) 
ATPase activity 
(μιηοΐ Ρ, /mg protein per h) 
M g ! ' A T P a s e 
К »activated ATPase 
control 
+ Nigericin 10 μ Μ 
+ € , , 8 , 0.03 mg/ml 
Orientation (%) 
ATP-sile 
S I : open structure 
S2: closed structure outside 
S3: closed structure inside 
M 
4 
0.55 ±0.01 
0 67 ±0.05 
8 
6 
35 
27 
15 
St 
18 
± 1 
± 1 
± 7 
± 6 
± 4 
± 9 
± 6 
A 
7 
0 6 2 ± 0.20 
0.83 ± 0.23 
1(1 
16 
36 
39 
37 
36 
27 
± 1 
± 6 
t l 8 
± 14 
±14 
±13 
± 4 
В 
8 
1 14 t 0.18 
1.1 
7 
3 
66 
59 
5 
92 
4 
4± 0.19 
± 1 
± 1 
± 1 6 
1 14 
i 2 
± 6 
1 7 
С 
7 
1 21 i 1121 
I 6 6 ± 0.26 
« 
71 
72 
7S 
71 
2 
27 
± 2 
±25 
± 2 1 
± 2 9 
± 1 1 
± 5 
± 8 
D 
6 
l t l 6 ± 0.32 
2.39 ± 0 42 
6 
.11 
1111 
115 
25 
53 
22 
± 1 
± 9 
± 2 9 
t » 
± 1 1 
± 1 2 
± 2 
The phosphorylation level and the ATPase aciiviiy were determined us described in Materials and Methods. From these data Ihe onenlalion of 
Η,Κ-ATPuse in the membrane preparations in calculated, sec Materials and Methods The data are expressed as mean values t S . D for the 
number of experiments as indicated. 
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visualized by SDS-PAGE, see Fig. S. Fraction D prepa- Discussion 
rations reached in the presence of C^E,, (activation of 
28%) an ATP phosphorylation level of 1.6-2.8 (2.39 ± Free fatti acids and И.КАП'аае 
0.42, mean ± S.D.) nmol Ρ per mg protein. Im and Blakeman [17] were the first who reported 
Flg. 6. Electron micrograph of fractions A. B. C, and D (see text). Multilamellar structureb are indicated with arrow heads Bar - 1) S μη 
68 
291 
inhibition of the overall K + activated ATPase activity 
by unsaturated fatty acids They found inhibition of the 
K + activated ATPase activity, the K+ stimulated ρ 
nitrophenylphosphatase activity and the phosphoen-
zyme formation In their study no mechanistic explana 
lion for the inhibitory effects of fatty acids was given 
We can distinguish three different effects of unsatu 
rated free fatty acids on H,K ATPase (ι) Short term 
inhibitory effects decrease of the rate of the K* 
activated dephosphorylation of the phosphoenzyme 
(u) Long term inhibitory effects inactivation of the 
enzyme, depending on the enzyme concentrations, 
temperature and hgands present ( IN) Enhancement of 
the ATP phosphorylation level increase of accessible 
ATP sites by disturbance of vesicular structures The 
inhibitory effects d and u) of free fatty acids on H,K-
ATPase were comparable with the effects on Na.K-
ATPasetlS] 
The onenialion of H,K ATPase in /he membrane prepa­
ration 
The observed increase in the steady-state ATP 
phosphorylation level by free fatty acids as well as by 
the detergents cholate, SDS and C,2EK of H,K-ATPase 
means that under 'normal' conditions not all ATP-sites 
are available for phosphorylation 
For determining maximal K*-activated ATPase ac­
tivity and orientation in inside-out vesicles (S2, Fig 1) 
the use of lonophores is preferred Detergents, alone 
or m combination with lonophores, cause inactivation 
even at the low concentrations needed for opening 
membrane vesicles because of the high temperature 
(37 °C) and the long incubation period needed for 
determination of enzyme activity This could also ex­
plain the absence of a further stimulation by detergent 
of the Reactivated ATPase activity [15,16] In our 
study we combined the data of two different assays, 
phosphorylation (with and without detergents) and 
Reactivated ATPase activity (with and without 
lonophores) and avoided the just mentioned difficulties 
of a combined use of detergent and lonophore 
Our results show that it is very difficult or even 
impossible to prepare membrane Η,Κ-ATPase frac­
tions which contained only one type of membrane 
structure Only fraction В contained 92% closed vesi­
cles with the ATP site at the outside Preparing open 
structures (SI, Fig 1) by freeze-drying or by osmotic 
shock treatment was not possible Pretreatment of the 
enzyme fractions, at high protein and rather high de­
tergent (cholate, SDS or C,2Ee) concentrations for 60 
mm at room temperature, as described by Ray and 
Nandi [16], led also to loss of phosphorylation capacity 
(data not shown) 
An alternative explanation for the increase in ATP 
phosphorylation level in the presence of C|2EB and the 
absence of stimulation by nigérian of the R ^-activated 
ATPase activity is the existence of multilamellar vesicle 
structures (S3b, Fig 1) In the presente of the R*-
lonophore the ATP site of an intravcsicular structure is 
still inaccessible, but is set free in the presence of 
detergent and can be determined during 10 s phospho 
rylation, without inactivation The presence of these 
multilamellar structures was confirmed by electron mi-
croscopy This means that the vesicles determined as 
S3 may contain unilamellar structures (S3a), with the 
ATP site at the insule, as well as multilamellar struc-
tures (S3b) 
The phosphorylation capacity of Η К A TPuse 
A simple purification method of Η К ATPase lead­
ing to a very high phosphorylation capacity is described 
in this paper Closed vesicles are isolated first After 
treatment with low buffer concentrations these vesicles 
are opened resulting in a change in density to higher 
values By repeated centrifugation over a 7% f icoll m 
0 25 M sucrose cushion the mimbrancs containing 
Η,Κ-ATPase are further purified 
In the presence of Ο,,Ε,, these osmotic shock treated 
vesicles (fraction D) reached ATP phosphorylation lev­
els up to 2 8 nmol Ρ per mg protein These values are 
expressed in Lowry protein values, which have to be 
corrected by 1 42 to compare (hem with amino acid 
data [21] This results in a maximal ATP phosphoryla­
tion capacity of 3 9 nmol Ρ per mg protein, which is 
equal to 1 phosphorylation site per 256 kDa Η R-
ATPase As has been deduced from their cDNA the a 
subunit of pig H,R ATPase has a mol mass of 114 kDa 
[3], while the β subunit has a mol mass of 33 kDa on 
protein base [6] Assuming a molecular ratio of a and 
β of I [28,29] our H,R-ATPase preparations could 
reach phosphorylation levels as high as 0 57 mol Ρ per 
aß (0 52 ± 0 10, mean ± S D ) This is only a minimal 
value, since it would increase with the degree of purity 
of the enzyme and absence of inactivated enzyme 
These results indicate, as in case of Na.R-ATPase [9], 
one ATP phosphorylation site per a subunit Η,Κ-
ATPase 
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CHAPTER 6 
Expression of the catalytic subunit of gastric Η,Κ-ATPase 
in insect cells using a baculovirus expression vector. 
A preliminary study. 
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De Caluwé, Jacques J.M. Janssen and Jan Joep H.H.M. De Pont 
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'The abbreviations used are: 
Η,Κ-ATPase (EC 3.6.1.36), magnesium-dependent hydrogen ion transporting and potassium-stimulated 
adenosine triphosphatase; AcNPV, Auiographa califomica nuclear polyhedrosis virus; FCS, fetal calf 
serum; BSA, bovine serum albumin; kb, kilobase; X-gal, 5-bromo-4-ch]oro-3-indolyl-ß-D-galactopyrano-
side; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate; PAGE, Polyacrylamide gel electro-
phoresis; Tween 20, polyoxyethylene sorbitan monolaurate; HRP, horseradish peroxidase. 
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INTRODUCTION 
Gastnc Η,Κ-ATPase1 is a membrane-
embedded enzyme (hat catalyses the active 
transport of H* and K* ions across the apical 
membrane of the parietal cell in the stomach 
[1-3]. The enzyme is composed of two subunits, 
a catalytic ot-subunit of 114 kDa [4,5] and a 
heavily glycosylated fl-subunit of 60-80 kDa 
that has a core molecular mass of 33 kDa, and 
which functions are unknown [6-11]. 
In order to study the role of the individual 
subunits in Η,Κ-ATPase function and assembly, 
the heterologous expression of the subunits in 
an eukaryotic expression system is potentially a 
powerful experimental approach. For the struc­
tural and functional analysis of the expressed 
proteins, however, it is of great benefit if large 
quantities (mg amounts) of heterologous 
protein are produced. From this point of view, 
the baculovirus expression system [12] is very 
attractive, since the major advantage of this 
invertebrate viral expression system over other 
eukaryotic expression systems is the very 
abundant expression of recombinant proteins. 
An other advantage is that many of the higher 
eukaryotic post-translational modifications, 
such as N-glycosylation, phosphorylation and 
oligomerization, and which are important for 
the biological activity of the protein produced, 
are similar to those occurring in other euka­
ryotic expression systems. 
The baculovirus expression system uses the 
Autographe califomica nuclear polyhedrosis 
virus (AcNPV) to express foreign genes, which 
are placed under transcriptional control of the 
very strong viral polyhedrin promoter, in 
Spodoptera frugiperda (Sf9) cells. Recombinant 
viruses are produced by homologous recombi­
nation between a recombinant transfer vector, 
which contains the foreign gene with 5' and 3' 
flanking sequences of the polyhedrin gene, and 
the polyhedrin gene sequence of wild-type 
AcNPV. Recombinant AcNPV contains an 
inactivated polyhedrin gene and can be recog­
nized by the absence of polyhedral occlusion 
bodies when inspected by light microscopy [12], 
or by the detection of the foreign gene by dot 
blot or plaque hybridization with foreign 
nucleic add probes [13,14], in situ detection 
using antibodies [IS], or the constitutive ex­
pression of the bacterial ß-galactosidase gene 
[16]. 
High-level expression of a great variety of 
biologically active recombinant proteins has 
been reported [17]. Functionally active 
membrane proteins, such as rhodopsin [IS], the 
human multidrug transporter [19] and human 
EGF (embryonic growth factor) receptor [20], 
have also been expressed with this system. 
Therefore, we decided to use the baculovirus 
expression system for the heterologous expres-
sion of such a complex protein like gastric 
Η,Κ-ATPase. In this report preliminary results 
of the in vitro expression of the catalytic 
a-subunit of rat gastric НДС-ATPase are 
described. 
MATERIALS AND METHODS 
Materials 
The cDNA clones pRHKAl-8 and 
pRHKA3-3 encoding amino and carboxyl ter­
minal regions of the catalytic a-subunit of rat 
gastric Η,Κ-ATPase, respectively, were kindley 
provided by Dr. G.E. Shull, University of 
Cincinnati College of Medicine, OH, USA. The 
baculovirus transfer vector pAcDZl was pro­
vided by Dr. J. Vlak, Agricultural University, 
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Wageningen, The Netherlands. Enzymes used 
for recombinant DNA techniques and low 
melting point agarose were obtained from 
Bethesda Research Laboratories, MD, USA. 
The site-directed mutagenesis kit Muta-Gene 
was from Biorad, Richmond, CA, USA Bgfll 
linkers were purchased from New England Bio-
labs, Beverly, MA, USA Grace's insect 
medium was prepared with ingredients from 
Merck, Darmstadt, FRG and Sigma, St Louis, 
MO, USA. TC yeastolate and lactalbumin 
hydrolysate were from Difco, Detroit, MI, 
USA Fetal calf serum (PCS) was purchased 
from PAA, Austria. Sea Plaque agarose was 
from FMC Bioproducts, Rockland, ME, USA 
X-gal was obtained from Sigma, St Louis, MO, 
USA Tissue culture supplies were purchased 
from Costar, Cambridge, MA, USA. Immuno­
globulins were obtained from Dakopatts, 
Denmark. All other reagents were of the 
highest quality available. 
Cells and viruses 
The cell line Sf9, derived from the ovary of 
the fall armyworm Spodoptera frugiperda, was 
cultured at 27°C in Grace's insect medium 
supplemented with 3.3 g/liter TC yeastolate, 3.3 
g/liter lactalbumin hydrolysate, 5.5 g/liter BSA, 
10% (v/v) fetal calf serum, 50 units/ml penicil­
lin and 50 units/ml streptomycin. Cell culture, 
viral infections, isolation of extracellular virus 
and purification of viral DNA from infected 
Sf9 cells were performed as described [13]. 
Construction of recombinant transfer vector 
Full length cDNA encoding the rat gastric 
HJC-ATPase catalytic subunit [4] was inserted 
into transfer vector pAcDZl [16], which 
utilizes a B-galactosidase gene as a genetic 
marker for positive recombination between 
wild-type AcNPV and the transfervector, as 
outlined in Fig. 1. A 1.7 kb gel-purified 
Clal-BamHl fragment of the parent clone 
pRHKAl-8 [4] encoding the amino terminal 
region of the Η,Κ-ATPase catalytic subunit was 
ligated into the polylinker region of plasmid 
pUCIS that had been double-digested using 
Acci and BamHl endonucleases. The obtained 
plasmid containing the 1.7 kb Clal-BamHl 
fragment was subsequently cesium chloride 
gradient purified. A gel-purified 3.6 kb £coRI 
fragment of the other parent clone pRHKA3-3 
[4] encoding the carboxy terminal region was 
Inserted into this plasmid, which had been 
digested with EcoRI endonuclease, to produce 
plasmid pUCRHKAl. 
Since the coding sequence of the rat 
НДС-ATPase catalytic subunit cDNA contains 
two BamHl sites, Bgfll linkers were used to 
convert the 5' and 3' ends of the coding 
sequence to compatible ends for the unique 
BamHl cloning site of transfer vector pAcDZl. 
In order to use Bgfll linkers, however, a single 
Bgfll site In the coding region of the catalytic 
subunit had to be deleted. Therefore, a gel-
purified 1.4 kb BamHl fragment of 
pUCRHKAl was subcloned into BamHl-
digested bacteriophage M13mpl9. Site-specific 
mutagenesis on the 1.4 kb AimHI fragment 
was performed according to the method of 
Kunkel [21] (see below). The 1.4 kb BamHl 
fragment containing the conservative mutation 
was subsequently ligated back into the 
parental, gel-purified ftamHI-digested 
pUCRHKAl to yield plasmid pUCRHKAZ A 
3.4 kb gel-purified Hindlll-Scal fragment of 
pUCRHKA2 was then isolated, blunt-ended 
with T4 DNA polymerase at the ЯтЛІІІ site, 
and ligated with Bglll linkers (d(pGAAGATC-
TTC)). Following digestion with Bglll endo­
nuclease, this fragment was subcloned into the 
BamHl cloning site of pAcDZl to form trans­
fer vector pAcRHKAl. Finally, this recom­
binant transfer vector was cesium chloride 
gradient purified prior to its use in the co-
transfection experiment. All procedures were 
carried out using standard techniques [22]. 
Site-directed mutagenesis [21] 
A 1.4 kb fragment, which contains the 
coding region for amino acid residues 506 to 
963 of the Η,Κ-ATPase catalytic subunit, was 
excised from pUCRHKAl (mentioned before) 
by BamHl endonuclease. The 1.4 kb BamHl 
fragment and the remainder of plasmid 
pUCRHKAl were gel purified, and the 1.4 kb 
fragment was subcloned into Zto/nHI-digested 
M13mpl9 to yield M13mpl9-1.4. Subsequently, 
uracil-containing M13mpl9-1.4 was produced 
in the dut' (dUTPase negative) and ung' 
(uracil-N-glycosylase negative) E. coli strain 
CJ236. In order to modify the single Bgfll 
recognition site at position 2922 of the 
Η,Κ-ATPase catalytic subunit cDNA, the 
15-mer oligonucleotide S'-CTTGAAGGTCTT-
GTA-3' was synthesized, changing the Τ base 
at position 2924 into а С base. The 
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Fig. 1. Construction scheme of the baculovinis transfer vector pAcRHKAl 
A. Restriction map for the rat H.K-ATPase cDNA clones pRHKAl-8 and pRHKA3-3. Black bars 
represent noncoding seqences. B. Construction scheme of pAcRHKAl. The black region represents rat 
Η,Κ-ATPase cDNA, the white region represents pBR322 plasmid DNA of plasmid pRHKA3-3. The 
direction of transcription of the Η,Κ-ATPase cDNA is indicated by the arrow. Restriction sites: 
A=/lccI; B=flamHI; P=ftil; C=CiaI; E=£coRI; Bg=ßgni; Н=ЯівЛІІ; S=&el. 
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mutagenesis reaction was performed by first 
kinasing 200 pmol of the oligonucleotide with 
5 units of T4 polynucleotide kinase, and 5 
pmol of this was annealed to 0.1 pmol of 
uracil-containing, single-stranded M13mpl9-1.4 
at 100°C for 2 min. The solution was allowed 
to slowly cool to 30°C, and deoxynudeotides 
(to final concentration of 0.4 mM), 3 units T4 
DNA polymerase and 1 unit T4 DNA ligase 
were added. After 1.5 h at 37°C the reaction 
was stopped by the addition of a tenfold excess 
of icecold 1 mM EDTA in 10 mM Tris-HQ 
(pH 8.0). This reaction mixture was then used 
to transform the dut* and ung* Rcoli strain 
MVI190. Numerous plaques were picked and 
analysed for the absence of the BglU site. The 
double-stranded form of the mutant 
M13mpl9-1.4 bacteriophage was subsequently 
cesium chloride gradient purified and digested 
with BamHl endonuclease. Finally, the mutant 
1.4 kb Bamtil fragment was gel purified and 
ligated back into the parental, gel-purified 
Ba/nHI-digested pUCRHKAl to yield 
pUCRHKA2. 
Production of recombinant baculovims 
For the production of recombinant baculo-
virus, Sf9 cells were cotransfected with transfer 
vector pAcRHKAl (4 μg) and purified wild-
type AcNPV genomic DNA (2 μg) using a 
modification of the calcium phosphate 
co-precipitation method as described [13]. Six 
days later, virus was harvested from the culture 
medium. The recombinant viruses, called 
AcRHKAl, were detected by plaque assays [13] 
both visually and by staining with the B-galac-
tosidase substrate X-gal (25 μg per 35 mm 
tissue culture dish). Five rounds of plaque 
purification were performed to eliminate 
wild-type AcNPV. 
Western blot analysis of infected Sf9 cell proteins 
2x10* Sf9 cells were infected with either 
wild-type AcNPV or AcRHKAl at an multi­
plicity of infection of 10 plaque forming units 
per cell [13]. Two to four days post infection, 
infected Sf9 cells were dislodged from the 
wells, resuspended in the culture medium and 
microfuged for 1 min. The protease inhibitors 
phenyl methyl sulphonyl fluoride to final con­
centration of 1 mM, and leupeptine and apro-
tinine to 100 Mg/ml were added to the cell pel­
let resuspended in 40 μΐ deionized water. Fol­
lowing repeated freezing in liquid nitrogen and 
subsequent thawing at room temperature, 1 μΐ 
of a stock DNAse solution (5 mg/ml) was ad­
ded, whereafter the cell lysate was incubated 
for 15 min at room temperature. The whole 
sample of lysate was mixed with SDS sample 
buffer [23] to a final volume of 100 μΐ, homo­
genized by sonification for 30 s in a Branson 
sonicator bath, incubated at 3TC for 30 min 
and, finally, microfuged for 5 min. The super­
natant of the sample was analysed by SDS-
polyacrylamide gel electrophoresis [23]. 
Proteins separated on a 10% Polyacryl­
amide gel were transferred to nitrocellulose 
membranes by electroblotting for 1 h at 100 V 
[24]. After transfer the membranes were rinsed 
twice with deionized water, and incubated for 2 
h with blocking solution (PBS containing 1% 
(w/v) gelatin and 0.05% (v/v) Tween 20). Sub­
sequently, the membranes were incubated for 2 
h with either anti-gastric H,K-ATPase 
antiserum HK73 (described in Chapter 4) or 
with antiserum "565-585", elicited against 
amino acid residues 565 to 585 of the rat 
gastric Η,Κ-ATPase a-sububit (kindly provided 
by Dr. MJ. Caplan, Yale University School of 
Medicine, New Haven, CT, USA), and for 1 h 
with HRP-conjugated swine-anti-rabbit immu­
noglobulins. Finally the blots were stained with 
4-chloro-l-naphtol as chromogenic substrate 
for HRP. All incubations were performed at 
room temperature and each incubation step 
was followed by extensive washing with PBS 
containing 0.05% (v/v) Tween 20, except for 
the last washing step before staining, which was 
done with PBS. 
Immunofluorescence 
Sf9 cells were grown on coverslips and 
subsequently infected with AcRHKAl added to 
a multiplicity of infection of 10 plaque forming 
units per cell [13]. Infected Sf9 cells were 
recovered 2 days post infection, washed with 
PBS, and fixed with ethanol/acetone (1:1) for 
60 sec. After extensive washing with PBS the 
fixed cells were incubated for 1 h with the 
anti-gastric Η,Κ-ATPase antiserum HK73 
(described in Chapter 4) diluted 1:300 in PBS. 
Following several washes with PBS, the cells 
were incubated for 1 h with rhodamine-con-
jugated goat-anti-rabbit immunoglobulins 
diluted 1:25 in PBS. Finally, the cells were 
washed again with PBS and mounted in PBS-
buffered glycerol under a coverslip. For 
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Fig. 2. Restrictìoo map of the bacutovirus transía vector pAcRHKAl 
The abbreviations used are: php=polyhedrin promoter, RHKA=rat gastric НДС-ATPase catalytic 
subunit; SV40 tenn=simiaii vine 40 bidirectional terminator sequence; LacZ=E. coli B-galactosidase 
gene; t&p=bsp70 pramoter; Ac=AcNPV genomic DNA sequences. Restriction sites: Bg=Bg/II; 
E=£coRt B=BamHI; St=Stul; Sp=Sphl; Н=ЯітіШ; X=AbûL 
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Fig. 3. Nucleotide sequence at the end of the polyhedrin leader sequence in the transfer vector 
pAcRHKAl 
Underlining emphasizes both the BamHl cloning site, into which the Η,Κ-ATPase cDNA with the 
cohesive Bglll sites is inserted, and the additional flg/II linker. Double underlining highlights the ATG 
start codons and the stop codon of the first open reading frame. Numbering refers to positions from 
the transcription initiation site. Nucleotide 97 (C base) corresponds to the Clal recognition site 
(position 44 in the Η,Κ-ATPase cDNA) in Fig. 1. 
77 
fluorescence analysis the coverslips were 
examined with an Olympus BH-2 microscope. 
RESULTS AND DISCUSSION 
Construction of recombinant transfer vector 
pAcRHKAl 
In order to consinici transfer vector 
pAcRHKAl, full length cDNA encoding the 
rat gastric HJC-ATPase catalytic subunit [4] 
was initially subcloned into plasmid pUCIS by 
successive insertion of two different fragments, 
obtained from plasmids pRHKAl-8 and 
pRHKA3-3 [4], to yield plasmid pUCRHKAl 
(Fig. 1). Since there is apparently no unique 
restriction site close to the translation initia­
tion site of the catalytic subunit of gastric 
HJC-ATPase, however, a relatively large 
noncoding region of 163 nucleotides (the Cla\ 
site is at position 44 whereas the translation 
initiation site is at position 207 of plasmid 
pRHKAl-8) was also subcloned into plasmid 
pUCIS. Following modification of the BgH\ 
recognition site at position 2922, plasmid 
pUCRHKA2 was obtained, which was subse­
quently digested with Hindin and Seal endo-
nudeases to release the 3.4 kb НДС-ATPase 
cDNA insert Using Bg/II linkers, this 3.4 kb 
cDNA fragment was finally inserted into the 
unique BanxHl cloning site of transfer vector 
pAcDZl to give recombinant transfer vector 
pAcRHKAl. Recombinant transfer vector con­
taining a single copy of the rat НДС-ATPase 
catalytic subunit cDÑA in the correct orienta-
tion was identified by restriction mapping (not 
shown). However, digestion of transfer vector 
pAcRHKAl with Bgñl endonuclease did 
release the 3.4 kb Η,Κ-ATPase cDNA insert, 
indicating that digestion of the linkers with 
Bgñl endonuclease had been incomplete and 
that therefore at least two BglW linkers are 
both 5' and 3' to the НДС-ATPase cDNA 
insert. 
The transfer vector pAcRHKAl obtained 
(Fig. 2) has the following characteristics: (i) 
the polyhedrin promoter drives the transcrip­
tion of the rat Η,Κ-ATPase catalytic subunit 
cDNA; (ii) the DrosophUa melanogaster heat 
shock promoter (hsp70) drives the constitutive 
expression of the LacZ gene; (iii) transcripts of 
both polyhedrin and hsp70 promoter will be 
polyadenylated on opposite strands by the sig­
nals present in the SV40 termination sequence. 
The nucleotide sequence at the end of the 
polyhedrin leader sequence in the transfer 
vector pAcRHKAl is shown in Fig. 3. The 
transfer vector pAcRHKAl contains the com­
plete polyhedrin promoter sequence of transfer 
vector pAcRP23 [25]. The latter carries a dele­
tion of 170 nucleotides (+1 •* +170, the A 
base of the ATG start codon is +1) of the 
polyhedrin gene, resulting in an unique BamHl 
cloning site at the end of the polyhedrin leader 
sequence. Following the Bgñl linker sequence 
and part of the pUCIS polylinker (from the 
Wmdlll site to the Acci site), the transfer 
vector pAcRHKAl contains the leader se-
quence of the rat gastric Η,Κ-ATPase catalytic 
subunit of 163 nucleotides. In this leader se­
quence there are eight ATG codons that lie 
in-frame with the ATG start codon in the 
pUCIS polylinker sequence and form part of a 
138-nucleotide open reading frame, terminating 
34 nucleotides upstream from the ATG start 
codon of the gastric Η,Κ-ATPase catalytic sub-
unit [4]. It has been experimentally demon­
strated, both in COS cells [26] and Sf9 cells 
[27], that reinitiation of translation by euka-
ryotic ribosomes can take place at secondary 
downstream ATG codons, provided that a ter­
mination codon in-frame with the first ATG 
start codon is upstream from the second ATG 
start codon. Therefore, it appeared to be pos­
sible that this construct would lead to expres­
sion of the gastric НДС-ATPase catalytic 
subuniL 
DNA analysis of recombinant AcRHKAl 
After co-transfection of Sf9 cells with 
transfer vector pAcRHKAl and wild-type 
AcNPV DNA, recombinant viruses, designated 
as AcRHKAl, were selected by visual inspec­
tion for polyhedron-negative plaques and by 
blue colouration. Following five rounds of 
plaque-purification, viral DNA was isolated 
and analysed by digestion with BamHl and 
Bgñl endonucleases, respectively (Fig. 4). The 
digestion pattern of the AcRHKAl DNA was 
compared with the equivalent endonuclease 
patterns of AcDZl DNA, obtained by recom-
bination of wild-type AcNPV DNA with trans-
fer vector pAcDZl. The АзтНІ and Bgñl 
digestion patterns showed that in comparison 
with AcDZl, an additional 1.4 kb BamHl frag-
ment (BamHl sites on the Η,Κ-ATPase cDNA 
are at position 1722 and 3092 [4]) and an addi­
tional 3.4 kb Bgñl fragment, respectively, 
appeared in recombinant AcRHKAl. This 
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Fig. 4. Restriction fragment analysis of recombinants AcDZl and AcRHKAl 
Lanes a: recombinant AcDZl. Lanes b: recombinant AcRHKAl. M: markeis; 16.6, 8.2, 5.3, 4.0, 2.6, 
1.9, 1.5, 1.2 and 0.8 kb. 
indicated that full length cDNA encoding the 
rat gastric Η,Κ-ATPase catalytic subunit was 
inserted into the AcNPV genome. 
Identification of proteins produced from infected 
SJ9 cells 
To confirm the identity of the proteins 
produced from recombinant AcRHKAl in­
fected Sf9 cells, immunoblots were done on 
protein extracts using anti-gastric Η,Κ-ATPase 
antiserum HK73 or antiserum "565-585". 
However, contrary to what had been expected 
there was, irrespective of the duration of the 
infection, no specific reaction with both anti­
serum HK73 and antiserum "565-585" (results 
not shown). Immunocytochemical analysis of 
Sf9 cells infected for 2 days with AcRHKAl 
with antiserum HK73 did also show no specific 
labelling of the cells (results not shown). Thus, 
these experiments suggest that reinitiation of 
the translation at the Η,Κ-ATPase start codon 
did not occur. 
In order to get expression of the rat gastric 
Η,Κ-ATPase catalytic subunit It is therefore 
necessary to eliminate the first open reading 
frame in the transfer vector pAcRHKAl (Fig. 
3). By using both the unique Sfi\ site 
(GGCCNNNN~NGGCC) at position 153 of 
the Η,Κ-ATPase cDNA and BgRl linkers, it 
has recently become possible in our laboratory 
to construct a transfer vector with a 5' 
noncoding sequence of 121 nucleotides. 
Recombinant AcNPV virus derived from this 
transfer vector showed abundant expression of 
the catalytic subunit of rat gastric Η,Κ-ATPase. 
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Introduction 
Gastric Η,Κ-ATPase forms the final link in 
the process of gastric acid secretion. This 
P-type ATPase with structural and functional 
similarities to Na,K-ATPase and Ca-ATPase 
translocates protons across the apical mem­
brane of parietal cells in exchange for ΚΛ 
Since the first report on gastric Η,Κ-ATPase in 
1973 by Ganser and Forte much information 
has been obtained on the mechanism of action 
of this proton pump. Especially highly purified 
vesicular Η,Κ-ATPase preparations oriented 
for 90% to 95% with their cytoplasmic side 
facing outwards and obtained from the porcine 
gastric mucosa, have been the preparations of 
choice in mechanistic studies on the identifi­
cation of sides for binding of nucleotides, 
cations and specific inhibitors. Limited struc­
tural information on gastric НДС-ATPase, like 
the molecular organization, conformations and 
essential amino acid residues, has been gained 
by radiation inactivation, crosslinking analysis, 
fluorescent probes, limited tryptic digestion 
and specific chemical modification. Ciystallo-
graphic data, however, that would lead to the 
construction of a model of the overall structure 
of gastric НДС-ATPase with rather high resolu­
tion are still not available. 
A wealth of structural information on 
gastric НДС-ATPase has brought the cloning of 
the cDNAs of the catalytic о-subunit (1986) 
and the heavily glycosylated B-subunit (1990). 
On basis of hydropathy analysis of the deduced 
amino add sequence a secondary structure of 
the a-subunit was proposed that traverses the 
membrane eight to ten times. Confirmation of 
the proposed secondary structure depends on 
the localization of specific probes of the 
enzyme to either cytoplasmic or luminal sides 
of the membrane. 
Therefore the main purpose of this study 
was to prepare monoclonal antibodies and 
polyclonal antisera against porcine gastric 
Η,Κ-ATPase. Antibodies directed against 
Η,Κ-ATPase, and which even specifically 
modify a particular reaction step of the 
enzyme, might provide clues answering ques­
tions about the actual folding of the subunits 
through the membrane, the location of 
functionally important domains and spatial 
relationships between different regions of the 
primary structures. An approach that has the 
potential to provide much structural and 
mechanistic information on gastric 
НДС-ATPase is the heterologous expression of 
the enzyme. For this purpose we used the 
baculovirus expression system, in which several 
other functionally active membrane proteins 
have been expressed. 
Inhibitory mechanism of anti-HJC-ATPase 
monoclonal antibodies 
By using a highly purified porcine gastric 
Η,Κ-ATPase preparation as antigen, we were 
able to produce several stable monoclonal 
hybridoma cell lines secreting antibodies 
directed against the catalytic subunit of the 
enzyme. Three of the monoclonal antibodies, 
named 5-B6, 4-D10 and 1-F11, inhibited the 
K'-ATPase activity of the enzyme, whereas 
they did neither inhibit the K*-p-nitrophenyl-
phosphatase activity nor the Mg2*-ATPase 
activity (Chapters 2 and 4). Since only antibody 
5-B6 bound to the catalytic a-subunit in the 
Western blot assay, which should make subse­
quent determination op the epitope possible 
(Chapter 3), the mechanism of inhibition of 
this antibody was elucidated first (Chapter 2). 
The monoclonal antibody 5-B6 inhibited 
the K*-ATPase activity in a concentration 
dependent way. The maximal extent of inhibi­
tion was pH-dependent and was maximal 
(100%) at pH 8.0. Lineweaver-Burk plots 
showed that inhibition of the K*-ATPase acti­
vity by antibody 5-B6 at pH 7.0 was noncom­
petitive with respect to ATP and uncompetitive 
with respect to K*. Since the stimulation of the 
ATP hydrolysis by K* is mediated through an 
increase of the dephosphorylation rate of Ej-P, 
the phosphoenzyme form that has a high affi­
nity for K+ at the luminal side, it was suggested 
that antibody 5-B6 bound either to the E^K* 
form or to the Ε,·Κ* form (or to a form 
which is intermediate between them). In this 
interpretation E, and E, represented confor­
mational states of the enzyme with cation 
binding sites facing the cytosolic and luminal 
side, respectively. Additional experiments 
concerning the effect of antibody 5-B6 on the 
steady-state phosphorylation level, the 
K*-stimulated dephosphorylation rate and the 
sidedness of the inhibition of the K*-ATPase 
activity, finally demonstrated that antibody 
5-B6 recognized the Ε, ·Κ* form of gastric 
НДС-ATPase at the cytosolic side. This means 
that the mechanism of inhibition of antibody 
5-B6 can be interpreted as inhibition of a step 
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in the consecutive reaction scheme of gastric 
Η,Κ-ATPase necessary for the release of K* at 
the cytoplasmic side. 
Although the inhibitory monclonal anti­
bodies 1-F11 and 4-D10, contrary to antibody 
5-B6, did not bind to the catalytic α-subunit in 
the Western blot assay, their mechanism of 
inhibition of gastric Η,Κ-ATPase showed to be 
indistinguishable from the mechanism of Inhi­
bition of antibody 5-B6 (Chapter 4). This was 
an indication that antibody 1-F11 and 4-D10 
also recognized the catalytic α-subunit. The 
different reactivities of the inhibitory mono­
clonal antibodies in the Western blot assay, 
however, already indicated that different 
epitopes were recognized by 5-B6 on the one 
side and 1-F11 and 4-D10 on the other side. 
Evidence for the existence of the different anti­
genic sites on the catalytic α-subunit was finally 
provided by experiments studying the effect of 
combinations of the antibodies on the K'-AT-
Pase activity of gastric Η,Κ-ATPase and by 
competitive ELISA experiments. Subsequent 
comparison of the mechanism of inhibition 
between the antibodies S-B6, 4-D10 and 1-F11 
and several other reported inhibitory anti-
Η,Κ-ATPase and anti-Na^C-ATPase mono­
clonal antibodies indicated that there is 
probably a common mechanism of inhibition of 
these P-type ATPases by monoclonal anti­
bodies. In case an antibody binds to a cyto­
plasmic epitope on the catalytic α-subunit and 
this amino acid sequence is involved in confor­
mational transitions, an E, conformation of the 
enzyme is stabilized. On the other hand, 
binding of an antibody to an extracellular 
epitope on the catalytic α-subunit, which moves 
upon conformational transitions, results in a 
stabilization of an £2 conformational state. 
This idea of the inhibitory mechanism of 
anti-P-type ATPase monoclonal antibodies has 
also arisen recently for the specific inhibitors 
of Η,Κ-ATPase and NaJC-ATPase, i.e. the K+-
competitive inhibitor SCH 28080 and ouabain, 
respectively. Inhibition of the enzymes by their 
respective inhibitors is antagonized by K*, 
binding is to the extracellular side, and the 
inhibitory mechanism involves the stabilization 
of the Ез-Р conformation. The binding site (or 
a part of the binding site) of both SCH 28080 
and ouabain was shown to be located in the 
extracellular region between the first putative 
transmembrane segments Ml and M2 (Chapter 
1, Fig. 1) of the respective enzymes [Munson et 
al. (1991) J. BioL Chem. 266, 18976; Price and 
Lingrel (1988) Biochemistry 27, 8400]. It was 
suggested that upon binding of ouabain the 
M1/M2 loop of Na,K-ATPase moves into a 
more hydrophobic environment, thereby stabi­
lizing inhibitor binding. Evidence for such 
motion of the M1/M2 loop of gastric 
Η,Κ-ATPase has been obtained recently by 
using a K* and SCH 28080-competitive fluo­
rescent hydroxyquinoline derivative that also 
binds to the extracellular side of the enzyme 
[Rabon et al. (1991) J. Biol. Chem. 266, 
12395]. With this inhibitor it was shown by 
changes in spectrum and quantum yield that 
the environment of the bound inhibitor 
increased in hydrophobic character upon phos­
phorylation of the enzyme, I.e. upon reaching 
the Ej-P conformational state. 
Transmembranous organization of the catalytic 
a-subunit of gastric ЦК-ATPase 
The binding of the inhibitory monoclonal 
antibody S-B6 to the catalytic subunit of gastric 
Η,Κ-ATPase in the Western blot assay made it 
possible to determine the cytoplasmic epitope 
(Chapter 3). This was done by identification of 
immunoreactive fragments of the α-subunit 
that were obtained either by limited tryptic or 
papain digestion. Upon specific chemical 
cleavage at Asp-Pro bonds of a 27 kDa immu­
noreactive fragment there was a loss of immu-
noreactivity of the obtained fragments of 17 
and 11 kDa. This indicated that the epitope for 
antibody S-B6 was very likely localized around 
the chemical cleavage site. Comparison of the 
primary structure of the a-subunits of gastric 
Η,Κ-ATPase and non-immunoreactive rat 
kidney Na,K-ATPase then showed that there 
was almost no similarity for the sequence from 
amino acid residue 504 to 512, containing two 
Asp-Pro bonds. Thus, these findings strongly 
suggested that the cytoplasmic epitope for 
antibody 5-B6 comprised this sequence, thereby 
supporting the previously proposed large cyto­
plasmic loop between transmembrane segments 
M4 and MS of the α-subunit predicted by 
hydropathy analysis (Chapter 1, Fig. 1). 
Selective tryptic cleavage of gastric 
ЩС-ATPase 
In order to identify immunoreactive 
proteolytic-digest fragments of the catalytic 
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subunit of gastric Η,Κ-ATPase it was necessary 
to know the selective proteolytic digestion 
sites. The tiyptic-cleavage sites exposed in the 
presence of K* (E2 conformation) were demon­
strated to be at Arg455, in the presence of ATP 
(E, conformation) at Lys47 and probably at 
Lys"8. The latter site was assigned on theore­
tical grounds. Tryptic cleavage at these sites 
under the respective conditions resulted in 
fragments with apparent masses of either 42 
and 56 kDa, or 67 and 35 kDa. Recently, it has 
also been demonstrated by Munson et al. [J. 
Biol. Chem. (1991) 266, 18976] that in the 
presence of ATP there is selective tryptic 
cleavage at Lys47. The other tryptic-cleavage 
site was reported to be at Arg*71. In this case, 
however, it could be possible that a secondary 
tryptic cleavage has occurred, splitting off three 
amino acid residues of the 35 kDa tryptic-
digest fragment microsequenced. 
The more precise identification of specific 
tryptic cleavage sites made it possible to cor­
relate the time courses of the biphasic inacti-
vation of the K* -ATPase activity, which had 
been observed in our laboratory during tryptic 
digestion in the presence of both K* and ATP 
[Helmich-De Jong et al. (1987) Biochim. 
Biophys. Acta 905, 358], with the appearance 
of well-defined peptide fragments on SDS Poly­
acrylamide gels. During the initial rapid phase 
of tryptic inactivation of the K*-ATPase acti­
vity, neither the K+-stimulated p-nitrophenyl-
phosphatase activity nor the phosphorylation 
capacity of the enzyme were inactivated. It was 
therefore concluded, that it is the interconver­
sion from Ε,Ρ to EjP that is interrupted during 
this rapid phase. 
Tryptic cleavage in the presence of ATP, at 
Lys47 and Lys"" could explain the observation 
that the K*-ATPase activity is inhibited in a 
biphasical manner. Since the time course of 
formation of the 35 and 67 kDa fragments cor­
responded with the rate of the slow phase of 
inactivation of the K*-ATPase activity it could 
be concluded that tryptic cleavage at Lys"8 is 
responsible for the slow phase of inactivation 
of the K*-ATPase activity, i.e. inactivation of 
phosphorylation capacity and K+-stimulated 
p-nitrophenylphosphatase activity. The initial 
rapid phase of inactivation of the K+-ATPase 
activity could be ascribed to cleavage at Lys47, 
causing an interruption of the interconversion 
from Ε,Ρ to EjP. 
Tiyptic digestion of Η,Κ-ATPase in the 
presence of K* also led to a biphasic inacti­
vation of the K* -ATPase activity which was 10 
to 20 times Caster than in the presence of ATP, 
although the locus of inactivation (the Ε,Ρ to 
EjP interconversion) was the same. Although 
inactivation was a biphasic process, only one 
tiyptic cleavage site at Arg455 was identified in 
the present study. Cleavage at this site resulted 
in a 42 kDa tryptic-digest fragment which con­
tained the Asp3* phosphorylation site, as well 
as a 56 kDa fragment. The rate constant for 
the formation of these fragments corresponded 
with the rate constant of the slow phase of 
inactivation of the K+-ATPase activity, i.e. 
inactivation of the phosphorylation capacity 
and the K*-stimulated p-nitrophenylphos-
phatase activity. In analogy with tryptic 
cleavage at Lys47 in the presence of ATP, we 
now suggest that the rapid phase of inactiva­
tion of the IC'-ATPase activity in the presence 
of K+ might be due to another tryptic cleavage 
site which interrupts the conformational 
transition from Ε,Ρ to E ^ and which has not 
been identified in this study. Since the sum of 
the molecular weights of the 56 and 42 kDa 
fragments is again the total molecular weight 
of the catalytic subunit, initial tiyptic cleavage 
should likewise result in release of a small 
fragment. As in the presence of ATP, such a 
putative tiyptic cleavage site is presumably also 
located in the N-terminal region. If this site 
would also be at Lys47, the greater sensitivity of 
this site to tiyptic cleavage in the presence of 
K* than to cleavage in the presence of ATP, 
suggests that this site, which is important for 
the conformational transition from Ε,Ρ to EjP, 
is more exposed to the cytoplasm in the E2 
than in the E, conformation of the enzyme. 
Phosphorylation capacity of gastric 
НДС-ATPase 
Although there are numerous structural 
and kinetic similarities between Η,Κ-ATPase 
and Na,K-ATPase, there was until recently one 
apparent stoichiometric difference concerning 
the staedy-state phosphorylation level of both 
enzymes. Whereas for NaJC-ATPase it had 
been established that each catalytic a-subunit 
can be phosphorylated at the same time, the 
maximal phosphorylation level found for 
Η,Κ-ATPase was 1.5-2.3 nmol per mg protein, 
corresponding with 0.35 mol/mol catalytic 
a-subunit. In the study on the effects of free 
fatty acids and detergents (Chapter 5) on 
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gastric HJC-ATPase it was observed that 
limited concentrations of these compounds 
could increase the steady-state phosphotylatkm 
level of the enzyme, indicating the presence of 
additional rightside-out oriented vesicular 
structures in the Η,Κ-ATPase preparations. 
Subsequent analysis of the tightness and orien­
tation of different НДС-ATPase preparations 
then showed that in gastric membrane vesicles, 
treated by osmotic shock. It was possible to 
obtain ATP phosphoiylation levels above 0.5 
mol/mol catalytic a-subunit This suggests that 
in НДС-ATPase each a-subunit can be phos-
phoiylated at tbe same time. 
Penpectim 
The Immunological experiments described 
in this thesis demonstrated that the C-terminus 
of the НДС-ATPase α-subunlt is not veiy 
immunogenic. Therefore, to study the trans-
membranous organization of this part of the 
a-subunit it will be necessary to produce 
specific C-terminal peptkle-antibodies. 
Many studies on the mechanism of gastric 
НДС-ATPase have led to the reaction scheme 
of Fig. 2 in Chapter 1. However, much more 
information is required to settle the questions 
about a possible variable coupling in the ion 
transport process, a putative regulation of 
Η,Κ-ATPase by other cations like Na* and 
Mg1* and the minimal structure required for 
transport activity. Part of the ausweis to these 
questions will be given by comparative studies 
of НДС-ATPase and other P-type ATPases, a 
strategy which has already been successfully ap­
plied on the stniaural field of the НДС-ATPase 
a-subunit and which may also be veiy fruitful 
for the recently identified НДС-ATPase 
0-subuniL Also by sequence comparisons with 
other related ATPases important structural 
features of НДС-ATPase may be identified. 
A veiy promising approach for unraveling 
structural and functional problems will be the 
DI vitro expression of НДС-ATPase, with which, 
as described in Chapter 6, a start has been 
made. In such an expression system the basic 
structure for transport could be established. 
Moreover, site-directed mutations to single 
amino add residues may contribute to elud-
datlon of the cation-binding sites, for which 
fiist indications are given by the fC'-com-
petitive inhibitor SCH 28080. With the enzyme 
expressed In an in vitro system. It is also 
possible to study the function of the B-subunit 
and spedfic domains of the a-subunit by 
making deletion mutants. In addition in such a 
system It might be possible to study the 
properties of chimen of NaJC-ATPase and 
Η,Κ-ATPase, two veiy similar enzymes with 
different function and membrane localization. 
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Het HJC-ATPase, of de protonenpomp, is 
een complex membraangebonden enzym dat 
voor de maagzuursecretie verantwoordelijk is. 
Deze pomp, die alleen voorkomt in de apicale 
plasmamembraan van parietale cel van de 
maag, gebruikt de energie die vrijkomt bij de 
splitsing van ATP in ADP en anorganisch fos­
faat voor een actief countertransport van pro­
tonen naar het maaglumen toe en van kalium-
ionen de cel in. Dit geschiedt middels een op­
eenvolgende fosforylering en defosforylering 
van de katalytische subeenheid, hetgeen 
gepaard gaat met veranderingen van affiniteiten 
van het HJC-ATPase voor de te transporteren 
ionen. 
Het H.K-ATPase bestaat uit een kataly­
tische a-subeenheid van 114 kDa en een 
complex geglycosyleerde S-subeenheid van 33 
kDa (60-80 kDa bij volledige glycosylering). 
Met de klonering van de a-subeenheid in 1986 
en de B-subeenheid in 1990 is er een enorm 
potentieel aan structurele informatie over het 
Η,Κ-ATPase beschikbaar gekomen. Door in 
eerste instantie een hydrofobiciteits analyse uit 
te voeren op de afgeleide aminozuursequeniies 
van de o- en S-subeenheid heeft men getracht 
de topologie, d.w.z de wijze van vouwing van 
deze subeenheden door de plasmamembraan te 
bepalen. Een definitiever antwoord op de vraag 
hoe de transmembraan-organisatie van de α- en 
de β-subeenheid is, kan echter worden gegeven 
wanneer men, hetzij specifieke plaatsen op het 
eiwit kan identificeren die gevoelig zijn voor 
chemische modificaties, hetzij specifieke antili-
chaam-binding$plaatsen kan lokaliseren. 
Het hoofddoel van het in dit proefschrift be­
schreven onderzoek was dan ook de topologie 
van de katalytische a-subeenheid (de B-subeen­
heid was aanvankelijk nog niet bekend) met 
behulp van monoclonale antilichamen te bestu­
deren. Daarnaast stond het onderzoek naar 
enkele aspecten van het werkingsmechanisme 
van het HJC-ATPase centraal. 
In Hoofdstuk 1 wordt een overzicht gege­
ven van de structurele en functionele 
eigenschappen van het HJC-ATase. Als gevolg 
van de recente ontdekking dat een complex 
geglycosyleerde 8-subeenheid deel uitmaakt van 
het HJC-ATPase, vormen met name de struc­
turele aspecten van het enzym een zwaartepunt 
in dit hoofdstuk. 
Hoofdstuk 2 beschrijft een monodonaal 
antilichaam dat is opgewekt tegen het natleve 
HJC-ATPase en dat een bindingsplaats op de 
a-subeenheid blijkt te hebben. Dit antilichaam 
remt enerzijds de enzymactiviteit, maar ver­
hoogt anderzijds de affiniteit voor kallum-
ionen. Een analyse van het remmings-
mechanisme toont aan dat het antilichaam bij 
voorkeur een interactie met het enzym aangaat, 
wanneer dit zich in een speciale conformatie 
bevindt 
In Hoofdstuk 3 wordt vervolgens met 
behulp van een combinatie van selectieve 
proteolytische digestie en chemische klieving 
van de a-subeenheid de bindingsplaats van het 
remmende monoclonale antilichaam bepaald. 
Deze blijkt aan de cytoplasmatische zijde van 
hel enzym de sequentie van aminozuur 504 tot 
en met 312 te omvatten. Voor deze analyse was 
het noodzakelijk de amlno-terminale amino­
zuursequenties van verschillende specifieke 
proteolytische fragmenten van de a-subeenheid 
te bepalen. Deze bepalingen stelden ons 
zodoende bovendien in staat om een correlatie 
te leggen tussen het tijdsverloop van ontstaan 
van tryptische fragmenten van de a-subeenheid 
en de eerder in ons laboratorium gevonden 
door tiypsine veroorzaakte bifasische inacti-
vering van de kalium-gestimuleerde ATPase-
activiteit van het HJC-ATPase. 
Hoofdstuk 4 beschrijft de eigenschappen 
van twee polyclonale antisera en vijf andere 
monoclonale antilichamen die opgewekt zijn 
tegen het natieve Η,Κ-ATPase. Immunoblot-
analyses laten zien dat de polyclonale antisera 
zowel de α- als ook de B-subeenheid herken­
nen, waarbij opvallend is dat het carboxy-ter-
minale gedeelte van de a-subeenheid weinig 
immunogeen is. Twee van de monoclonale 
antilichamen, die echter niet in de immuno-
blotassay binden, blijken dezelfde remmende 
werking op het Η,Κ-ATPase te hebben als het 
antilichaam dat in Hoofdstuk 2 beschreven is. 
Competitieve ELISA's laten tenslotte zien dat 
deze twee antilichamen een gemeenschappe­
lijke epitoop hebben, die verschilt van de epi-
toop die geïdentificeerd is in Hoofdstuk 3. 
In Hoofdstuk S worden de effecten van 
vrije vetzuren op de H,K-ATPase-activiteit 
onderzocht en vergeleken met die van deter-
gentia. Vrije vetzuren blijken het enzym, even-
als het NaJC-ATPase, reversibel te remmen en 
de affiniteit voor kalium te verlagen. Daarnaast 
wordt een irreversibele inactivering van het 
HJC-ATPase gevonden, die waarschijnlijk het 
gevolg is van effecten op de lipide-eiwit inter-
88 
actie door vrije vetzuren. Bovendien wordt een 
methode beschreven om in Η,Κ-ATPase prepa­
raten de mate van geslotenheid en de orienta· 
tie te bepalen. Tevens blijkt het mogelijk voor 
dit enzym een zodanig fosfoiyleringsniveau te 
verkrijgen, dat hieruit geconcludeerd kan wor­
den dat iedere a-subeenheid gefosfoiyleerd kan 
worden. 
Hoofdstak б beschrijft de eente resultaten 
van de in vitro expressie van de katalytische 
a-subeenheid van het HJC-ATPase in het ba-
culovirus-expressiesysteem. De bedoeling van 
dit project is het Η,Κ-ATPase in aaieve vorm 
te synthetiseren, waarna door site-directed 
mutagenesis de rol van essentiële aminozuren 
zal worden onderzocht. 
Het laatste hoofdstuk tenslotte geeft een 
algemene beschouwing over de in dit proef· 
schrift weergegeven resultaten. 
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bij de vakgroep Biochemie (Faculteit der Medische Wetenschappen) van de Katho­
lieke Universiteit te Nijmegen. Gedurende deze periode werd onder leiding van Prof. 
Dr. JJ.H.H.M. De Pont het in het proefschrift beschreven onderzoek verricht. In het 
kader van zijn opleidings/begeleidingsplan werd in mei 1989 aan het J.A. Cohen 
Instituut te Leiden het examen Stralingsdeskundigheid-niveau 3 behaald. Tijdens zijn 
promotieonderzoek was hij betrokken bij het onderwijs aan studenten Geneeskunde 
en Gezondheidswetenschappen en heeft hij twee doctoraalstudentes Scheikunde, twee 
H.B.O.- en één M.B.O.-stagiair begeleid. 
In 1988 trouwde hij met Martina Lottermoser; ze hebben twee kinderen, Tim 
(1988) en Jan (1991). 
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